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Abstract
This thesis focuses on the development of a contraceptive decision-analysis tool 
(My Way) for young people and exploratory research to examine its application in a 
clinical setting. Decision analysis is essentially a method for breaking down complex 
problems or questions into manageable components, and then combining them 
quantitatively and logically to show the best course of action. The rationale for this work 
is that taking young people’s current lifestyles and values into account when selecting 
and initiating a contraceptive method will increase user effectiveness and acceptability 
of the method, which will ultimately lead to a reduction in unplanned pregnancies and 
other negative outcomes, such as acquisition of sexually transmitted infections (STIs).
My Way works by combining the best available scientific evidence on the outcomes and 
effectiveness of available contraceptive options, such as probability of pregnancy 
while on the pill, with quantitative assessments of the user’s own preferences and 
values, such as how they feel about the consequences of pregnancy. The under-lying 
decision-analysis model provides a ranking and rating of the various available options 
for each user, based on both scientific evidence and their own personal values. Best 
available evidence on each contraceptive method was collected on the following 
attributes (i.e. characteristics):
■ effectiveness in preventing pregnancy,
■ risk of STI acquisition,
■ other outcomes and factors affecting attractiveness including possible side effects 
(e.g. weight gain) and ‘bother’ considerations (e.g. having to go to a health service 
to obtain a contraceptive method).
For the pilot study young people (10 men and 15 women) aged 13-21 years were to be 
introduced to the program during their consultation with the contraceptive nurse or 
doctor in a young people’s sexual health clinic. The aim of the pilot was to assess the 
feasibility, acceptability and potential effectiveness of the My Way program.
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Chapter 1. Background and overview
1.1. Introduction
My interest in young people’s contraceptive decision making first developed after 
conducting an assessment of young people’s contraceptive needs, with an evaluation of 
sexual health service provision in two London local authorities in 2000.(1) Part of this 
work involved observing consultations with health care workers and conducting in- 
depth interviews with young people. One key finding was that the context of young 
people’s contraceptive use and factors that influence their choices were often not 
explored at the time they were seeking contraceptive supplies. One interview that made 
a great impression on me was with a young woman who had been prescribed the oral 
contraceptive pill. This was a method that most of her friends were using and she 
found the method acceptable. Over the course of the interview she explained that she 
did not want her parents to know that she was sexually active, and therefore did not 
keep her pills at home. Her boyfriend kept her pills and they generally met two or three 
times a week, when she would take her pills. She had no idea that she was putting 
herself at risk of pregnancy.
These findings led to discussions with my supervisor (Dr. Frances Cowan) about the 
appropriateness of using decision analysis to help young people understand their 
contraceptive choices. The rationale was that if young people’s current lifestyles and 
values were taken into account when selecting and initiating a contraceptive method, 
user effectiveness and acceptability of the method would increase. This thesis focuses 
on the development of a contraceptive decision-analysis tool for young people and 
exploratory research to examine its application in a clinical setting.
The objectives of this introductory chapter are:
• to describe the sexual health of young people in the United Kingdom (UK)
• to examine young people’s contraceptive behaviour
• to summarise what we have learnt from behavioural interventions and policy 
programmes that aim to increase young people’s use of contraception
• to investigate the research literature to understand what we know about the 
factors that influence young people’s contraceptive decision-making
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1.2. The sexual health of young people in the UK
The sexual and reproductive health of young people living in the UK remains a public 
health concern. In response to the UK having the highest teenage pregnancy rate in 
Western Europe and a desire to tackle social exclusion related to teenage pregnancy 
the Teenage Pregnancy Strategy was launched in 1999.(2) In 1998, there were 46.6 
pregnancies per 1000 young women aged 15-17 years. By 2004, this rate had declined 
to 41.5 per 1000 young women.(3) Although this represents an annual decline of 2% 
since the introduction of the Strategy, the decline is below that needed to meet the 
government’s target of a 50% reduction by 2010.(4) Concerns about the high rates of 
sexually transmitted infections (STIs) amongst young people led to them being 
identified as a target group in the National Strategy for Sexual Health and HIV.(5) The 
diagnosis of STIs amongst young people, particularly chlamydial infection, is 
rising.(6) In 2006, young women aged 16-24 years accounted for 74% of all 
chlamydial infection and 70% of all gonorrhoea diagnoses identified in females 
attending genitourinary medicine (GUM) clinics. Young men aged 16-24 years 
contributed to 56% of chlamydial infection and 39% of gonorrhoea diagnosed amongst 
male attendees.
Young people who commence sexual activity at an early age and those with multiple 
partners put themselves at risk of poor sexual health. Data from the second National 
Survey of Sexual Attitudes and Lifestyles (Natsal 2000) show that the median age at 
first sexual intercourse for both men and women is 16 years.(7) Twenty-six percent of 
young women and 30% of young men aged 16-19 years report first sexual intercourse 
before the age of 16 years. The median age of first sexual intercourse has been fairly 
stable over the last decade, but prior to this time a sharp decline in age at first 
intercourse was observed. For example, the median age at first intercourse for women 
bom in the 1930s was 21 years and for men was 20 years.(8) Stuart-Smith, in a BMJ 
editorial, argued that while age at first intercourse had decreased, the duration of 
adolescence in Western cultures had increased.(9) This phenomenon has led to a 
widening gap between sexual and social maturity. Wellings and colleagues looked at 
sexual competence at first intercourse amongst Natsal 2000 respondents.(7) Four 
criteria were used to measure sexual competence: regret, autonomy, willingness and 
contraceptive use at first intercourse. The data suggest greater sexual competence 
amongst young men in comparison to young women, 56% of young men aged 16-19 
years compared to 43% of young women the same age. Natsal 2000 also provides data
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on young people’s number of sexual partners. The median number of lifetime partners 
for men and women aged between 16-24 years is three; however 20% of men and 15% 
of women in this age group report 10 or more lifetime partners and similar proportions 
report concurrent sexual partnerships in the last year.(10)
Changes in sexual risk behaviour, which are consistent with the increases in STIs, can 
be explained by demographic shifts in the UK. For example, the gap between first 
sexual intercourse and first birth has widened, resulting in greater numbers of 
heterosexual partnerships in this period. The mean age at first birth for women bom in 
the late 1970s is projected to be over 29 years.(l 1) This represents an increase of over 
five years when compared to mean age of 23.8 years at first birth of women bom in the 
early 1940s. This rise is, in part, explained by greater uptake of education, particularly 
amongst women, and increased availability of effective contraception^ 12) However, 
despite the trend towards older age at first birth, under 18 year old pregnancy rates 
have remained fairly constant in recent decades. Teenage pregnancy does have 
negative social, economic and health consequences to both mother and child, as well as 
costs to the wider community.(13-17) Economic analyses have suggested that 
compared with use of no contraception, contraceptive methods of all types result in 
substantial cost savings, in both financial and health terms.(18) Improving young 
people’s access to and use of contraception is one way of reducing the consequences of 
unplanned pregnancy and other poor sexual health outcomes.
1.3. Contraceptive behaviour amongst young people
1.3.1. Contraceptive users and non-users
Contraceptive use is generally high amongst women in the UK.(19) Over half of all 
women aged 16-17 years are using at least one method of contraception. The majority 
of young people (over 90%) report using contraception, predominantly the condom, at 
first intercourse.(7)
Reasons sexually experienced women give for contraceptive non-use include that they 
are trying to get pregnant or are pregnant, they currently have no heterosexual partner, 
or they believe themselves to be infertile.(20) The Omnibus Survey (a national 
population survey carried out at regular intervals by the Office for National Statistics 
[ONS]) found that the reason the 43% of young women aged between 16-17 years who
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were not using contraception gave for their non-use was that they were not in a 
heterosexual relationship^ 19)
1.3,2. Use of different contraceptive methods
Table 1.1. shows that the male condom and the contraceptive pill are the methods most 
commonly used by young women. These data refer to all women, including those not 
yet sexually active. If the denominator includes only sexually active women, the 
prevalence of condom use is highest amongst 16-17 year olds. Condom users (both 
male and female) have been found to be significantly younger than non-users,(21) 
although those young people that report first sexual intercourse at 13 years or below 
are less likely to report condom use compared to those having first sexual intercourse 
at an older age.(22) Pill use peaks amongst women aged between 18 and 24 years. Use 
of long-acting reversible contraceptive (LARC) methods is low in the UK, despite the 
fact that these are very effective methods of pregnancy prevention.
Table 1.1. Current use of contraception by age (adapted from O’Sullivan et al, 
2005(19))
Women aged 16-49____________________________________________________ Great Britain:2004/05
Current use of contraception Age
16-17 18-19 20-24 25-29 30-34 35-39 40-44 45-49
% % % % % % % %
Pill1 39 55 47 41 31 15 13 5
Minipill 4 17 7 8 7 5 6 4
Combined pill 21 33 37 31 21 10 7 2
Male condom 33 38 33 31 22 14 14 15
Withdrawal - 3 2 4 7 4 4 4
Intrauterine device 2 - 2 4 3 5 6 5
Injection/implant
Safe period/rhythm method/
3 8 9 8 3 2 2 1
Persona - - 2 2 3 2 3 1
Cap/diaphragm 2 - - - 1 1 2 1
Hormonal intrauterine system - - 1 1 1 3 2 -
Female condom 1 - - - - - - 1
Emergency contraception 
Total using at least one
3 7 2 2 “ 1 “
method2 57 76 78 79 76 75 78 70
Notes:
1 Includes women who did not know the type of pill used
2 Includes surgical procedures and sterilisation
1.3.3. Contraceptive failure
Women can be ‘at risk’ of pregnancy for nearly 40 years, around half of their average 
lifespan.(23) Unfortunately, data on the proportion of conceptions leading to abortion 
amongst young people show they are putting themselves at disproportionate risk of
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‘unwanted’ pregnancy. The proportion of under 18 year-old conceptions leading to 
abortion is 45.6%, compared to 22.4% for all women.(24) The proportion of those 
opting for abortion peaks at 14 years, at 63.0% of all conceptions within this age 
group, and declines with age until 35 years, where it increases. Studies have suggested 
that half of young people become pregnant because they were not using any 
contraception.(25;26) If withdrawal and cycle awareness are included as contraceptive 
methods this proportion increases even more. The main reason that young people give 
for not using contraception is the belief that they cannot get pregnant. It has been 
shown that young women often inaccurately report fertile times of the month.(27) 
However, this still leaves a large proportion of young people who become pregnant 
whilst using contraception, predominantly the pill and condoms.(26) A paper by 
Churchill and colleagues examined the extent to which pregnant teenagers had utilised 
general practice prior to their pregnancy.(28) They examined 240 cases of women 
registered in their practice who had experienced a pregnancy before their 20th birthday. 
The majority of these women (93%) had consulted a health professional within the 
practice in the last year, 71% had discussed contraception with their general 
practitioner (GP) in the last year and half (50%) had been prescribed the pill. It 
therefore appears that health professionals are missing opportunities for discussing 
contraception with young women, but even when contraception has been addressed, 
information and the supply of contraception does not necessarily impact on behaviour.
The fact that an individual reports contraceptive use does not necessarily mean that
they are protecting themselves from pregnancy. Contraceptive failure is highest
amongst young women.(29;30) Young women are more likely to be sporadic
contraceptive users in comparison to older women.(31) Table 1.1. illustrates the
methods young people are most likely to use are the condom and the pill, methods
reliant on consistent and correct use. Qualitative interviews with 30 women aged 16-25
years on factors influencing use and non-use of emergency contraception showed how
some women felt less vulnerable to pregnancy and were less stringent in their
contraceptive use as they became established on a method.(27) The failure rate for the
pill at one-year is 0.3% if it has been used consistently and correctly (described as
method failure or perfect-use failure).(32;33) With typical use, which takes account of
user error, such as missed pills, this increases to 8% at one year of use. It has been
suggested that imperfect use of the pill can lead to failure rates of up to 30%.(34) A US
study which monitored 103 pill users aged 18 years and above over a three-month
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period, found nearly two-thirds reported missed pills and around half missed enough 
doses to put themselves at risk of pregnancy.(35;36) Users appear to be at greatest risk 
of pregnancy around the time when the method is initiated and just prior to 
discontinuation.(37) It has been reported that one in five women seeking an abortion 
had changed their contraceptive method in the last month.(25) Over half of women 
using the pill or injectables will discontinue these methods within one year of use.(38)
1.4. Does intervening work?
In recent decades, trends in teenage conception rates appear to have coincided with 
periods in which there have been numerous influences, both environmental and 
intervention-related, on teenage conception. Dramatic falls in the rate of under 18 
pregnancies were observed in the early to mid-1970s. This was a decade of extensive 
public health activity surrounding the issue of teenage sexual activity and fertility, 
including the greater availability of free contraception irrespective of marital 
status.(39;40) However, while rates in other Western European countries continued to 
decline, the momentum was not sustained in the UK.(41) The high rates in the UK 
have been attributed to deprivation and poverty, and widespread inequalities.(2) Yet it 
has been suggested that other factors more amenable to public health intervention may 
also contribute to the lower rates in other European countries, including a more 
positive attitude towards sex education and better access to sexual health services.(42) 
The Netherlands has seen an increase in its teenage pregnancy rates coinciding with 
some dismantling of sex education and sexual health services.(41) There is some 
evidence that young people compare unfavourably with peers from other Western 
European countries in terms of use of contraception at first sex and use at the last 
episode of intercourse.(43) There are grounds, therefore, for believing that 
interventions based on education and provision of services are likely to impact upon 
the prevalence of teenage pregnancy.
However, reviews of targeted behavioural interventions aiming to reduce poor sexual 
health outcomes amongst young people, including unplanned pregnancy, have made 
for some depressing reading.(44-47) There have been some benefits identified, such as 
increased knowledge about sexual health or positive evaluation, but interventions to 
date appear to have had little sustained impact on sexual behaviour, contraceptive use 
or rates of unintended pregnancy.
20
A criticism of both prevention programmes and the research literature is that although 
there may be the common aim in the reduction of both teenage pregnancy and STIs, 
they do not address the differences in young people’s risk perceptions or behaviours 
related to these outcomes.(48) So, for example, a couple in an established sexual 
relationship may decide to stop using condoms and use a more effective contraceptive 
method to protect against pregnancy, but this action may increase their risk of 
acquiring an STI. Some have even argued that greater provision of designated young 
people’s contraceptive services is associated with an increase in teenage STI rates 
because more young people will be sexually active.(49) There are also problems 
generalising such programmes and interventions across different populations; 
populations that are going to be defined by different demographic characteristics and 
cultural influences. Individual beliefs and values surrounding sexual health are varied. 
As discussed in greater detail in the following section, contraceptive use and adherence 
is influenced by a multitude of factors, including age, relationship status, attitude 
towards pregnancy, partner’s attitude, side effects, and choice of services.(50) 
Therefore, designing an intervention to change sexual behaviour without taking 
account of young people’s individual values is going to be challenging, at the very 
least.
1.5. Contraceptive decision-making
Studies conducted over the last decade illustrate that the factors influencing young 
people’s decision-making around the avoidance of pregnancy and the use of 
contraceptive methods are complex. Two broad themes emerge from examining the 
literature: values relating to sexual behaviour and pregnancy, and contraceptive 
method attributes.
1.5.1. Values
In the context of this work, values are defined as principles or standards that shape 
behaviour. These values can be influenced at both individual and external levels. The 
research evidence on how values can affect young people’s contraceptive decision­
making is outlined below.
Research suggests young people do make independent decisions on the contraceptive 
method of choice based on their individual circumstances and beliefs. One of the
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strongest factors that appears to be related to the contraceptive method of ‘choice’ is 
the type and stage of sexual relationships.(51-55) Condoms are more commonly used 
in casual relationships or in the early stages of subsequently more stable relationships. 
As a relationship progresses and frequency of sexual intercourse increases, condom 
use declines and use of other contraceptive methods, most commonly the pill, 
increases.(56;57) However, over the course of a relationship, consistency in method 
use declines. A number of reasons have been given as explanation for these shifts. 
Young people’s perceived risk of STI acquisition is lower with regular sexual partners 
than with casual partners.(53) It has been suggested that women stop using condoms to 
obtain more intimacy and greater trust with their partner.(58;59) Wanting to give 
sexual pleasure to your partner and avoidance of embarrassment and conflict, and thus 
maintaining the sexual relationship, are also reasons women have given for not using 
condoms with their regular partner.(27) Young women who describe relationships as 
‘romantic’ are less likely to report always using condoms compared to those who do 
not.(58) Young women are more likely to describe relationships as romantic in 
comparison to young men. For men, other individual characteristics not directly related 
to the sexual partnership, such as higher cognitive test scores and greater religiosity, 
and family influences are more associated with contraceptive use and consistency. 
Other relationship dynamics that have been found to positively influence contraceptive 
use include partner’s approval of contraception, communication about contraception 
prior to first sexual intercourse, previous sexual experience, and having a relationship 
with someone of similar age and level of education.(31;54;60-63)
Most young people report that they want to be a parent at some point, but those with 
specific educational and career aspirations usually wish to defer pregnancy until after 
these goals have been established and they have enjoyed the freedom of their youth. 
Free and colleagues found that women’s attitudes to risk were linked to their 
aspirations.(27) Women with higher aspirations were more risk adverse with respects 
to pregnancy and tended to choose the pill over the condom. Those disengaged from 
education are more likely to be at risk of pregnancy. For example, non-use of 
contraception is higher amongst those who are truant from school compared to those 
who are not.(45;64)
Contraceptive use is associated with having a positive sexual identity, responsibility,
and being ‘sensible’.(27) Young people with poor negotiation skills and lower
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emotional well-being are less likely to use contraception.(57;65;66) The extent to 
which other risk behaviours, such as alcohol use, have on contraceptive use is 
inconclusive.(67) A study of 4 255 French students aged 11-20 years selected 
randomly from 42 secondary schools found an association between smoking, alcohol 
and illicit drug use and sexually activity, but no association was found between these 
‘risks’ and contraceptive use.(68)
Cultural influences, such as ethnic background and religious beliefs, have been shown 
to have an influence on contraceptive behaviour. For example, in the UK contraceptive 
use amongst Black-Caribbean people is significantly lower than use amongst the 
general population.(69) Young Asian men and women are significantly more likely 
than non-Asians to report religious beliefs as the reason for their sexual abstinence.(70) 
Decisions around contraceptive use may be based on the individual’s own moral 
codes.(27) However, the extent to which young people feel attached to structures 
within their community, such as schools, ethnic groups and religious organisations, has 
been shown to influence their sexual risk-taking including contraceptive use.(65;69)
Contraceptive use amongst young people, as well as early initiation of sexual activity 
and teenage pregnancy, are directly associated with factors relating to family structure 
and dynamics.(45;64;65) For example, young people are more likely to use 
contraception when they report greater connection with their parents, there is greater 
family supervision and parents have a positive view of contraception. Contraceptive 
use is lower amongst young people of single-parent families and amongst young 
people from families with low levels of education and income.
Extra-familial circumstances also influence the values young people place on
contraceptive use. For example, employment and income levels at a community level
affect adolescent risk-taking, including contraceptive use.(65) Within communities
where the social costs of teenage pregnancy are perceived to be less, the young
person’s motivation or desire to use contraception may not be so great.(13) As well as
being influenced by the wider social norms within a community, young people’s
contraceptive use is influenced by peer norms. Relatively sexually inexperienced
young people tend to use what their friends are using.(54) Sheeran and colleagues
found that young people’s condom use was strongly influenced by believing their
friends and peer group were using condoms.(57) This association was even stronger
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than the influence of their partner’s attitude towards condoms and perceived social 
pressures. The lack of the subdermal implant’s popularity has in part been explained 
by the fact that it is not accepted and used by peers, and is viewed as a method used by 
‘other’ older women or ‘other’ younger women who are considered promiscuous.(71)
Change of social norms and greater awareness of STIs over the last decade years has 
coincided with an increase in overall condom use.(19) However, knowledge by itself 
may not be a marker for safer sex practices.(72;73) A Swedish study by Andersson- 
Ellstrom that followed up 16-year old women in a teen clinic for two years showed 
young women with more sexual partners had better knowledge, but were also more 
likely to have had unprotected sexual intercourse.(72) Nor does having knowledge 
always lead to young people seeking contraceptive advice and supplies when required. 
Sorensen and colleagues found that despite younger women having greater knowledge 
of emergency contraception, users of emergency contraception tended to be older.(74) 
In their study of 217 women aged 16-45 years seeking abortion in Denmark, they 
found that 64% had known of their pregnancy risk. Forty-two percent of this group had 
sufficient knowledge of emergency contraception, and of these only 15% had used it. 
However, ‘knowledge’ may not necessarily always have positive effects. For example, 
pregnancy rates have been shown to increase after media attention to pill scares.(8) 
Therefore how information is delivered and linked to appropriate support are going to 
affect contraceptive decisions.
The attitudes and behaviours of health care providers can also influence the 
contraceptive options young people are presented with.(54) Unfortunately, young 
people are often not presented with sufficient information to make choices and are not 
always confident enough to ask health professionals for further details.(75;76) Young 
women report less satisfaction with the amount of information received from health 
care workers in comparison to older women.(77) Young men receive even less 
information about contraception, and are far less likely to access sexual health services 
than women.(21) The fact that they perceive services to be female-orientated and not 
relevant to their needs are reasons given for not attending services
1.5.2. Attributes
An attribute is a characteristic or outcome of a contraceptive option. These can be 
desired characteristics or outcomes as well as undesired. Attributes can be broadly
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divided into three categories: 1) method effectiveness in preventing pregnancy, STIs or 
both; 2) side effects and health risk; and 3) situational factors.
The desired attributes of a contraceptive method will be influenced by young people’s 
values, including past experience and (correct or incorrect) knowledge. As described 
above, past experience may not only be influenced at the individual level, but also by 
the experiences of partners, peers and family.
Effectiveness
Free and colleagues have suggested young people’s perceptions of their vulnerability 
‘are partly socially mediated’.(27) It has been argued that health providers need to 
address young people’s perception of risk to pregnancy and STIs whilst taking account 
of current circumstances, such as relationship status.(21) A key factor in the decision 
to use contraception will be that the chosen method used is effective in preventing 
pregnancy. Yet, there appears to be very little literature of young people’s perception 
of the pregnancy risk for different contraceptive methods, and how this judgement 
affects their decision-making. Studies of young women’s use of emergency 
contraception illustrate that those who use the condom and experience problems, such 
as a condom split, are more likely to use emergency contraception than those who have 
had a pill ‘problem’, such as missed pills.(78;79) Pill problems are perceived to be 
lower risk. Past contraceptive failure has been shown to influence subsequent use of 
methods.(54) Women’s motivation to use contraception is greater than men’s as they 
are more affected by the consequences of pregnancy.(80) However, as discussed in 
Section 1.3.2., use of the more effective contraceptive methods (i.e. LARC) is low 
amongst young women in the UK. Young people may be willing to trade-off relatively 
less pregnancy protection offered by condoms and oral contraceptives in comparison to 
LARC for other attributes, such as convenience or not having to have an invasive 
procedure.
Perceived risk of chlamydial infection and gonorrhoea has been found to be low
amongst young people, even amongst those engaging in more high-risk behaviour.(81)
However, Sheeran and colleagues, in their meta-analysis of 121 studies to quantify the
correlation between psychosocial variables and self-reported condom use, found that
young people tended to over-estimate the risk of acquiring human immunodeficiency
virus (HIV) infection during unprotected sexual intercourse.(57) Interestingly they
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found that perceived susceptibility to HIV infection was only weakly correlated with 
condom use. Small associations were also found for condom use and greater concern 
or worry about HIV, and condom use and perceived efficacy of condoms in protecting 
against HIV infection.
Young people appear to use condoms more so for pregnancy prevention than for the 
prevention of STIs or HIV infection.(22;57) However, once young people’s perceived 
risk of STIs declines, the main driver in their choice of method is greater pregnancy 
prevention and hence the desire to move to a more effective contraceptive.(21) Most 
young people use only one contraceptive method, and once young people start using 
methods other than condoms, condom use declines. The more effective the other 
contraceptive method is in preventing pregnancy the less likely young people are to 
use condoms. Sayegh and colleagues conducted a prospective study of 176 14-17 year 
old women recruited from United States (US) adolescent clinics and found that 
condom non-use was higher amongst users of the Depot Medroxyprogesterone Acetate 
(DMPA) injection in comparison with users of oral contraceptives.(56)
Given that when used consistently and correctly the majority of contraceptive methods 
are highly effective in preventing pregnancy, other attributes often affect user 
satisfaction. Walsh comments that it is difficult “to value an outcome which is a non- 
event” (i.e. a hypothetical pregnancy).(77) Therefore individual experiences can focus 
on the negative, and choices are often made on which contraceptive method is the least 
worst option in terms of side effects and convenience.
1.5.3., Side effects and health risks
Concerns about side effects and health risks are a major cause for discontinuation, 
despite the risks of pregnancy being far greater than the risks associated with 
contraceptive use.(25;29;77;82;83) Qualitative research has found that women tend to 
over-estimate the risks of adverse side effects, while underestimating the effectiveness 
of hormonal contraception.(84) Concerns relating to weight gain, nausea and 
headaches with pill use are cited as the most common reasons for its discontinuation, 
while the most common reasons for discontinuation of implants and injectables are 
changes to bleeding pattems.(38;85)
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Socio-demograhic factors can affect how side effects and health risk are perceived. For 
example, some young women report that one of the benefits of the pill is menstrual 
regulation and the importance of having a regular menstrual cycle to know that they 
are not pregnant.(27;54) Therefore methods, such as implants and the hormonal 
intrauterine system (IUS), where there are higher chances of amenorrhoea, may be less 
acceptable to some younger women. The health risks associated with contraceptive use 
seem to become more important to women as they become older.(54)
Most women are ignorant of the non-contraceptive benefits associated with different 
methods, and it appears these benefits have little influence in decision-making. Bryden 
and Fletcher found that 40% of 215 female university students they interviewed 
thought pill users had an increased rather than decreased risk of ovarian cancer.(86) 
There was no notable difference between pill users and non-users who believed this.
1.5.4. Situational factors
Young people tend to use contraceptive methods they can obtain easily with minimal 
embarrassment. Condoms are popular because of their wide availability and the fact 
that they require little planning; this being particularly pertinent to casual 
relationships.(21;22) Although most young people are aware that condoms are freely 
available from sexual health clinics,(41) other factors, such as having to travel to a 
clinic, may outweigh this benefit. There is also the embarrassment of having to ask for 
condoms. Young men are significantly more likely than young women to report that 
contraception is expensive, is a hassle to use, involves too much planning and 
adversely affects sexual pleasure.(21) The main barriers to use of condoms, and other 
barrier methods, are the interrupted spontaneity of sex, reduced sexual pleasure and 
intimacy, and the difficulty in using them properly.(27;57;77) There is also concern 
that one’s partner will be offended by the suggestion of using a condom.
Young people have also described practical barriers to the use of other methods of
contraception.(75) A lack of routine can make correct pill use difficult. Home
environment, such as living with one’s parents, can present problems with storing
contraception. LARC methods overcome some of these barriers. Reasons women give
for choosing injectables and implants over the pill are because they do not have to
remember to take them each day and the LARC methods have a longer duration of
protection.(38) However, there are also situational factors that limit their uptake. One
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explanation for the low uptake of LARC is that the invasive procedures involved with 
these methods are a deterrent.(87) The lack of availability of these methods may also 
affect choice. For example, general practices, the main contraceptive provider in the 
UK, are less likely to provide a comprehensive range of contraceptive services and 
methods than community contraceptive services. An audit undertaken by the Teenage 
Pregnancy Unit found that while over 90% of general practices provided oral 
contraceptives and emergency contraception, less than a third provided implants.(88) It 
is generally easier for GPs to prescribe the pill in comparison to other contraceptive 
methods, as it is less time consuming, more financially rewarding and does not require 
any specialist family planning training. Designated young people’s services have been 
found to be less likely to provide a wide variety of contraceptive methods in 
comparison to mainstream contraceptive services.(89) Therefore, availability may also 
play a part in young people’s decision making. However, it has been argued that even 
young women who are established on the pill have problems returning to health 
services for repeat prescriptions, which puts them as risk of pregnancy.(90)
1.6. Need for interventions that address decision-making
There is the assumption that young people have contraceptive choices. However, 
personal factors that affect decision-making are often not explored when contraceptive 
advice and supplies are sought. Observations of consultations within sexual health 
services have shown that young people’s lifestyles and the context in which they use 
(or do not use) contraception are often not discussed.(75) Trussed argues in The 
Essentials o f Contraception; Efficacy, Safety and Personal Consideration that 
contraception is often perceived as a medicine and that the sexual aspects of 
contraception are sometimes ignored: “it’s a long way from the exam room to the 
bedroom”.(33) It should be the potential user who makes the decision on the best 
method for them based on the importance they attach to method effectiveness and 
other characteristics. Unfortunately, choice is not usually based on information on the 
entire range of methods available and attempts to categorise people’s contraceptive 
needs are often too simplistic.(51)
Research into contraceptive acceptability has been criticised because it has not looked
at the context of contraceptive use.(27;54;60;80) Contraceptive behaviour is often
defined as use and non-use. The use of cross-sectional surveys often means that
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information is gathered at a single point in time, for example, current contraceptive 
use, or for a particular event, such as whether contraception was used at first 
intercourse. This information does not provide a picture on patterns of method use over 
time.
Although there is much literature on young people’s sexual risk taking behaviour, 
there is little understanding of their perception of risk, and how this affects their 
contraceptive decision-making. Research into the weight young people place on 
contraceptive attributes, the relative trade-offs they make, either consciously or sub­
consciously, and how this is affected by socio-demographic characteristics is lacking. 
In addition, contraceptive use will be dependent on life circumstances and current 
values, which are certainly not constant. Teenagers are in transition from child to adult. 
Therefore comparing adolescent sexual health outcomes with those for older age 
groups is not necessarily useful.(30) Adolescence can be a time of conflicts, such as 
the moving away from accepting parents’ beliefs and values to norms more determined 
by peers, and major life events, such as puberty, exams and leaving home. The 
complex interplay between the individual and their current circumstances, 
contraceptive method attributes and external factors, such as availability of sexual 
health services, will contribute to the decision-making process. Again our knowledge 
of what influences individual decisions over time is limited. The same person may 
make different choices at different points in their life.
1.7. Aims of this work
The aims of this thesis are to describe the development of a tool (My Way) which uses 
decision-analysis to help young people understand their contraceptive choices and to 
conduct an exploratory pilot to investigate its feasibility, acceptability and potential 
effectiveness when used in clinical consultations with young people.
The application of the My Way program within a clinical setting fits the criteria for the 
development and evaluation of a “complex intervention”. The Medical Research 
Council (MRC) in their guidebook A Framework for Development o f RCTs for 
Complex Interventions to Improve Health Care, explain that complex interventions 
“are built up from a number of components, which may act independently and inter-
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dependency.”(p.2).(91) In relationship to sexual health, complex interventions can 
range from health promotion activities targeting individuals at risk of STI to the 
delivery and organisation of sexual health services across primary and secondary 
care.(92) The MRC describes five phases in the development and evaluation of 
complex interventions. Figure 1.1. provides the MRC’s schematic representation of 
these phases and the structure for my thesis.
Figure 1.1 Framework for the development and evaluation of complex 
interventions and illustration of thesis structure
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Source: Adapted from MRC Guidelines(91)
The initial phase is to identify the theoretical basis for the effects that would be 
expected from the intervention (Chapter 2). In this phase the population and context
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should be established (Chapters 1. and 3.). The modelling Phase I stage identifies the 
components of the intervention and the underlying mechanisms that influence 
outcomes (Chapter 4 to 6.). Phase II involves the development of the pilot study to 
inform the main Phase III randomised controlled trial (RCT) (Chapter 7.). Phase IV is 
the long-term implementation of the intervention and surveillance.
In this work I will:
■ examine the theory behind decision analysis and assess its potential application as 
a new approach in helping young people understand contraceptive choices 
(Chapter 2)
■ use national population-based survey data to investigate where young people go for 
contraceptive advice and supplies to help inform the appropriate setting for an 
intervention (Chapter 3)
■ describe the development of a computer-based intervention based on the principles 
of decision analysis, My Way, to be used by young people in consultations with 
health care professionals (Chapter 4)
■ determine the feasibility, acceptability and potential effectiveness of the My Way 
program when used in a designated young person’s sexual health clinic through a 
phase I pilot study (Chapter 5)
■ discuss the implications of the phase I study and explore further development and 
application of the intervention in light of the pilot findings (Chapter 6).
■ propose a phase II study of My Way's application in a school setting to inform a 
definitive RCT (Chapter 7.).
1.8. Key points
• Rates of pregnancy and STIs amongst young people living in the UK continue to 
be of public health concern.
• Young people’s use of contraceptive methods other than the pill and condom is 
low.
• Contraceptive failure is highest amongst young women.
• Targeted interventions aiming to reduce poor sexual health outcomes amongst 
young people have had little sustained impact on sexual behaviour, contraceptive 
use or rates of unintended pregnancy.
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• The values we place on sexual behaviour and pregnancy influence our 
contraceptive decision-making. These values are shaped by individual 
circumstances and social norms.
• The desired characteristics (or attributes) of contraceptive methods also affect our 
decision-making. These attributes include 1) method effectiveness in preventing 
pregnancy, STIs or both; 2) side effects and health risk and 3) situational factors.
• Health services often adopt a medical approach when delivering contraceptive care. 
Young people’s lifestyles and the context in which they use (or do not use) 
contraception are often not discussed in consultations.
• The aims of this thesis are to describe the development of a tool (My Way) which 
uses decision-analysis to help young people understand their contraceptive choices 
and to conduct an exploratory pilot to investigate its feasibility, acceptability and 
potential effectiveness when used in clinical consultations with young people.
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Chapter 2. Decision-making theory and decision aids: rationale for
My Way
2.1. Introduction
Decision-making is an activity we are all involved in each day; from the more 
mundane decisions around which toothpaste to purchase to the more exciting, where to 
go on holiday. Making the ‘wrong’ decision is highly unlikely to have life threatening 
consequences in either of these examples and the outcomes in both are likely to be 
fairly reversible. However, there are decisions we all face that have a greater impact or 
longer term consequences.
Decision theory is not a modem concept. An examination of the early decision 
theorists provides an understanding how the concept first developed and subsequently 
evolved. Bernstein in his history of risk, Against the Gods: The Remarkable Story o f  
Risk, identifies two key players in decision theory.(93) The first is the French 
mathematician Blaise Pascal. In the mid-seventeenth century Pascal argued that the 
value placed on an outcome and the likelihood that the outcome will occur will differ 
because the consequences of the two are not the same. He illustrated this argument by 
examining the consequences of believing God exists versus the consequences of 
believing God does not exist. The decision to be made is whether or not to lead a pious 
life. If an individual leads a pious life and God exists, Pascal argues there is the 
possibility of salvation. While if an individual leads a sinful life and God exists there is 
the risk of eternal damnation. If God does not exist, whether an individual lives a pious 
or sinful life is immaterial. Based on the value that salvation is a more preferable 
outcome than damnation, Pascal decides the best course of action is to lead your life 
assuming that God exists. Around 80 years on, the Swiss mathematician Daniel 
Bernoulli was to explore the relationship between measurement and gut feeling in 
terms of human behaviour. This was the first time the idea of utility of an outcome (or 
object), that is its usefulness, desirability or satisfaction, was formally recognised as 
determining worth rather than just its price (or probability of occurrence). Bernoulli 
assumed while individuals may have the same probability of an event happening, 
people value anticipated risk differently. Therefore, subjective considerations needed 
to be borne in mind when making decisions that have uncertain outcomes. The concept 
of utility did not penetrate other disciplines until it was “rediscovered” by the early 
philosopher-economists. This movement was started by the English philosopher
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Jeremy Bentham in the late eighteenth century.(94) Bentham maintained that what is 
good is pleasure and what is bad is pain. The goal of human action is to seek pleasure 
and avoid pain. Therefore the optimum state to be in is where there is a greater balance 
of pleasure (positive utility) over pain (negative utility).
Following on from the utilitarian philosophers, the research literature on decision­
making theory boomed, particularly within the economic and psychology disciplines. 
Over the last two decades, there has also been increasing interest in applying decision­
making theory to clinical decisions. The application of decision theory to health care 
and management, and the development of tools to help with decision-making has 
grown alongside the greater focus on evidence-based medicine, the adoption of a more 
consumer approach to healthcare and increased opportunities offered by advancements 
in technology. There are also more ‘treatment’ options available to people. This may 
not only make reaching a decision a more complicated process for the decision-maker, 
but may also have cost implications for the provider.(95)
The focus of this thesis is the development and application of a computer-based 
program that uses decision analysis to help young people with their contraceptive 
choices. The outcomes of interest were very much public health focused, that is if 
young people are using a contraceptive method that is acceptable to their needs (and 
values), consistent and correct use of contraceptive methods will increase. More 
effective use of contraception will result in a reduction of unplanned pregnancies and 
other negative sexual health outcomes, such as STIs. Therefore it is not my intention to 
provide a detailed review of decision theory. I use this chapter to provide a broad 
overview of the theoretical literature and how decision theory forms the basis of the 
intervention we developed. My objectives in this chapter are:
• to describe how we make decisions.
• to examine the role of decision-making in theoretical models of behaviour 
change, and to investigate how decision theory can be applied to contraceptive 
decision-making and interventions.
• to look at the role of decision aids in health care, and more specifically the role 
of decision analysis.
• to provide the rationale for the development of an intervention that uses 
decision analysis to help young people with their contraceptive choices.
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Terms associated with decision theory and decision analysis are defined as they are 
introduced in the chapter. A glossary of these terms is also provided below in Box 2.1.
Box 2.1. Decision analysis glossary box
Term Definition
Attribute A characteristic or outcome of a contraceptive option (e.g. the possibility of 
getting pregnant or experiencing a side effect when using a particular 
contraceptive method).
Rating The degree to which a contraceptive option possesses a specified attribute (e.g.
the need to visit a clinic to get a coil fitted) or the chance that an option will 
produce a specified outcome (e.g. the chance of getting pregnant on the pill). The 
rating of the option on each attribute must be a number in the range of 0 to 1. 
Weight The relative desirability or undesirability attached to an attribute or outcome. The
(or utility) weight given to each selected attribute must be a number in the range of 0 to 1.
Score (or A summary measure of how well an option performs in relation to the other
expected selected options, given the evidence reflected in the ratings of the options on the
utility) selected attributes, and the weightings of those attributes by the user. The score is
calculated by combining these ratings and weightings.
2.2. Decision-making theory
2.2.1. How do we make decisions?
The Oxford English dictionary defines a decision as “a conclusion or resolution 
reached after consideration”.(96) Decision-making is the process by which we weigh 
up the pros and cons of different choices available to us, and then decide which choice 
is the most attractive. This is not necessarily a conscious process. By definition an 
action that requires a decision to be made must have at least two possible courses of 
action and there is some degree of uncertainty.
Bekker and colleagues in their review of decision aids describe three broad decision­
making theories: 1) normative theory, 2) description theory, and 3) prescriptive 
theory.(97) Normative theory assumes that the decision-maker has all the information 
required to make a decision, including knowledge of all the alternative options, and is 
aware of their values and preferences with regard each of these options. The decision is 
rational and is based on the most benefits and the least costs to the decision-maker. 
This forms the basis of subjective expected utility (SEU) theory. Most psychological
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models of decision-making behaviour have the roots in SEU theory. In 1954, Ward 
Edwards wrote a seminal review drawing together the psychological and economic 
literature around decision-making.(98) In this paper he describes how in order to be 
rational the decision maker must first be able to weakly order preferences and second, 
choices must be made to maximise something, where there is some risk involved in the 
choice it is assumed to want to maximise expected utility. He explains that “expected 
value of a bet is found by multiplying the value of each possible outcome by its 
probability of occurrence and summing these products across all possible outcomes. In 
symbols:
EU= P \ $  1 + /? 2 $ 2 +  • • • -+ P n $ n
where p stands for probability, $ stands for the value of an outcome, and 
/? i+ /? 2+ . . . . . / ? n = l - ”  (p.391). The driver behind the economic theory of decision-making 
was to improve prediction of decisions, rather than to facilitate individual decision­
making.
The descriptive theory of decision-making describes the process of how people make 
decisions. Unlike normative theory, descriptive theory assumes that decision-making is 
a more ‘simplistic’ process and is rarely rational.(97) The American psychologist 
Valerie Reyna argues that rather than individual decision-making being a logical 
computation of information, where precision is seen as the ‘hallmark of good 
reasoning’, it is a qualitative process, which she refers to as ‘fuzzy-tracing’. She 
provides the example of how most people chose a definite win of $100, 000 over a 
gamble of a one-third chance of winning £300,000 (and a two-thirds chance of 
winning nothing).(99) This is based on the qualitative assessment that it is better to 
win something rather than nothing. It is not a decision based on the weighing up of 
probabilities, outcomes and expected values. Gist-based reasoning is valuable when 
data on the probability of an outcome are not known.
Finally, there is prescriptive theory, which believes that we are generally poor 
decision-makers, and we need assistance with our decision-making as heuristic ways 
of thinking can lead to misperceptions of risk and poor decisions.(97) With 
prescriptive theory, decision aids are developed and include individual user values and 
beliefs. These aids are described in more detail later in the chapter (section 2.5.4.)
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There are a number of reasons that can explain poor decision-making (and therefore 
illustrate the need for decision aids).
1. Lack of knowledge: People may have insufficient knowledge or information 
available to them to make an informed decision.(lOO) For example, it will be 
difficult for a potential contraceptive user to find out what the probability is of 
acquiring chlamydial infection when using condoms in comparison to when 
using the cap. It has also been argued that too much information can also 
confuse our decision-making.(97)
2. Failure to retrieve known information in context: Sometimes people need 
cues to help them retrieve knowledge or on how best to implement the 
knowledge they already have.(99)
3. Difficulties in estimating and interpreting levels of risk: In the main, people 
tend to be ‘optimistic’.(lOl) This is not just limited to patients or the general 
public. A US study that asked health professionals to estimate an adolescent 
girl’s risks after unprotected sexual intercourse found that the professionals 
tended to under-estimate the risk of pregnancy and infection compared to the 
evidence available from studies. They also tended to over-estimate the 
effectiveness of condoms.(99) Professionals with greater knowledge were more 
likely to give more accurate estimates. The authors argue that knowledge 
deficits are the simplest source of risk estimation errors. While we generally 
tend to under-estimate risk, small risks are often over-estimated (such as risk 
from terrorism or airplane crashes), because of denominator neglect. 
Presentation of risk also affects which course of action is more likely to 
taken.(lOl) For example, people tend to choose options that involve taking a 
risk when the potential outcome is presented as a loss, such as there is a 2/3 
chance that 100 people will die, but will avoid risks when the outcomes are 
described as gains, such as a chance that 1 in 3 people will be saved.
4. Difficulties in understanding different measurements of risk: Many 
different measurements are used to express risk, even within the same health 
areas. Unsurprisingly, some people find the different ways of expressing 
contraceptive effectiveness difficult to interpret and trading off different 
dimensions challenging.(102)
5. Difficulties in interpreting overlapping categories of risk: For example,
amongst the general population the risk of acquiring human papilloma virus
(HPV) is fairly high, while the risk of HIV acquisition is small. If you asked
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someone what there risk of STI acquisition is, which would include both of 
these infections, the risk would have to be high.(99)
6. Difficulties in understanding the lack of precision around the estimates of 
risk: For example, understanding that the risk of x is not y, but y+/-z.
Bekker and colleagues conclude that informed decision-making probably involves a 
combination of all three theories described above.(97) They describe their definition of 
informed decision-making as a form of compromise, “an informed decision is one 
where a reasoned choice is made by a reasoned individual, using relevant information 
about the advantages and disadvantages of all the possible courses of action, in accord 
with the individual’s beliefs.” (p.l) Box 2.2. illustrates the broad range of decision­
making processes. While we all use instinct, intuition and verbal reasoning (‘taking 
into account the pros and cons’) everyday to make decisions about which course of 
action to take, the use of decision analysis is somewhat alien (as the quote in Box 2.2. 
suggests).
Box. 2.2. Basic decision-making processes 
Instinct
“I couldn’t help myself. "
“I acted without thinking. ”
Intuition
“I simply felt I  could trust him/her. ”
Verbal reasoning
“I took into account my friend’s experiences. ”
‘7 considered the pros and cons. ”
Decision analysis
“I assessed the probabilities and utilities for the outcomes of each course of action and 
maximised expected net benefit. ”
The literature comparing the differences in how adolescents and adults make decisions 
suggest that decision-making is a learnt process.(lOl) Children and adolescents are 
more likely to quantify risk and benefit trade-offs than adults. Adults, on the other 
hand, are more likely to make decisions in a more qualitative manner and this explains
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how we move towards making more intuitive decisions as we become more efficient in 
our decision-making with experience.
Reyna and Farley are critical of models of deliberative decision-making for use with 
adolescents that result in behavioural intentions and planned behaviour as these models 
fail to take account of how much of their risk-taking is “spontaneous, reactive and 
impulsive”.(103) It is difficult for young people to anticipate future goals or outcomes 
associated with current decision-making. The perceived benefits of behaviour, such as 
the pleasure of sexual activity, may outweigh the perceived risks or long-term 
consequences. Interestingly, few studies focus on the potential benefits of risky 
behaviour amongst adolescents.(104) Young people continue to take risks when they 
“get away with it”,(103) such as those who continue to have unprotected sex when 
they have managed to avoid pregnancy or STI acquisition in the past. This may be 
because they do not know how to interpret the evidence; for example they may not 
understand that STIs can be asymptomatic or that young women are more fertile at 
some times than others. Reyna and Farley comment that much of adolescent risk- 
taking could be seen as rational, given the information and experience they use to 
inform their decisions and behavioural03) They maintain that providing young people 
with rational reasoning skills will not be sufficient to reduce unhealthy risk-taking 
behaviour.
The context in which we make decisions can affect the decision process and the 
outcome. This will include the type of decision to be made, the seriousness and 
consequences of the outcome, familiarity with the decision, the level of certainty, 
where the decision is being made, and who the recipient is.(97) There is still little 
understanding of the demographic and social influences on decision-making.(105)
2.2.2. Decision-making and models of behaviour change
Theories of behaviour change identify factors that affect our behavioural06) The 
theories identify cognitions (beliefs, attitudes and intentions) and, sometimes, skills 
that influence or explain behaviour. It is assumed that cognitions and skills can be 
changed to reach a better outcome, such as improved health. Theories of behaviour 
change are therefore used to both develop and evaluate behavioural interventions.
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Decisional balance, the weighing up of the perceived costs and benefits of a given 
behaviour, is a crucial component of most theories of behavioural change. Reyna and 
Farley explain how these models incorporate “mechanisms to explain how people 
actually make decisions (a descriptive focus) and, to varying degrees, implications of 
these mechanisms for improving decision making (a prescriptive focus)” (p.l6).(103) 
The Health Belief Model, for example, focuses on the role of attitude in the decision­
making process, including the perceived susceptibility and severity of an outcome 
associated with a target behaviour, and the relative gains and losses associated with 
that behavioural07) The Theoretical Model for Change identifies five stages of 
change: pre-contemplation, contemplation, ready for action, action and
maintenance^ 108) The perceived costs and benefits associated with a behaviour can 
change as an individual progresses through each of these stages.(109) Another widely 
used model of behaviour change is the Theory of Reasoned Action (or Theory of 
Planned Behaviour).(llO) In this model it is proposed that intentions are the best 
predictors of future behaviour. Intentions are influenced by 1) an individual’s attitude 
or beliefs towards a behaviour, including judgment on the probability or improbability 
that a given behaviour will lead to certain consequences and 2) the subjective norm, 
that is what an individual feels other people expect them to do or the desire to do what 
other people feel they should do. However, examination of the effectiveness of sexual 
behavioural interventions shows that while these interventions may have a positive 
effect on people’s intentions, such as the intention to use condoms and oral 
contraceptives, there is very little evidence of their effect on actual behaviour.(27) 
Many prevention programmes are based on the belief that knowledge of the negative 
consequences will deter risk-taking behaviour. Parson and colleagues examined the 
perceived risks and benefits, behavioural intentions and reported involvement in 18 
risk-taking behaviours over a three-month period amongst US college students.(104) 
Behaviours were identified as low (such as taking prescription drugs) to high-risk 
(such as having sex without a condom). The authors found the perceived benefits to the 
individual were more predictive of involvement in risk taking behaviours than the 
perceived risks.
Models, such as the Theory of Planned Behaviour, assume that people make decisions
based on the information they have accumulated, and the decision is therefore
rational.(110;lll) This adoption of a rational approach has been criticised as it
assumes that by providing people with information and correcting misconceptions that
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any ‘rational’ person will be able to change their behaviour in the ‘desired’ 
directional00) However, this is not necessarily the case, for example, increased 
knowledge of how HIV is transmitted does not necessarily equate with the adoption of 
safer sex practices. Perceived invulnerability, dependence on others and positive 
reasons for non-rational behaviour can act as ‘impediments to rationality’.
In reality those involved in the development and application of behavioural 
interventions appear to adopt more than one theoretical approach. A review of 
behavioural interventions aiming to reduce STIs, HIV and pregnancy amongst 
adolescents found that interventions were based on a combination of theories rather 
than a single theoretical model of behaviour change.(112) As explored in Chapter 1 
(see 1.5.), the influences on contraceptive use and adherence are complex. Our 
understanding of how people weigh up the costs and benefits of different contraceptive 
methods (or even use of no method) and the effect this process has on subsequent 
behaviour is still limited. This limited understanding of the decision-making process 
has been cited as one of the reasons we have not developed effective interventions that 
reduce unplanned pregnancy and the spread of STIs.(l 13) There can also be problems 
generalising behavioural interventions across different populations; populations that 
are going to be defined by different demographic characteristics and cultural 
influences. Individual beliefs and values surrounding sexual health vary enormously.
2.2.3. Application o f Decision Theory to Contraceptive Decision-Making 
Contraceptive decision-making is a complex process. An individual has to decide 
whether or not to have sexual intercourse, and if yes, whether to continue, whether to 
use contraception and then what method to use.(114) There are also decisions to be 
made around the consequences of sexual activity. These can be biological 
consequences, such as if they or their partner become pregnant would they opt to 
continue with the pregnancy or have an abortion, or social and emotional 
consequences, such as maintaining a relationship by agreeing to have sex. Deptula and 
colleagues looked at young people’s sexual behaviour using a cost and benefit 
approach. (109) They found that young people who have not yet had sex report more 
costs and less benefits compared to those who are already sexually active. Amongst 
those who were sexually active, young men are more likely to report greater benefits 
associated with sexual activity in comparison to young women.
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Using the Health Belief Model and the Theory of Planned Behaviour as frameworks, 
predictors for decisions around sexual activity and contraceptive use would be:(l 15)
1) consideration of costs and benefits of contraceptive behaviour;
2) assessment of the risks, such as unplanned pregnancy or STI acquisition;
3) perceived norms towards contraceptive use and sexual health outcomes, such as 
teenage pregnancy, held by significant others, such as family, peers and 
partners;
4) willingness of young people to conform to wishes of significant others; and
5) self-efficacy around contraceptive use, such as confidence in putting on a 
condom or accessing a health service to obtain contraceptive supplies.
The reason an individual chooses a particular contraceptive method is not usually 
based on a rational act of weighing up its pros and cons. Young people often have 
insufficient knowledge to make an informed decision and are unaware of or have not 
thought through the consequences of their actions. Some feel that the application of 
‘rational’ models of decision-making and behaviour change to contraceptive choice is 
therefore somewhat limited. For example, Heise provides a number of limitations of 
the Theory of Planned Behaviour: “First, such models have mostly been used to 
estimate the expected value of a particular target (e.g. using the pill), without 
considering how a woman integrates this assessment with her assessment of the 
alternative options. They assume women make an affirmative choice to adopt a 
particular contraceptive method: yet qualitative research suggests that women opt for 
the least worst option. Finally, they assume that individuals give equal weight to 
potentially negative and positive consequences, whereas studies suggest that when 
choosing contraception, women tend to weigh possible negative consequences more 
heavily than positive ones.” (p. 12)(54) Another criticism is that research and 
interventions have tended to focus on the benefits of contraceptive use and the costs of 
non-use, and therefore ignore the costs of use and benefits of non-use.(l 16) Parsons 
and colleagues found that among US students the perceived benefits or consequences 
of not using condoms during sexual intercourse were better predictors of sexual risk- 
taking behaviour than were the perceived costs (which in this study were STI or 
HIV).(117) More people experience the benefits of risky sexual behaviour, such as 
unprotected sexual intercourse, than the costs associated with this behaviour, such as 
unplanned pregnancy and STIs. This is further exacerbated by the fact that the benefits 
of risky sexual behaviour are more immediate than the potential costs. At an individual
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level, we rarely know the “true” probabilities of outcomes associated with sexual 
behaviour, such as the chance of getting pregnant during one episode of unprotected 
vaginal intercourse. We generally tend to under-estimate our susceptibility to adverse 
outcomes. Young people who do not use condoms have been found to under-estimate 
their risk of acquiring an STI.(4) The less likely they are to use condoms the less they 
perceive themselves to be at risk from STIs. Much sexual behaviour is habitual, that is, 
it is automatic or instinctive having being acted out many times previously, rather than 
intentional. Whether or not people have used condoms in the past is a strong predictor 
of future condom use.(57)
Approaches to understanding our contraceptive decision-making, particularly through
health decision-making models, have been criticised for not acknowledging the
contextual nature of contraceptive use and for making the assumption that
contraceptive use is static.(27;l 15) The context of contraceptive behaviour needs to be
borne in mind when applying decision theory. This will apply to contraceptive
decision-making within as well as between individuals. People’s beliefs and values
around contraception and the consequence of use and non-use will vary depending on
current circumstances, as well as past experience. The relative importance placed on
these beliefs and values will also vary. For example, in Chapter 1, the role of
relationship status and patterns of contraceptive use was discussed. O’Campo and
colleagues surveyed 291 young single women with a current unplanned pregnancy
about partner influences on contraceptive decision-making.(l 13) They found that
around half of the 72 women who reported more than one sexual partner reported
inconsistent contraceptive use or use of different methods with each partner. One in
five of these women reported differences by partner in the decision-making
responsibilities about method choice. Young women with only one partner were more
likely to report taking sole responsibility for contraceptive decision-making, explained
by the fact that most women in more stable relationships were using oral
contraceptives. When condoms were used, women were more likely to report that the
male partners were ‘involved’ in the decision. This study is in line with findings from a
systematic review of 268 qualitative studies to identify factors that shape young
people’s sexual behavioural 19) This review found that women are generally
responsible for pregnancy prevention, despite the stigmatising effect for women in
carrying condoms and using other contraception. One of the major barriers to young
people’s communication about sex and contraceptive use identified was the fear of loss
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of face, hurting other’s feelings or damage to one’s reputation by appearing to be too 
forward. The authors conclude: “This makes safer sex difficult to plan if the possibility 
of sexual intercourse is not acknowledged, contraception is unlikely to be discussed.” 
(p. 1584).
Whitley Jr. and Schofield describe two models of contraceptive behaviour in their 
meta-analysis of studies of adolescent contraceptive use: the career model and the 
decision model.(80) In the career model, an individual moves through different stages 
in their use of contraceptive techniques, that is the focus of the model is on the 
longitudinal process of being a contraceptive user. The decision model focuses on 
factors that influence contraceptive use at one point in time and the weighing up of the 
advantages and disadvantages as seen by the decision-maker. In their analysis both the 
career and decision models applied well to women’s use of contraception, but not so 
well to men’s. For example, the career model emphasises the importance of social 
support in influencing contraceptive use. Social support was correlated with reported 
contraceptive use for women, but not for men. With regards the decision model, the 
authors comment that a prerequisite for contraceptive decision-making is the 
perception that a decision needs to be made and young women were more likely than 
young men to have a positive attitude towards contraception, reflecting the lower 
perceived costs and the greater perceived benefits. The authors argue that the career 
and decision models are not mutually exclusive, in fact they compliment one another, 
and a comprehensive model of the contraceptive process would combine both 
theoretical approaches.
2.3. Decision aids
2.3.1, Definition
Decisions in healthcare can be difficult because there is no one best option as people’s 
values and circumstances vary. Advances in technology and more available treatment 
choices have added further complications to decision-making. Decision aids are 
broadly described as tools that provide a structured framework to systematically 
analyse the available options and their possible outcomes to help the decision maker 
select the option that best takes account of their individual needs and values.(120;121) 
They are different from health education material, as the latter’s aim is to provide 
broad understanding of the health topic through the provision of information^ 122) As
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well as providing information required to assist a decision, decision aids identify the 
risks and benefits attached to the decision and ask the decision maker, either on their 
own or with the assistance of, for example, a doctor, to implicitly or explicitly consider 
their values associated with the risks and benefits. Decision aids can take a number of 
formats, including written, visual, oral presentation in conjunction with written and 
visual, computer-based and programmed with interpersonal counselling. Aids can 
adopt different approaches, from scenario planning to more structured approaches, 
such as decision analysis.(123) Decision analysis is described more fully in Section
2.3.4.
The information required to facilitate decision-making in decision aids needs to be 
“relevant, accurate and complete”.(124) It is important that those who will be doing the 
decision-making are involved in identifying the categories that need to be addressed in 
the decision. The information contained within the decision aids should, where 
possible, be scientifically reliable, for example based on evidence from good quality 
studies.
Most decision aids have been developed to help with decisions connected to acute or 
chronic medical conditions. Fewer have been developed to help with screening or 
preventative options.(120)
2.3.2. Who is the decision-maker?
Who the decision-maker is should be defined by the decision in question. For example, 
decision aids can be used to inform policy, such as should patients routinely offered a 
specific treatment or should a screening programme be introduced.(125) This can 
allow clinicians or policy makers to compare the expected outcomes of different 
strategies. Decision aids can also be used to inform the most appropriate healthcare 
and management for individuals. In this scenario the decision-maker could be the 
consumer/patient, the clinician or both.
There has been much debate in the medical literature over the last decade around the 
shift from the doctor taking complete responsibility for health care decisions to greater
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consumer participation. This has led to changes in how the doctor-“patient”‘ 
relationship is perceived and acted out. Emanuel and Emanuel describe four models of 
physician-patient relationship: the paternalistic model, the deliberative model, the 
interpretative model and the informative model.(126) The paternalistic model assumes 
that the doctor is the “guardian” and expert with the patient playing a passive role. The 
doctor uses their skills to diagnosis, treat and manage medical conditions. This model 
is generally regarded as outdated as it assumes that the patient and the doctor have the 
same values.
Patients’ values are open to development and revision in the deliberative model. In 
this approach the doctor adopts the role of “teacher” and helps the patient choose the 
best health-related values in a given clinical situation. A criticism of this approach is 
that the patient has come to see the doctor for health reasons and not to have their 
values judged or changed.
The interpretative model assumes that the doctor takes on the role of the adviser or 
counsellor and helps the patient identify and clarify their values. The doctor does not 
lead on the decision-making in terms of clinical management, but instead guides the 
patient to apply their values to a medical context. A criticism of this approach is that it 
is time-consuming and there is no attempt to explore the patient values or make any 
attempts to revise them.
In the informative model, the patient decides on the most appropriate course of action 
based on their own values and the information that the doctor has given them, such as 
risks and benefits of possible interventions. It is the role of the doctor to ensure that 
they are up to date and to consult others as required. A criticism of this approach is that 
the doctor does not attempt to understand the patient’s values. The use of this approach 
may leave the patient feeling unsupported.
1 All the reviewed papers on shared decision-making in health care settings used the word “patient”. I 
use also the word “patient” in this section to be consistent in the reporting of findings or observations 
from these papers.
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Doctors may use different approaches for different circumstances. For example, in an 
emergency situation a paternalistic approach may be the most appropriate while a 
deliberative approach may be most appropriate with a young person who reports 
unsafe sex with multiple partners. Whatever the circumstances, most patients express a 
desire for more information about their condition and the options available to 
them.(127) However, many do not ask for further information or greater involvement 
in the decision-making, and health care workers do not necessarily seek patients’ 
views.
Shared decision-making has been put forward as the method that is appropriate for 
most clinical situations as it is somewhere in-between the paternalistic and informative 
approaches.(128;129) Montgomery and Fahey in their paper looking at shared 
decision-making, describe how the clinician and patient should exchange relevant 
personal and medical information, share treatment preferences and then agree on the 
way forward.(130) The authors argue the goal should be consensus between clinician 
and patient. Although shared decision-making focuses on the active partnership 
between the doctor and patient, it can also bring in others, such as family and partners, 
into the process.(131) Some critics of the shared decision-making approach still feel it 
is too ‘middle ground’ and it is still clinician-led.(132)
By involving the user in the decision-making process, it is hoped knowledge is
increased, more appropriate treatment is given, and outcome measures, such as clinical
outcomes, adherence and patient satisfaction, are improved.(131;133) All these factors
hopefully lead to a better use of health service resources. However, decision aids have
been criticised, as their use in the ‘real world’ may not be very effective. Patients may
appear to comply with expected norms, particularly if health service providers do not
actively support their decision, but in reality will not comply. In order to be effective,
health care workers need to be able to properly elicit the patient’s true values or beliefs
so they can be appropriately incorporated into the decision making process. As
described above, a goal of shared decision-making is consensus, but consensus is hard
to reach when the physician and patient (and the general public) have different
preferences, values or norms.(130) Adequate training and experience in using this
approach is also lacking, in particular the ability of physicians to elicit values from
their patients. In a qualitative study, GP registrars described how they tended to bias
their presentation of the available information and consciously steer patients towards a
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particular decision.(127;131) Some of the registrars felt that patients did not have the 
expertise to make informed decisions (‘they had not gone to medical school’) and that 
patients could become over-burdened by the amount of information and responsibility. 
Clinician’s motivation is a facilitator to shared-decision making.(134) However, there 
are also practical reasons that can provide barriers. The time allocated for consultations 
for shared decision-making may be too limited and clinicians may lack the time or 
skills to seek out robust data.(127;131) Data about the risks and benefits associated 
with different treatments are often lacking and patients may not like clinician 
uncertainty.
The popularity of decision aids has risen alongside the move away from paternalistic 
medicine and a more consumer focused approach to health care.(120;121) The need for 
an individual focus is recognised as outcomes are likely to be valued differently by 
different people. However, much of the literature still focuses on decision support 
systems (i.e. systems that provide information) rather than the application of decision 
aids that are completely user-led and take account of values. We still need greater 
understanding of how decisions are made within clinicians and patient relationships. In 
order to develop, implement and evaluate decision aids in health care we need to be 
clear who the decision-maker is or should be.
2.3.3. Do decision aids work?
The proposed benefits of decision aids provide a strong case for their use in clinical 
settings.(120;131;135-137) They include:
■ improvement of patient/user knowledge
■ better communication between the health care provider and the patient/user
■ promotion of shared decision making -  i.e. joint negotiation and decision 
making between patient/user and clinician
■ developing decisions based on individual values which take account of the 
probability of a range of outcomes and the relative weight that the patient/user 
puts on these outcomes
■ developing the ability to communicate risk data to patients/users in a 
meaningful and non-technical way
■ a decision making process that is transparent
■ a dynamic tool that can be updated to incorporate new research
■ the potential to be made easily accessible to users, e.g. via the Internet
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■ increased patient/user satisfaction with the information, process of care and 
management
■ improved patient/user adherence to treatment.
However, the evidence from systematic reviews on whether or not decision aids work 
remains inconclusive.(97;121;122;138) The three reviews that have focussed on 
decision aids include:
• Bekker and Colleagues(97): The aim of this review was to provide an annotated 
bibliography of controlled studies that may inform patient health care decision­
making. A variety of study designs were included in the review: 114 RCTs, 114 
non-randomised concurrent studies, 34 retrospective studies and 63 ‘before and 
after’ same sample studies.
• Estabrooks and colleagues(121): The aim of this work was to identify outcomes 
influenced by decision aids targeting the consumer and the particular effects of aids 
on these outcomes. There was no restriction on study design. Twelve studies were 
included (eight RCTs and four observational studies).
• O’Connor and colleagues(122;138): Their aim was to review RCTs of decision 
aids, aimed at people having to make treatment or screening decisions, to improve 
decision-making and the outcome. Thirty-four RCTs of 31 decision aids were 
included in their review.
All three of the systematic reviews of decision aids included studies of individuals who 
were making real, rather than hypothetical, health decisions. Studies of university 
students or studies assessing health professional decision-making were excluded. 
Decision support tools, such as counselling, or tools that did not support a specific 
decision were excluded.
One of the criticisms of the research into decision aids to date is the lack of underlying
theory and limited use of decision-making process measures.(97;120) Bekker and
colleagues found that less than 20% of the studies in their review were informed by
any underlying theory and had used measurements associated with decision-
making.(97) Another criticism of the development and study of decision aids is that
users are not involved when deciding what information should be included in the
decision aid. A systematic review of information provided in decision aids found that
while most aids contained information or data that had been identified through some
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form of external consultation, patients were rarely involved in this process.(124) This 
could influence the effectiveness, relevance and acceptability of decision aids as 
patient/consumer priorities may differ from those of the clinician/provider.
In terms of impact, O’Connor and colleagues found that users of decision aids had 
greater knowledge, more realistic expectations, less decisional conflict, greater 
participation in the decision-making process, were less likely to remain undecided 
post-intervention, and had improved agreement between values and choice compared 
to individuals who are provided with ‘usual’ care.(122;138) The systematic review 
conducted by Estabrooks and colleagues also found a significant increase in the 
knowledge scores amongst users of decision aids, but changes in other outcomes, such 
as user satisfaction and treatment choice, were negligible.(121)
There are too few studies to assess impact decision aids have on continuation of 
treatment, effect on health outcomes and cost. In 1999, Bekker and colleagues 
concluded in their systematic review of interventions that may affect patient decision­
making, “Given the small number of high-quality studies and the relatively slow 
increase in research in this area there is no need for the NHS to revisit this topic as a 
review for 5 years. Resources should be concentrated on better primary research.” (p. 
iv).(97) There is no evidence from examination of the more recent literature on 
decision aids that the situation is any different. We have little understanding of 
decision aids’ impact in the short-term, and impact in the long-term has not been 
investigated.
We still do not know what the “essential ingredients” are and how best the decision aid 
should be delivered. More process evaluations of decision aids are needed to address 
these questions. For example, in a clinical situation is it best to introduce decision aids 
prior to the consultation or should the aid be used with a clinician as part of the 
consultation? What is the best format, how should the information to help inform the 
decision be presented? We do know that just providing people with information and 
education is not the most effective way to help informed decision-making, and that the 
context and social influences on individual decision-making are important.(97) Few 
studies have looked at differences between users of decision aids, such as whether 
socio-demographic characteristics have an effect on the decision-making process. We 
do know that the highly numerate tend to draw more affective meaning from
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probabilities and numerical comparisons than do the less numerate.(139;140) More 
visual approaches to present data may be a way to overcome this. Most research on 
decision aids has focused on English-speaking, white, adults, most of whom have been 
middle-class and relatively well-educated.(121) There is certainly a need to look at 
how these aids can be introduced to other groups, such as young people, and how best 
to develop decision aids and/or translate findings across different populations.
2.3.4. Decision analysis
Decision analysis is essentially a method for breaking down complex problems or 
questions into manageable components, and then combining them quantitatively and 
logically to show the best course of action.(141) It is the only decision technology in 
which the belief judgements and value judgements needed to make decisions are made 
separately and then integrated in a transparent fashion.(137) The decision takes 
account of 1) the probability of a range of outcomes or attributes and 2) the value that 
user puts on these outcomes.(137;142;143)
1) Probabilities: The probability of the occurrence of a particular event or outcome 
equals the proportion of times that the outcome would (or does) occur in a large 
number of repeated trials. It has a value between 0 (the outcome can never occur) and 
1 (it is certain to occur). A probability can also be expressed as a percentage, taking a 
value from 0% to 100%. The sum of probabilities for each outcome must add up to 1 
(i.e. the probability of an outcome occurring and the probability of it not 
occurring).(141) For example, the sum of the probability of getting pregnant on the pill 
will be 1 minus the probability of not getting pregnant. Ideally data used to provide 
probabilities for the decision analysis come from well-designed studies.(144;145) In 
reality, data may have to be drawn from other sources such as field experts. For this 
reason, decision analysis is not just a tool that is based on rationality, but it also 
encompasses intuition. As Dowie explains, “decision analysis is an approach which by 
definition is more systematic than less analytical approaches, but it still involves 
substantial use of intuition, especially in the form of judgements concerning those 
aspects of most decisions for which ‘hard’ and relevant data are unavailable.” 
(p.l76)(132)
2) Values: The relative weight placed on values, or utility, represents the decision­
maker’s preference for one outcome over others. Utilities are a quantified
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measurement, usually on a scale of 0 to 1.(143-145) It is up to the decision-maker to 
assign these weights. Emotional, social and developmental factors will be 
considerations when the decision-maker weighs up the costs and benefits.(103) 
Therefore, although decision analysis is a logical process it does not ignore the factors 
that influence our values.
The scores produced by combining the probabilities and the quantified weighting of 
values result in a recommendation based on the underlying decision analytic principle 
of maximising the person’s expected utility.
The use of decision analysis is not appropriate for all clinical situations. For example, 
if the administration of a treatment means survival for a patient who wants to live and 
no administration means death, there is no decision to be made about the appropriate 
course of action. Decision analysis is appropriate when the decision-maker is faced 
with two or more choices, there is some uncertainty about the most appropriate course 
of action to take, and a meaningful trade-off can be made.(146) The key factors in the 
risk-benefit trade-off need to be identified, otherwise the model will be unable to help 
the decision-maker understand the trade-offs. The time-frame also needs to be explicit, 
and this will be dependent on the nature of the problem being addressed.
A number of benefits of decision analysis over other decision aids have been 
described. First, not only can decision analysis incorporate different outcomes, it can 
also incorporate different levels of risk depending on either individual or population 
characteristics and preferences, such as age and gender.(132;146)
Second, the framework for decision analysis and the data that are contained within this
framework are explicit and transparent.(143) This allows the user to criticise and
improve the model as required, and new data can be incorporated when they become
available. Data and the formulae for combining probabilities and utilities can be
incorporated into spreadsheets. Decision trees are a pictorial way of displaying
data.(144;147) These trees are basically flow diagrams that provide an order of
decisions and events, with decision nodes represented by square nodes and points
where outcomes occur represented by round nodes. They can also be a means of
identifying gaps in knowledge, and therefore act as a means of generating research
questions. Figure 2.1. shows the decision tree designed for a modelling exercise which
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compared radical hysterectomy versus no treatment for microinvasive cancer of the 
cervix.(148) Observational data suggest that women opting for surgery would have a 
lower expected mortality in comparison to women opting for no treatment (1.5% 
versus 2%, respectively). However, those opting for surgery will be infertile following 
a hysterectomy. A woman may be willing to trade-off a slight increase in death when 
having no treatment for a chance of a fertile life.
Figure 2.1. A decision tree examining treatment and outcome options in women 
with microinvasive cancer of the cervix
No further 
treatment Cancer death
Death from canceroSurvival (uterus intact)
----------------- ► Fertile life
Surgical death
oDeath from surgery Cancer death
Radical surgery
Survive surgery oueath from cancer )
Survival after hysterectomy
Life but infertile
Source: Johnson et al, 1992(148)
Finally, sensitivity analyses can (and some argue, should) be used within decision 
analysis models to explore the effect of changing probabilities or values, and the 
consequence this has on the subjective expected utility.( 125; 141) For example, where 
there is uncertainty in the data used, such as where there are wide confidence intervals 
around an estimate, a sensitivity analysis can be conducted using the lower and upper 
limits. A similar process can be done by getting the user of the decision analysis model 
to see the effect changing their values has on the result. If the result changes through 
sensitivity analysis it is said to be “sensitive” to that variable. The result is described as
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“robust” if changing probabilities or values through their plausible ranges does not 
alter the findings.
2.3.5. Examples of the application of contraceptive and fertility control-related 
decision aids
There are few examples of decision aids having been developed to assist with 
contraceptive decision-making. A database search (Medline, Embase and The 
Cochrane Library) conducted in April, 2007 to identify contraceptive-related decision 
aid interventions only found two decision analysis studies.(149;150) One further paper 
on contraceptive-related decision analysis was identified through a search of reference 
lists.(151) There were a few more studies relating to STIs and HIV, predominantly 
decision analyses to inform screening strategies.(152-154)
The earliest example of a contraceptive/fertility-related decision aid identified was a 
study conducted in the late 1970s. Beach and colleagues used decision analysis as an 
academic exercise to calculate the SEU for having a(nother) child amongst American 
married couples.(151) All couples were actively considering whether to have a(nother) 
child and were using contraception at the time of recruitment. Study participants were 
predominantly white and middle-class, and just under a third had not yet had children. 
The aim of this study was to assess whether or not subsequent birth planning decisions 
could be predicted from the calculated couple SEUs. The SEUs were calculated by 
asking couples to assign subjective probabilities and weights to a set of value 
categories, such as those centred around their own personal identity and around 
parenthood. The authors hypothesised that if the SEU favours having a child then this 
should be in line with their behavioural intent to have another child, and their findings 
suggest SEU and intent are related. Although they find that asking couples what they 
intend provides the best prediction to subsequent family size, this alone provides little 
understanding of why they make the decisions they do. SEUs were obtained for each 
couple and then they were followed up at one and two years to see if they had had a 
child or had stopped using contraception.
Another study conducted around the same time used decision analysis to assess the 
impact (i.e the costs and benefits) of a sterilisation program in Bangladesh.(149) 
National survey data were used in the decision analysis model to estimate the number 
of pregnancies and deaths amongst women who had been sterilised compared with the
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number of deaths in the same group if they had not been sterilised. This exercise 
suggested that sterilisation was the optimal choice, this mainly being driven by the 
reduction of deaths associated with maternity.
The final paper identified described the use of decision analysis to describe the health 
consequences for women using different contraceptive methods in comparison to the 
health consequences amongst women using no method.(150) The authors used data 
from the literature to calculate the numbers of unintended pregnancies, live births, 
induced abortions, spontaneous abortions, ectopic pregnancies, upper genital tract 
infection and cases of infertility that would occur in a hypothetical cohort of 100,000 
American women within a specified time-period and given a set of probabilities for 
each outcome. They found the use of any method prevents more deaths than are 
associated with method use. The authors’ work differs from other studies looking at 
the costs and benefits associated with contraceptive use in that it takes account of the 
fact that different contraceptive methods offer different combinations of risks and 
benefits at different stages of women’s reproductive life stages. The implications of 
contraceptive behaviour on current and subsequent health were examined. For 
example, in their modelling they found that among 100 000 women aged 15-19 using 
barrier or spermicidal methods there would be nearly four fewer pregnancy-related 
deaths than if these women had been using no method. In the more long-term, for 
every 100 000 who use these methods at ages 15-19 around 60 deaths from cervical 
cancer before the age of 45 years are prevented.
These three applications of decision analysis have a public health rather than 
individual perspective. They are interested in predictions of desired family size, or 
morbidity and mortality associated different methods for preventing pregnancy in 
comparison to use of no method. Factors that may affect individual decision-making 
(and therefore will also impact on outcomes such as pregnancy), including side effects 
associated with contraceptive use were not addressed. The only decision aids I 
identified that had been developed to help women with contraceptive decision-making 
were a computerised intervention aimed at young women attending family planning 
clinics in the US and a tool produced by the World Health Organization 
(WHO).(155;156) The WHO tool is a 100-page flipchart that uses a decision-making 
algorithm and can be used by clients and providers during contraceptive counselling 
consultations(156). An introduction is provided and then evidence-based information
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is provided for 14 contraceptive methods. This information includes medical eligibility 
for methods, side effects, when to start, and how to use the method. Corresponding 
sheets are presented for the provider and the client (see Figures 2.2. and 2.3.). It can be 
downloaded from the WHO website. An evaluation was conducted in hospital and 
community settings in Mexico to assess the effect the aid had on the counselling and 
decision-making process, and to evaluate the flipchart’s acceptability with providers 
and clients(157). A two and a half day training course on use of the flip chart was run 
for the providers. Evaluation methods included the videoing of consultations three 
months prior to the training and implementation of the tool in consultations, and then 
again one month after implementation. Decision-making behaviours were assessed as 
well as modes of communication between provider and client. In-depth interviews and 
focus groups were conducted with providers and clients to investigate acceptability. 
The evaluation found that clients received more information after implementation of 
the decision aid and there was more shared decision-making with clients having a 
greater involvement in decisions. Providers did raise some concerns about the 
additional time required in consultations. The impact that this tool has on contraceptive 
use and health outcomes has not been evaluated.
Figure 2.2. WHO Decision-Making Tool: Client Sheet
You can find a method 
right for you
No method in mind? We can discuss:
• Your experiences with family planning
• What you have heard about family planning 
methods
• Your plans for having children
• Protection from sexually transmitted 
infections (STIs) or HIV/AIDS
• Your partner’s or family’s attitudes
• Other needs and concerns
N ow  le t’s  d isc u s s  h ow  
a m eth od  can m eet
you r n eed s
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Figure 2.3. WHO Decision-Making Tool: Provider Sheet
You can find a method right for you
No method in mind? We can discuss:
• Your experiences with family planning
• What you have heard about family 
planning methods
• Your plans for having children
• Protection from sexually transmitted 
infections (STIs) or HIV/AIDS S 3
• Your partner’s or family’s attitudes
• Other needs and concerns
(D
Next Move:}
Go to next page to discuss what methods could suit the client’s needs
Explain that everyone needs to consider protection from 
both pregnancy and STIs such as HIV/AIDS.
Encourage client to speak openly about her/his situation, 
her/his relationships) and sexual behaviour.
If client needs protection o r is unsure, go to  Dual 
Protection tab.
• The Special Needs tab or Appendices may help.
Helping client with no  m ethod in mind to  make a 
decision:
- Use this page to help client think about her/his situation and 
life and what seem s most important about a method.
■ Discussing some of the topics at left can help the client 
consider different methods. You can say:
"Here are some things to consider when choosing a family 
planning method. ”
"What is most important to you?" .
" The choice is yours. I want you to be happy
with your choice. ” ^
Choosing 
method: 
NO method 
in mind
The aim of the second identified computerised decision aid, developed by Chewning
and colleagues in the US, was to promote the effective selection and use o f
contraception amongst young people aged 20 and under attending family planning
clinics.(155) This aid was to be used alongside usual care and accessed by young
women in the waiting room prior to their consultation with the clinician. The aid was
divided into five broad sections: 1) a demonstration of how different contraceptive
methods work and are used, 2) a graphical illustration of the effectiveness o f different
methods, 3) a series to questions to help the user identify personal characteristics and
circumstances that may affect their use of different methods, 4) the relative costs and
benefits of different methods, 5) advice and feedback regarding the user’s disclosed
potential barriers to effective use, and 6) provision of a personalised printout, which
included steps on how to use methods effectively, questions that the user had wanted
answering and their individualised feedback. The aid was evaluated through use of a
longitudinal experimental design. In the intervention group young women were
allocated the decision aid plus usual care and the control group received usual care.
Recruitment took place in two family planning clinics. It was not deemed possible by
the investigators to randomly allocate women to the two groups because of the clinic
set-up, but a pseudo randomisation approach was adopted, where women were
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alternatively allocated to the intervention or to the control group as they came into the 
clinic. Participants were interviewed prior to using the computer program and then 
again immediately after their consultation with the clinician. These interviews 
collected data on the participants’ demographic characteristics, contraceptive 
knowledge, contraceptive intentions and method prescribed at the clinic visit. 
Participants were interviewed for a third time a year later where information was 
collected about contraceptive use and, where appropriate, reasons for discontinuation 
of methods. The authors report that the characteristics of those in the intervention and 
the control arms were similar, although the numbers recruited into the intervention 
group were less than the number in the control group, 456 and 493, respectively. A 
large proportion of the total sample (82.6%) was included in the 12 month follow up. 
The young women who had used the decision aid had greater short-term contraceptive 
knowledge (i.e. at the second interview immediately after using the aid) than the 
women in the control group. In the long-term (i.e. at 12 months) there was no overall 
significant difference between the intervention and control groups in terms of 
knowledge, length of time using contraceptive (nearly all the women were prescribed 
the pill) and pregnancies.
2.4. Rationale for My Way
Based on what we know from the literature (identified in this chapter and the 
introduction), the rationale for the development of a tool based on decision analysis to 
help young people with contraceptive choices includes:
1. Most people are faced with decisions around fertility control and STI avoidance 
at periods during their life.
2. At an individual level the repercussions of ‘poor’ contraceptive decisions can 
be long-lasting and can have negative consequences on both health and social 
outcomes. At a societal level, ‘poor’ contraception decisions can have public 
health and cost implications.
3. There are continuing concerns around young people’s poor sexual health. 
Traditional ways of delivering contraceptive care and behavioural interventions 
have had limited success in reducing poor sexual outcomes in young people.
4. People, in particular young people, may have insufficient knowledge about 
different contraceptive methods and the risks (and benefits) associated with 
these methods to make an informed decision.
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5. There are over ten different contraceptive methods currently available in the 
UK. All these methods have different belief judgments and values attached to 
them, making decisions about which method to choose complex. These beliefs 
and values will be shaped by a number of internal and external influences. A 
decision analysis tool will allow the user to break down the decisions into more 
manageable components.
6. Systematic reviews of decision aids have shown them to be popular with users 
and to encourage shared-decision-making. People seeking contraception are 
generally ‘healthy’ and therefore a personal and social approach to care is more 
appropriate than adoption of a purely medical model.
7. There has been no research identified that has involved the development and 
evaluation of a decision analysis tool that helps individuals with their 
contraceptive choice.
The assumption is that a computer program that uses decision analytical principles can
help young people choose contraceptive methods that are more acceptable to them, and
are therefore more effective in preventing unplanned pregnancy.
2.5. Key points
• Decision-making is the process by which we weigh up the pros and cons of 
different choices available to us, and then decide which choice is the most 
attractive. This process is a crucial component of most theories of behavioural 
change.
• However, good decision-making is often limited for various reasons, including lack 
of accessible information and difficulties in estimating and interpreting levels of 
risk. Therefore decision aids have been developed to assist with the decision­
making process.
• Approaches to understanding our contraceptive decision-making have been 
criticised for not acknowledging the contextual nature of contraceptive use and 
how our values affect uptake and use of contraceptive methods.
• The popularity of decision aids has risen alongside the shift from paternalistic 
medicine to a more consumer-focused approach to health care, however the 
evidence from systematic reviews on whether or not they work remains 
inconclusive.
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• Decision analysis, one form of decision aid, is essentially a method for breaking
down complex problems or questions into manageable components, and then
combining them quantitatively and logically to show the best course of action.
• There are few examples of decision aids having been developed to assist with
contraceptive decision-making.
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Chapter 3. Establishing the setting for the intervention: Where do 
young people go to get contraceptive advice and supplies?
3.1 Introduction
The uniqueness of contraceptive services is that first, they are generally for ‘well 
people’, and second, a choice of venue is available.(158) Two primary provision 
outlets exist side-by-side, community contraceptive clinics (including mainstream 
family planning and designated young people’s clinics) and general practice. In 
addition, retail outlets, such as pharmacies, play a crucial role in the delivery of 
contraceptive supplies, in particular condoms and, more recently, emergency 
contraception. Over the last few years, the availability of contraception in other 
settings, including school-based services and GUM clinics, is becoming more 
widespread.
The first clinic to offer contraceptive services to women in the UK was opened by 
Marie Stopes in 1921. The early birth control campaigners of the 1920s focused their 
attentions on poorer, married women who up until this time had been little affected by 
the fertility decline more apparent amongst upper and middle class women.(159) It was 
during the inter-war period that the concept of “family planning” was developed, with 
its emphasis on birth spacing, which it was hoped would lead to healthier children. 
However, it was not until the late 1960s and early 1970s that contraceptive service 
provision was to become widely available to the majority of people in the UK.
The first major factor that led to this change was the general availability of the 
contraceptive pill, and increasingly women were approaching their GP wanting the 
pill.(160) It was this ‘decisive factor (that) brought the medical profession into family 
planning’ (p. 104).(161) Another important event was the opening of the first centre 
for young unmarried people by Helen Brook in 1964. By 1972, there were 11 Brook 
Advisory Centres in Great Britain. The third factor to influence contraceptive 
provision was legislation, with the 1967 Abortion Act and the National Health Service 
(Family Planning) Act of the same year. The main purpose of the Family Planning Act 
was to enable local authorities in England and Wales to provide contraceptive advice 
and supplies to all women as part of the National Health Service (NHS), although 
charges could be made at the discretion of the authority. In the early 1970s, lobby
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groups increased pressure for the provision of a free, comprehensive family planning 
service and such a service was announced in 1974. Whilst overall attendance of family 
planning clinics has declined in the UK, since the mid-1970s numbers of women aged 
under 20 years accessing these services have increased.(40)
The objectives of this chapter are to:
• report on young people’s knowledge of contraceptive availability, describe 
where young people go for advice and supplies and examine factors associated 
with use of different services.
• use these data to help inform the most appropriate setting for the My Way 
intervention.
Data from the national Teenage Pregnancy Strategy Evaluation (TPSE) tracking 
survey, alongside other relevant literature, are used to address these aims.
3.2. The Teenage Pregnancy Strategy Evaluation tracking survey and methods
3.2.1. Background
As described in Chapter 1, in 1999, England embarked upon a 10-year Teenage 
Pregnancy Strategy.(2) There are two broad aims to the Strategy:
1) To halve the under 18 conception rate in England by 2010 (with an interim 
reduction target of 15% by 2004); and
2) To increase the participation of teenage mothers in education, training or work 
to 60% by 2010 to reduce the risk of long-term social exclusion.
The component of the Strategy that aimed to prevent the causes of teenage pregnancy 
included better sex and relationship education (SRE) both in and outside of school 
settings; a national information campaign that targeted young people and provided 
support for their parents; improved access to contraception and the targeting of ‘at- 
risk’ groups.
An independent evaluation of the strategy was carried out by a consortium of 
researchers at the London School of Hygiene & Tropical Medicine (LSHTM), 
University College London (UCL) and the British Market Research Bureau (BMRB).
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One of the aims of this evaluation was to assess progress made towards achieving the 
Teenage Pregnancy Strategy goals in relation to reduction of teenage pregnancies and 
social support. Details of the evaluation methods and findings are available 
elsewhere.(41) In this chapter, data collected from this evaluation are used to describe 
young people’s knowledge and use of contraceptive services over the initial stages of 
the Teenage Pregnancy Strategy (2000-2004), and to investigate factors that are 
associated with young people’s use of different types of service.
3.2.2. Methods
As part of TPSE, a national tracking survey was conducted. A random location sample 
of young people aged 13-21 years was interviewed in twelve waves at four-monthly 
intervals between October 2000 and June 2004. Young people living in the randomly 
selected geographical areas (enumeration districts with on average 150 households) 
rather than the same individuals, were interviewed at each wave. Fieldwork was spread 
across 200 sampling points in England, and to increase fieldwork efficiency, areas 
were chosen with a higher representation of 13-44 year olds. Screening interviews 
were conducted on the doorstep to ensure that young people were eligible with regards 
age group. The sample included only young people living in a family home or those 
who were living independently. Where a young person was aged 17 years or younger 
and not living independently, written permission was sought from a parent or guardian. 
Face-to-face multi-media computer-assisted personal interviews (CAPI) were 
conducted by trained interviewers at the young person’s home. The more sensitive 
questions, relating to sexual experience and experience of pregnancy, were contained 
within a self-completion section in the questionnaire, to afford privacy. As well as 
collecting information about young people’s awareness of Strategy media campaigns, 
the survey monitored changes in knowledge, attitudes and behaviour over time at an 
individual level. This included data on their knowledge and use of contraception and 
contraceptive services. With regards to knowledge of contraceptive availability, young 
people were asked, “can you think of a clinic or place in your area you could visit if 
you wanted advice about sex? (for example, advice on contraception or infections 
passed on by sex).” They also were asked to report whether the following statements 
were true or false (or that they did not know):
■ Contraceptives are available to everyone, free of charge.
■ People of any age can get free condoms from a Family Planning Clinic
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■ A girl under 16 can be prescribed contraceptives without her parents knowing.
The young people were provided with a list of services and sources, and asked 1) if 
they had ever accessed any of the places for contraceptive advice and 2) if they had 
ever accessed any of these places for contraceptive supplies. Young people could tick 
as many responses as applicable. The questions with all the possible responses are 
provided in Appendix A.I. For the purpose of this analysis, the aim of which was to 
focus on the main contraceptive providers for young people, the following responses 
or categories were examined:
■ School-based services
■ General practice (either GP or practice nurse)
■ Community contraceptive services (family planning clinics or youth advisory 
centres / Brook Advisory centres)
■ Retail (pharmacies or vending machines)
In order to focus on factors that may be associated with use of different services the 
young person’s age at interview was examined, as well as whether or not they lived in 
a deprived area and whether or not they had experienced sexual intercourse before 
their 16th birthday (analysis was limited to those 16 years and older for this last 
outcome). The distance young people had to travel to local services was calculated to 
provide information on availability. Individual surveys were linked with routine data 
on deprivation scores(162) and availability of sexual health services in a merged 
dataset (this was done by colleagues at LSHTM). The postcodes of contraceptive 
services identified from the 2004 Sexwise database (a source which provides 
information on sexual health services for young people, excluding general practice, in 
the UK), were used to calculate how far individuals lived from their nearest 
contraceptive service. The distance from services was calculated as a population 
weighted average of the road distance (in kilometres) from ward centroids to the 
nearest service (for sexual health services and also specifically young person specific- 
services).
Analysis was conducted in SPSS (Version 12.0).(163) The survey data were weighted 
by social grade. Statistical significance is considered at p<0.05 for all analyses.
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3.3. Young people’s knowledge and use of contraceptive services
3.3.1, Characteristics of respondents
Interviews were achieved with 8879 young people across the 12 waves of the tracking 
survey. The summary characteristics of respondents are presented in Table 3.1., 
including data on the distance young people were from any sexual health service and 
from a designated young people’s service. There were no significant variations in these 
characteristics over the 12 waves of the evaluation.
Table 3.1. Characteristics of all TSPE survey respondents
Men n(%) Women n(%)
Total 4418(49.8) 4461 (50.2)
Age a t interview, years
13-15 1497 (33.9) 1531 (34.3)
16-17 1400 (31.7) 1369 (30.7)
18-21 1520 (34.4) 1561 (35.0)
Living in most deprived quintile 1000 (22.7) 1158(26.0)
Had heterosexual intercourse before 16* 778 (27.1) 846(29.1)
Distance to any sexual health servicef
<lkm 1276 (29.0) 1339 (30.1)
l-<2km 1510(34.3) 1540 (34.6)
2-5km 1226 (27.8) 1187(26.7)
>5 km 391 (8.9) 387 (8.7)
Distance to designated young people’s sexual 
health service
<lkm 827(18.8) 879 (19.7)
1 -<2km 1218(27.7) 1275 (28.6)
2-5km 1634 (37.1) 1604(36.0)
>5 km 724 (16.4) 695 (15.6)
Notes
* Denominator = respondents aged 16 or over
t  Includes mainstream sexual health services and designated young people’s services, but excludes general practice. 
Services identified though the Sexwise database
Less than half of the total sample reported that they had had heterosexual intercourse, 
44.2% of all the young women and 42.4% of the young men. Sixteen percent of the 
sexually experienced young women and 17.0% of the sexually experienced young men 
reported that they did not use any contraception at first sexual intercourse. Those 
having sexual intercourse before their 16th birthday were less likely to have used 
contraception at first intercourse compared to those who waited until they were 16 
years or older, 20.9% versus 10.7%, p>0.001 for women, and 22.3% versus 11.1%,
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p>0.001 for men. Those living in the more deprived areas were less likely to use 
contraception at first intercourse compared to those living in more affluent areas, 
22.2% versus 13.6%, p>0.001 for women and 26.2% versus 13.7%, p>0.001 for young 
men. Just under one in five of the young people (17.9% of young men and 18.4% 
young women) reported unprotected sexual intercourse (i.e. had not used any 
contraception) in the last week. The proportion of women living in the more deprived 
areas who reported unprotected sex in the last four weeks was 22.9% and amongst men 
it was 26.4%.
3.3.2. Young people’s knowledge of contraceptive availability and services 
Analysis of the TPSE tracking survey data showed that 77.4% of all young women and 
65.0% of all young men knew of a clinic or place they could visit if they wanted 
information about sex (Figure 3.1.). Sexually experienced young women and men were 
more likely to know of a place (88.9% and 75.3%, respectively). Young people aged 
under 16 years had poorer knowledge of contraceptive availability compared to those 
aged 16 and over. For example, 47.0% of young women under 16 were aware that 
contraceptives were available free of charge, compared to 69.8% of those 16 and over 
(p<0.001) and 40.0% of young men under 16 were aware, compared to 61.1% of those 16 
and over (p<0.001). This association remained after controlling for whether or not 
respondents had experienced heterosexual intercourse.
Two-thirds (64.3%) of all young women and nearly half (45.3%) of all young men 
(including those who had not yet experienced sexual intercourse) reported that they 
had accessed a service to obtain contraceptive advice (data not shown). The most 
frequently cited service accessed for advice by young women was general practice 
(34.4%) and for young men was school, which included teachers, school nurses and 
school-based clinics (24.6%).
Overall young men and women who reported sex before 16 years of age were less 
likely to have obtained contraceptive advice prior to first sexual intercourse than were 
those who had experienced first sex at 16 years or above (for women: 35.6% versus 
54.4%, p<0.001, and for men: 48.8% versus 63.8%, pO.OOl, respectively). Young 
men living in more deprived areas were less likely to seek advice before first 
intercourse compared to those from more affluent areas (49.8% versus 58.3%, 
p=0.015). No association with deprivation was observed for young women.
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Figure 3.1 Knowledge of contraceptive services and contraceptive availability
100 i
90 - 
80 -
W om en Men
□  Place to get information
■  Contraception free o f  charge
□  Any age can get free contraception
□  Can get contraception w ithout parents's knowledge
3.3.3. Where do young people go fo r contraceptive supplies?
The majority of young women and men who had experienced sexual intercourse 
reported accessing a health or commercial service to obtain contraceptive supplies at 
some time (91.5% and, 78.5% respectively, Table 3.2.). The proportions of women 
reporting that they had at some point accessed community contraceptive services or 
general practice for contraceptive supplies were similar, 54.5% and 54.0%, 
respectively. Commercial venues (either pharmacies or vending machines) were the 
most common source for young men (54.3%), followed by community contraceptive 
services (31.7%). Use o f designated young people’s clinics amongst young women and 
men contributed a relatively small amount to overall community contraceptive service 
use, 15.9% of the female community contraceptive service users and 20.8% of the 
male users.
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Table 3.2. Use of different contraceptives services1 for supplies by gender
(Denominator -  respondents reporting heterosexual intercourse)
Women
n(%)
Men
n(%)
Any service
1648 (91.5) 1344 (78.5)
School-based services
357(19.8) 398 (23.2)
General practice
972 (54.0) 183 (10.7)
Community contraceptive service
982 (54.5) 543 (31.7)
Commercial
704 (39.1) 930 (54.3)
Notes
1 Use of different services is not mutually exclusive, therefore the proportion reporting use of specific services is 
greater than the proportion reporting use of any service.
3.3.4. Factors influencing young people’s use of services
Data on type of service accessed and age at interview, age at first intercourse and living in a 
deprived area are presented in Table 3.3. Young people who reported having first sexual 
intercourse prior to 16 years and those living in more deprived areas were significantly 
more likely to use community contraceptive clinics than those who reported first sexual 
intercourse at 16 years or over and those living in more affluent areas. Increased use of 
general practice was significantly associated with increased age at interview. No significant 
association was found between age at interview and use of community contraceptive 
services. However when family planning clinics and designated young people’s clinics 
were examined separately, both young women and men’s use of family planning clinics 
increased with age at interview. The proportion reporting use of designated young people’s 
clinics was highest amongst the under 16 year olds (13.4% of all sexually active women 
under 16 years and 9.8% of all sexually men under 16 years). The decrease in use with age 
at interview was significant amongst young men (p=0.006, decreasing to 5.3% of sexually 
active young men 18 years and over).
68
Table 3.3. Characteristics of respondents reporting having accessed different 
types of service for supplies [%)] (Denominator -  respondents reporting 
heterosexual intercourse)_________________________________________________
Any service School-based
clinic
General
practice
Community
contraceptive
services
Commercial
WOMEN
Age at interview
<16 (n=157) 
16-17 (n=615) 
>=18 (n= 1029)
p<0.001
83.4
89.9
93.7
p=0.001
40.1
25.2 
19.8
p<0.001
30.6
45.9
62.4
p=0.528
51.5
53.5 
57.2
p=0.001
32.5
35.3
42.4
Age at first 
intercourse1
<16 (n=771) 
16 and above (n=851)
p=0.011
94.2
90.8
p=0.05
19.6
15.9
p=0.416
57.6
55.6
p<0.001
62.6
47.5
p=0.388
41.1
39.0
Deprivation2
Least deprived (n=1292) 
Most deprived (n=506)
p=0.136
92.1
89.9
p=0.326
20.4
18.4
p=0.385
54.6
52.4
p=0.003
52.3
60.1
p<0.001
42.7
30.0
MEN
Age at interview
<16 (n=132) 
16-17 (n=554) 
> 18(n=1026)
p=0.001
70.5
75.8
81.0
p=0.001
37.1
28.9
18.4
p=0.012
8.3
8.1
12.4
p=0.518
31.1
30.0
32.7
p<0.001
39.4 
50.2
58.5
Age a t first 
intercourse1
<16 (n=710) 
16 and above (n=827)
p=0.966
79.7
79.8
p=0.543
22.8
21.5
p=0.372
11.8
10.4
p=0.002
35.9
28.5
p=0.029
53.1
58.6
Deprivation2
Least deprived (n=1273) 
Most deprived (n=430)
p=0.056
79.5
75.1
p=0.699
23.6
22.6
p=0.495
10.4
11.6
p=0.004
29.8
37.4
p<0.001
57.6
44.4
Notes
1 denominator = sexually active respondents aged 16 years or more
2 Least deprived = Upper three quintiles o f the Indices of Multiple Deprivation scores. Most deprived =Lower two 
quintiles of the Indices of Multiple Deprivation score
3.4. How do the TPSE findings compare with other data sources and surveys?
The first aim of this chapter is to examine survey data on young people’s knowledge 
and access of services. The TPSE data showed that over three-quarters of sexually 
active young people knew of a place from which they could obtain information about 
sex, including contraception. However, awareness was lower amongst those who had 
not yet had sex and amongst young people under 16 years, irrespective of whether or 
not they had had sexual intercourse. TPSE data showed that overall community
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contraceptive clinics and general practice were the main providers of contraceptive 
supplies to young women and commercial sites were the main providers to young men.
Routine data sources monitoring use of contraceptive services are available, although 
there is much variation between health authorities and clinics in terms of the data 
collected.(164) Data are only consistently available from NHS family planning clinics 
and from Brook Advisory Centres. Both of these services provide KT31 returns, which 
give national data on the number of attendees, the age and sex of attendees, and the 
contraceptive method provided. The KT31 returns show a slight increase over the last 
decade in the number of first contacts at community contraceptive clinics amongst 
under 16 year olds, 7.2 per 100 of the female resident population aged under 16 years 
in 1995-6 to 8.7 in 2005-6.(165) The highest rate was observed amongst the 16-19 age 
group, with 21.5 per 100 of the resident female population aged 16-19 years accessing 
community contraceptive clinics in 2005-6. Again a slight increase was observed over 
the last decade. Amongst older age groups of women (i.e. aged 20 years and over) 
either no increase or a slight decrease in use observed. Data has only recently become 
available for men by age. In 2005-6, 2.0 per 100 of the male resident population under 
16 years and 2.6 per 100 of the male resident population aged 16-19 year attended 
community contraceptive clinics. A criticism of KT31 data is that their validity has 
never been independently assessed.(164) In addition, there is no information on other 
demographic and behavioural characteristics of the users of these services.
A limitation of routine data and of much of the research on contraceptive service 
provision is that the information is collected within health services. This has meant that 
knowledge of contraceptive use at a population level was lacking. People who were 
going to places other than general practice or community clinics, such as those 
obtaining their supplies from pharmacies, or those who were not accessing any form of 
contraceptive provider were being excluded from research. Selection bias has therefore 
been an important limitation of much research to date. Population surveys have 
allowed a better understanding of the demographic and sexual behavioural 
characteristics of the users of different types of contraceptive service.
Population surveys consistently show that general practice is the main provider of 
contraceptive services for women in the UK. The Natsal-2000 survey asked women 
and men aged between 16-44 years about the services used in the last year to obtain
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contraceptive supplies. General practice was the most commonly reported service by 
sexually active women, used by 59%.(166) Commercial sites were used by 23% of the 
women and community contraceptive clinics by 15%. Around one in five of the 
women reported that they had not accessed a service in the last year (although it is not 
possible to determine how many of this group were trying to get pregnant as this 
question was not asked). The survey found that women’s use of general practice 
peaked between the ages of 18-24 years (73% had used this source for supplies in the 
last year). Use of community contraceptive services (i.e. family planning and 
designated young people’s services) peaked between the ages of 16-17 years (34%), 
although general practice was still the main provider in this age group (54% of 
sexually active 16-17 year olds had used this service). Other recent population surveys 
have also found that general practice is the most used contraceptive service by women 
to obtain supplies,(167;168) although the Omnibus Survey" did find that women aged 
16-19 years were more likely to report using family planning clinics in comparison to 
general practice^ 167)
Another benefit of population surveys over routine statistics is that they give us a 
better understanding of men’s use (or non-use) of contraceptive services. Nearly half 
(45%) of all the sexually active men responding to Natsal-2000 reported that they had 
not accessed a service for contraceptive supplies in the last year.(168) The most 
common source of supplies was commercial sites, with 43% having accessed this type 
of service. General practice was cited by 12% of male respondents and community 
contraceptive clinics by 8%. The prevalence of use of general practice and community 
contraceptive services by men was highest for the 18-19 year group, 16% and 20% 
respectively.
TPSE respondents were selected through random-location sampling, therefore at each 
wave people living in the selected geographical areas were interviewed rather than the 
same individuals. However, we noted no difference in the characteristics of 
interviewees over time. A random probability sample, the method of sampling in
11 The Om nibus Survey is carried out in G reat Britain by the Office for N ational Statistics. It is a m ulti­
purpose survey and is used to  obtain results on key topics quickly. A wide range o f  subjects have been 
included in the survey, including contraception, fam ily income, transport, Internet access and fire safety. 
Each m onth around 1800 adults are surveyed, w ith only one adult selected per household.
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Natsal-2000, was excluded on grounds of cost and time as it was calculated some 25 
addresses would need to be screened to identify each within-scope contact. Random- 
location sampling has been shown to perform as well as random probability sampling 
in most circumstances,(169) and this methodology was viewed to be beneficial due to 
the compatibility of the survey data with the area-level data collected. Another major 
benefit of our survey was that both male and female respondents between the ages of 
13-21 years were interviewed. Other large-scale UK population-based surveys, such as 
Natsal-2000 and the Omnibus Surveys, looking at contraceptive service use have 
interviewed people aged 16 years and above.(10;167;170) Therefore patterns of service 
use amongst some of the most vulnerable young people were not examined.
It was not possible to produce the number of non-responders, either due to young 
people or their parent/guardian declining participation, because of the random location 
sampling approach. Another factor that needs to be considered when interpreting 
results is that those young people not living at home or not living independently, such 
as those living in care homes, were not approached to take part in the survey.
Population survey data enables us to look at overall characteristics of users of the 
different contraceptive services, rather than being limited by surveys of specific 
service users. Use of specific services is not mutually exclusive, since some people use 
more than one service in a given time period. However, the purpose of the analysis 
presented in this chapter was to look at characteristics of all users in each type of 
service rather than compare the characteristics of users across each separate service. 
The population surveys described (i.e. the TPSE tracking survey, Natsal-2000 and the 
Omnibus Survey) are not able to describe individual changes in patterns of 
contraceptive use or if people have used different services for different contraceptive 
needs, for example obtaining condoms from pharmacies, oral contraception from 
general practice and implants from community contraceptive clinics. Nor is it possible 
to distinguish whether use is by choice or necessity. For example a young person may 
have to attend general practice for contraceptive supplies if community contraceptive 
service provision is limited in their locality. People’s actual and preferred use of 
different services was analysed from data collected from a population survey that 
formed part of a national evaluation of one-stop shop models of sexual health 
provisional68) Survey respondents were aged between 16-44 years and identified
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through the registers of general practices that were either in the close proximity of 
sexual health services taking part in the evaluation or were themselves general 
practices taking part in the evaluation. Findings from the survey showed that the 
characteristics of those reporting use of a specific sexual health service for identified 
sexual needs (including STI testing and obtaining condoms and other contraceptive 
methods) were similar to the characteristics those reporting preference of the same 
service, thus suggesting most people (at least those aged 16 years or above) are 
accessing their service of choice.
3.5. Identifying the setting for the My Way intervention
The second aim of this chapter is to use the TPSE data and other relevant literature to 
help inform what would be the most appropriate setting to introduce the My Way 
intervention. Four categories of contraceptive service were examined in the TPSE 
analysis: general practice, community contraceptive clinics, school-based services and 
commercial sites. School-based services and commercial sites, such as pharmacies, 
were ruled out as these sites are limited in the range of contraceptive methods 
provided. There may be some potential in using decision-aids in these settings to 
inform young people about their contraceptive options. However, as the aim of this 
particular piece of work was to develop an intervention within a contraceptive 
consultation and assess its impact on decision-making, services that offered a wider 
range of methods were felt to be more appropriate. The strengths and weaknesses of 
general practice versus community contraceptive clinics are examined within three 
broad themes: the service users’ characteristics, the services’ impact, and 
environmental and organisational factors.
3.5.1. Service user characteristics
The TPSE tracking survey showed that the proportions of sexually active young
women attending general practice and community contraceptive clinics were fairly
similar. Although overall young men were more likely to report using commercial
sites, such as pharmacies, a greater proportion report accessing community
contraceptive services in comparison to general practice for contraceptive supplies.
Lack of contraceptive choice for men and limited availability of condoms in some
health services will influence men’s use of services. For example, condoms are often
not distributed in general practice. An audit of general practices in 2002 found that
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only around a half of practices provided condoms.(88) Women are more likely to 
attend health services than men as, with the exception of condoms which are the only 
method available for men, women are most often responsible for obtaining 
contraceptive supplies.(171) Even when young men do access sexual health services, 
health care workers are less likely to raise the issue of contraception with them in 
comparison to women,(77) and qualitative work with young men has shown that they 
still view contraceptive services as female orientated.(21) However, other data from 
TPSE show that young men’s use of general practice and community contraceptive 
services is increasing. Men, also, appear to be more likely to access contraceptive 
services when other sexual health care, such as STI screening, is available.(168)
The TPSE tracking survey showed that young people reporting sex before age 16 and 
those living in more deprived areas were more likely to use community contraceptive 
clinics than those reporting sex aged 16 years or above and those living in more 
affluent areas. Younger age at first sexual intercourse and social deprivation are 
associated with a higher risk of teenage pregnancy.(2;7) The TPSE data therefore 
suggests that community contraceptive clinics are seeing young people who are at 
‘higher risk’ of teenage pregnancy. The Natsal-2000 survey and data from the One- 
Stop Shop Evaluation also indicate that users of community contraceptive clinics are a 
‘higher risk’ group, with use of these services associated with greater number of 
partners, previous unplanned pregnancy and previous STI diagnosis. This highlights 
the fact that some attendees of these services may be at risk of poor sexual health 
outcomes, and may not just be in need of contraceptive supplies. Other research has 
shown that users of community contraceptive clinics are a different group from those 
who use general practice. Women who use general practice tend to be older, married, 
parous, spacing their pregnancies more widely and using the pill.(172;173) Users of 
community contraceptive clinics tend to be younger, single, and wanting to either 
delay their first pregnancy or wanting no further pregnancies.
3.5.2. Services’ impact
The TPSE data showed that around two-thirds of young people lived within two
kilometres of a sexual health clinic (i.e. a community contraceptive, GUM or
designated young people’s clinic) and just under half were within two kilometres of a
designated young people’s clinic. For some young people, a visit to their general
practice may be the only option, particularly those living in more rural areas. Proximity
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and ease of getting to clinics have been cited as prominent reasons for choosing a 
particular service.(168) Allaby found that districts with more family planning clinics 
appear to be more effective than those where GPs were the main source of 
contraceptive provision, particularly in providing contraceptive services to under 16 
year olds.(174) The number of local health authority areas in which there was at least 
one sexual health service dedicated to young people has increased steadily from 68% 
at the beginning of 2000 to 84% by the end of 2001.(41) There is some evidence from 
ecological data that these types of services do have a greater impact on teenage 
pregnancy at a population level. Ingham and colleagues compared 20 health authorities 
in England and Wales with the largest increases in under 16 year old pregnancy rates 
with 20 health authorities with the largest decreases [1992-1996].(175) They found 
that all the selected health authorities in the latter category had introduced a specialist 
young person’s clinic compared to only 55% of heath authorities in the former 
category.
3.5.3. Environmental and organisational factors
From a user perspective, a number of environmental and organisational factors can 
affect service preference. For example, the advantages of community contraceptive 
clinics in comparison to general practice that have been cited include: the 
contraceptive expertise of staff, greater chance of being able to see a female doctor, 
more contraceptive methods available, a less disease-orientated approach, more 
consultation time available, and evening clinics.(168) In addition, clinics are more 
likely to offer other related services, such as pregnancy testing, STI screening and 
psychosexual counselling.(176) Young people’s concerns about confidentiality in 
general practice continue to act as a barrier to their use of this service.(168;177-179) 
The TPSE survey found that a third of young women and just under half of young men 
remain unaware that they can obtain contraceptives without their parents’ knowledge. 
There is also confusion amongst some working in general practice about 
confidentiality relating to provision of contraception to young people under 16 years of 
age in particular.(88)
Community contraceptive clinics are not without their disadvantages. Disadvantages 
that have been cited included their limited opening times and the limited range of 
contraceptive methods in some designated young people’s services.(89;168) General
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practice is preferred by some people as they feel there is greater continuity of care, less 
stigma associated with its use and the reason for the visit is not apparent.(168)
The data show that young people most at risk of unplanned pregnancy (and STIs) are 
more likely to access community contraceptive services. There are also environmental 
and organisational factors that suggest that community contraceptive services would be 
the most appropriate setting for an intervention aiming to improve young people’s 
contraceptive understanding and choices. From a logistical perspective it would be 
more feasible to conduct an evaluation of the intervention in a community 
contraceptive setting as it would be easier to identify those attending for contraceptive 
reasons in comparison to general practice. Also, the numbers of young people 
attending general practice for contraceptive reasons would contribute a small 
proportion of the overall attendance.
3.6. Conclusions
The proportion of sexually active women reporting use of services for contraceptive 
supplies is high at over 90%. However, ensuring good access to services is only part of 
the equation in reducing unplanned pregnancy amongst under 18 year olds. Ways of 
improving young people’s contraceptive choices and increasing correct use of methods 
also need to be addressed. In terms of developing an intervention to improve young 
people’s contraceptive decision-making it is appropriate to target those young people 
who are at greatest risk of unplanned pregnancy. The data from the TPSE tracking 
survey and other research literature suggests that community contraceptive services are 
attracting young people who are more vulnerable to poor sexual health. In the next 
chapter I describe how the My Way intervention was developed for use in a community 
contraceptive clinic.
3.7. Key points
• In the UK, a number of different services provide contraceptive advice and 
supplies.
• Data from the Teenage Pregnancy Strategy Evaluation tracking survey were used 
to examine young people’s knowledge and use of contraceptive services.
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• Interviews were achieved with 8879 young people aged 13-21 years. Young people 
were identified by random location sampling.
• Two-thirds of all young women and nearly half of all young men (including those 
who had not yet experienced sexual intercourse) reported that they had accessed a 
service to obtain contraceptive advice. The most frequently cited service accessed 
for advice by young women was general practice and for young men was school.
• Less than half of the total sample reported that they had had heterosexual 
intercourse, 44% of all the young women and 42% of the young men.
• The proportions of young women, who reported heterosexual intercourse, 
attending general practice and community contraceptive clinics were fairly similar, 
55% and 54%, respectively. Commercial venues were the most common source for 
young men who had reported heterosexual intercourse (54%).
• Young people who reported having first sexual intercourse prior to 16 years and 
those living in more deprived areas were significantly more likely to use 
community contraceptive clinics than those who reported first sexual intercourse at 
16 years or over and those living in more affluent areas.
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Chapter 4. The development of the My Way program
4.1. Introduction
The development (and subsequent piloting) of the My Way program was a collaborative 
project between a team of researchers, clinicians and information technology (IT) 
specialists (see Acknowledgements for the full details). Preliminary development work 
started in the summer of 2000, and the program was ready for piloting by Spring 2003. 
Some funding to help with the development phase was received from the Margaret 
Pyke Memorial Trust and from the former Camden & Islington Health Authority"1.
The computer-based program was developed to be used by young people during their 
consultation with doctors or nurses in a health service setting, but ultimately it was 
hoped that the program could be accessed in other settings or directly by young people 
via the Internet. The program was aimed at young people who were interested in 
understanding their contraceptive choices with respect to preventing unplanned 
pregnancy (either currently or in the future). Therefore the target group were young 
people who were having (or planning at some stage to have) vaginal sexual 
intercourse. It was not an aim to address other sexual behaviours or practices that may 
be adopted to prevent pregnancy within the program, such as abstinence or oral and 
anal sex.
The objectives of this chapter are to:
• describe how the epidemiological evidence for the identified options and 
attributes used within the underlying decision analysis program was collected 
and applied.
• outline the program’s structure and design.
• explain how the program works.
111 A round £60K  was received from these tw o organisations. This m oney essentially w ent tow ards salary 
and consultancy costs, and for som e program  softw are costs.
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4.2. Collection of the epidemiological evidence
4.2.1. Introduction
Eleven contraceptive options were included as the available choices in the program. 
These included: condoms (male and female), spermicides alone, withdrawal, oral 
contraceptive pill, Double Dutch (male condom and pill used together), cycle 
awareness, intrauterine device (IUD), cap, subdermal implants, and DMPA injections. 
In addition to these contraceptive methods, use of nothing was included in the list of 
options.
Research with young people had been previously conducted (by myself) which
identified the factors and outcomes that ‘mattered’ to them when they are choosing (or
not choosing) a contraceptive method or that might affect their continuation of a
method. The work was conducted as part of a contraceptive service needs assessment
in Camden and Islington, London.(l) Although this was a small piece of work and the
young people participating were not necessarily representative of all young people, it
was a useful exercise in identifying key themes and many of the concerns identified
were consistent with themes reported in other research literature (as described in
Chapter 1.). In brief, the research included a survey of 263 people aged 16-21 years in
a variety of community settings, including schools, general practice, sexual health
services and youth projects. In the survey young people were asked, taking account of
their current personal circumstances, to identify how concerned they would be about
factors that may influence their decision when choosing a new method of
contraception. In addition to pregnancy and STIs, side effects and ‘bother’ factors were
listed in the questionnaire. Focus groups involving 28 young people and in-depth
interviews with 30 young people were conducted to explore factors that influenced
contraceptive choice. Again these participants were recruited from community settings.
This work found that as well as young people being concerned about pregnancy and
STIs (although the young people often commented that they did not personally feel at
risk of STIs), side effects and ‘bother’ factors associated with contraceptive methods
did influence both initial uptake and continuation of methods. The side effects that the
young people identified as being of concern included: weight gain, acne, nausea, heavy
periods, no periods and thrombosis. The ‘bother’ factors associated with different
contraceptive methods included having to remember to take a method (for example
having to remember to take the pill each day), the effect on sex (such as having to put a
condom on ruining the spontaneity of sex), having to have an invasive procedure (for
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example, having an implant fitted or having an injection), and having to go to a health 
clinic to obtain contraceptive supplies. Interestingly most young people reported in the 
survey that views of friends, partners and parents had little bearing on contraceptive 
concerns and choices. This did contradict findings from the qualitative work.
Data were sought on the probability of these events happening for each of the 
contraceptive options to be included in the program. The best available evidence was 
collected on:
♦ the effectiveness of each contraceptive method in preventing conception,
♦ the risk of STI acquisition for each contraception method,
♦ the other outcomes and factors affecting the attractiveness of each method 
including possible side effects (e.g. weight gain) and ‘bother’ considerations (e.g. 
having to go to a health service to obtain a contraceptive method).
Evidence was selected in terms of study methodology and its appropriateness to the 
target group. The levels of evidence used to determine study quality were identified for 
each outcome (and are presented further on in this chapter). Levels of evidence used to 
‘grade’ quality would depend on the outcome in question. For example, the risk of 
nausea when using oral contraceptives could be determined in an RCT of oral 
contraceptives versus a placebo, but it would be inappropriate to conduct a similar trial 
to determine the risk of pregnancy. Where possible, data from studies with young 
people and from studies conducted in the UK were collected to try and increase the 
generalisability of findings to young people who would be using the My Way program. 
When calculating the prevalence of STIs (see p. 89) it was more appropriate to focus 
on UK data even if there were ‘higher quality’ data from other countries. For STI 
prevalence, the highest quality UK data were used, when available. It was not an aim 
of this exercise to conduct a systematic review of the evidence relating to outcomes 
amongst young people using different contraceptive method. The approach adopted 
was more pragmatic rather than systematic. Searches of Medline and Embase (using 
each of the identified contraceptive options and outcomes as keywords) were 
conducted in 2002 to identify literature and data of interest, alongside searches on 
relevant sites, such as WHO and the Health Protection Agency (HPA), and reference 
lists. Where no evidence was found, expert opinion was sought from within the team 
or from those working in the sexual health/contraceptive field.
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Where possible, the target time period for each of the outcomes was one year (for 
example, the chance of pregnancy occurring during one year’s use of the pill). A 
benefit of using a pre-determined time period rather than focusing on risks per sexual 
act is that with the former, behaviour is averaged out. Contraceptive users are more 
likely to have a contraceptive failure in the early stages of method use, so focusing on 
the first few months of use may over-estimate the failure rates.(180;181) The rationale 
for choosing a one year time period was that it was felt that most people who were 
likely to experience an outcome of interest would have experienced it within a year if 
they were going to experience it at all. A description of how data on outcomes were 
collected is provided below.
4.2.2. Pregnancy
Levels o f evidence
In order to measure true contraceptive efficacy you would need to have a double-blind 
RCT comparing different contraceptive methods against one another and against no 
method.(180) The women participating in the trial would be contraceptive naives. 
Information on whether the allocated methods had been taken consistently and 
correctly would need to be recorded. However, adopting such a design would be 
impossible. It would be unethical to randomise women who did not want to get 
pregnant to no method or a method they did not wish to use.
Selection bias, usually a greater problem in non-RCTs, is a limitation that needs to be 
considered when making an assessment on the effectiveness of a method in preventing 
pregnancy. Women choose methods depending on personal circumstances and factors 
such as their motivation to avoid pregnancy. Women who agree to take part in 
contraceptive studies may not be representative of the general female population of 
reproductive age.
Another problem is that studies of contraceptive effectiveness often exclude women 
with known fertility problems or only include women (and partners) with proven 
fertility. Therefore there may be more pregnancies observed amongst women in these 
studies than would be observed within the general female population. However, there 
may also be higher contraceptive failure rates in population-based surveys in 
comparison to those reported in clinical trials because women in the latter have agreed 
to take part in a contraceptive trial and therefore may be more motivated to take the
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methods correctly compared to those responding to a population-based survey. 
Population surveys may be more representative, but they also have their limitations, 
such as the validity of responses and problems with recall.
Data
Data on the probability of pregnancy in a one-year period when not using 
contraception and for each contraceptive method were obtained from Trussell.(182) 
These estimates come from different types of studies, including national surveys and 
clinical trials. Nearly all the studies were conducted in the US. Trussed provides both 
probabilities for method failure, which assumes the method was used consistency and 
correctly, and user failure, which takes account of user ‘error’. In the My Way program 
we used the user failure probabilities.
Table 4.1. Probability of unintended pregnancy in one year by contraceptive 
method: typical and perfect use (Adapted from Trussell, 1998(182))
Unintended pregnancy 
Typical use
Unintended pregnancy 
Perfect use
Chance 0.85 0.85
Spermicides alone 0.29 0.15
Fertility awareness (calendar) 0.09 0.09
Cap (nulliparous) 0.16 0.06
Withdrawal 0.27 0.04
Condom (male) 0.15 0.02
Condom (female) 0.21 0.05
Pill (combined and minipill) 0.08 0.003
IUD 0.008 0.006
Injectable 0.03 0.003
Subdermal implant 0.0005 0.0005
There were no estimates provided for Double Dutch. For the purpose of My Way 
Double Dutch was defined as condom and pill use together. Estimates for the most 
effective method of the two were used in the program. With regards pregnancy, the 
probability of pregnancy whilst using the pill was entered into the matrix, as the 
probability of pregnancy whilst using the pill is lower than that whilst using condoms. 
The principle of using the most effective of the two methods in preventing STIs and 
side effects, and the method least likely to cause ‘bother’ was also applied.
Assumptions and limitations
In order to measure true risk of pregnancy during perfect (or imperfect) use it needs to 
be established that a contraceptive method has been used consistently and correctly (or
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inconsistently or incorrectly) during a specified time period, ideally measured within 
each menstrual cycle to limit factors such as recall bias.(33;183) This level of follow- 
up is rarely achieved.
For the most part, the pregnancy data from Trussed presented above, apply to 
American women, and we can assume the reported probabilities of unplanned 
pregnancy for the different contraceptive methods would be fairly similar for women 
living in the UK. These probabilities may provide poorer estimates for individual 
woman because they do not take account of factors, such as partner’s fertility, STI 
history or age, and history of genital tract infections.
These probabilities may not apply as well to young women as a whole and may 
underestimate a young women’s risk of unplanned pregnancy when using different 
contraceptive methods. As discussed in the introductory chapter (see Section 1.3.3.) 
young people’s contraceptive use is likely to be more chaotic and less consistent than 
older women’s use. The more times you have sex, the increased likelihood of 
conception. Natsal 2000 data shows that women aged between 16-19 years report more 
episodes of sexual intercourse when compared to the whole sample surveyed, women 
aged between 16-44 years (See Section 4.2.3, Table 4.2.). As Trussed notes “Intrinsic 
to the definition of exposure (to pregnancy) is coital activity by fecund couples”.(181) 
Wilcox and colleagues followed up 221 women aged between 21-42 years, who were 
planning pregnancy and had no known fertility problems, to determine the chance of 
pregnancy with a single act of sexual intercourse.(184;185) They found that with one 
completely random act of sexual intercourse the chance of pregnancy was 3.1%. The 
chance of pregnancy ranged from being negligible at day three of the menstrual cycle 
and peaked at day 13 with 9% of women becoming pregnant. There are biological 
reasons why young women in their early teens may not be as fecund as slightly older 
women and therefore in this group the probabilities presented in Table 4.1. may be an 
overestimate. Women in their early teens often have irregular menstrual cycles and 
more irregular ovulation or anovulatory cycles, and therefore reduced fertility.(186)
4.2.3. Sexually transmitted infections
The following STIs were examined for inclusion in the MyWay program: Chlamydia
Trachomatis, Neisseria gonorrhoea, Herpes simplex virus, HPV, syphilis,
trichomoniasis and HIV. Each STI was examined separately, rather than looking at the
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general risk of STI acquisition, because of the differences in transmission probability, 
prevalence and whether or not use of different contraceptive methods were associated 
with an increased or decreased risk of acquisition. The studies examined investigated 
heterosexual transmission and acquisition of STIs.
In order to calculate the annual risk of STI acquisition for each contraceptive method it 
was necessary to calculate:
1. Transmission -  i.e. the chance that if you have vaginal sexual intercourse with a 
person with an STI it will be transmitted to you.
2. Prevalence -  i.e. the chance of having vaginal intercourse with someone who has 
an STI.
3. The risk increase or reduction of STI acquisition associated with different 
contraceptive options.
Details of the studies that formed the basis for these calculations are detailed in 
Appendix 2. In order to illustrate how the probabilities were derived I use the evidence 
collected for acquisition of chlamydial infection as an example in the equations. The 
Natsal 2000 survey is used to provide any data on sexual behaviour required in the 
equations.
1. Transmission - Probability of STI acquisition if sexual intercourse occurs with 
an infected partner
Levels o f evidence
In order to assess the probability of STI acquisition, we would want to know what the 
probability is of someone without infection acquiring an STI after having sexual 
intercourse with an individual who is infected.(187) Therefore the ‘ideal’ design would 
be a prospective cohort of monogamous discordant couples having unprotected sexual 
intercourse. There is one example of such a study that examined the transmission of 
gonorrhoea amongst of US navy men on shore leave.(188) This study was conducted 
in the mid 1970s and therefore prior the safer sex era. The study investigators assumed 
that the prevalence of gonorrhoea amongst women in the bars on shore was the same 
as the prevalence of infection amongst the sexual partners of the men. They were 
subsequently able to calculate that over 30% of the men who had had sexual 
intercourse with an infected woman acquired gonococcal infection. Obviously, such a 
study today would be unethical and in studies of non-treatable STIs, such as HIV, it
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would be unethical not to recommend safer sex. The other problem with STI 
transmission studies is when the uninfected individual is aware of their partner’s 
infection: the transmission risk is likely to be reduced with this knowledge. Wald and 
colleagues comment that both partners participating in their clinical trial of a vaccine 
for HSV-2 knew that one partner had genital herpes and that the other was at risk.(l 89) 
This knowledge, and the concern about possible transmission being a reason to enrol in 
such a study, was likely to be associated with a lower risk of transmission. Another 
factor that may lead to underestimating transmission risk in prospective cohort studies 
is that those couples recruited in these studies are likely to be in fairly established 
partnerships or at least to have had sexual intercourse prior to enrolment. One of the 
eligibility criteria for Wald and colleagues study was that couples had been together 
for at least six months. Therefore the period of highest transmission risk (see 
Assumptions and Limitations on p. 87) will have already passed. Retrospective cohort 
studies on the other hand tend to overestimate the probably of transmission. In these 
types of design it is often difficult to predict the direction of transmission. Studies that 
identify the index patient as they are seeking care are problematic as it could have been 
the contact who originally infected the index patient rather than the other way 
round.(187) With infections, such as Chlamydia trachomatis, which have short 
incubation periods and are often asymptomatic, it is not possible to use the time 
symptoms first appear as a way of determining who is the source of the infection.(190)
Therefore because of these problems with partnership studies we often have to rely on 
modelling to provide estimates of transmission risk.(187) The levels of evidence in 
terms of collecting evidence on transmission risk for My Way were as follows:
1. Prospective cohort of discordant couples
2. Retrospective study of infected couples
3. Modelling
4. Expert opinion
Calculating probability o f transmission
The majority of the evidence for the transmission calculations came for hypothetical 
modelling exercises (see Appendix A.2.1. and A.2.2.).
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In order to calculate the risk of acquiring chlamydial infection (or any STI) per 
partnership (Pptr) we need to know the probability of acquisition per sexual act (pact) 
and the average number of acts per partnership (n).(190) The risk per partnership is 
calculated as follows:
pptr=l-(l-pact)n
Natsal 2000 data tell us that the median number of heterosexual partners reported in 
the last year for 16-19 year olds is one for both men and women (see Table 4.2.). The 
median rather than mean was used in the program as the mean’s distribution is highly 
skewed. The median number of episodes of vaginal sexual intercourse in the last four 
weeks reported by men aged 16-19 years is four and for women aged 16-19 years is 
six. This allows us to estimate that within a year (and one sexual partnership) young 
women will have 59 episodes of vaginal intercourse and young men will have 26. This 
difference between young men and women is explained by the fact that the young men 
were more likely to have shorter relationships (median of two months compared to 
seven months for women), and women tend to have older partners. The young people 
were more likely to report a new partner in the last year compared to the general 
sample (median 1 vs. 0, respectively).
Table 4.2. Using Natsal-2000 survey data to estimate median episodes of vaginal 
intercourse, with lower and upper quartiles presented1
Episodes of vaginal 
intercourse in last 
four weeks 
25%, 50%, 75%
Heterosexual 
partners in the last 
year 
25%, 50%, 75%
Estimated number 
of sexual acts per 
partnership 
25%, 50%, 75%
Women
Aged 16-19 2, 6, 11 1 ,1 ,2 22, 59, 104
Aged 16-44 2, 5 ,9 1 ,1 ,1 26, 52, 104
Men
Aged 16-19 1 ,4 ,9 1 ,1 ,3 10, 26, 78
Aged 16-44 2 ,5 ,9 1 , 1 , 1 25,52,104
Notes
1 Base= Those who reported at least one episode of vaginal sexual intercourse in the last four weeks
2 Calculated as number o f sex acts in the last four weeks* 13/number of sexual partners
A study by Katz and colleagues estimated the probability for transmission of 
chlamydial infection per sexual act from male to female is 0.395 and from female to 
male is 0.323.(190) Therefore the chances of transmission in a year if you have one
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partner for young men is 1-(1-0.323)26=T.0 and for young women is 1-(1-0.395)59=1.0. 
Thus illustrating that the estimates suggest if  your regular partner is infected you will 
also get chlamydial infection.
For some infections, such as trichomonaisis, transmission per partnership rather than 
transmission per act o f sexual intercourse was obtained from the literature. For all the 
infections the risk o f male to female transmission was higher than the risk o f female to 
male transmission.
Assumptions and Limitations
Transmission within a single partnership is going to be influenced by the type o f 
sexual behaviour and frequency o f sexual intercourse. Based on the Natsal 2000 data it 
was assumed a typical person aged between 16-19 years would have one new 
partnership in a year and the median episodes of vaginal intercourse was 59 for young 
women and for men was 26. The effect o f lowering and increasing a person’s risk of 
STI acquisition is further explored in the section on sensitivity analysis (see p. 97). 
Figure 4.1. shows that the chance o f acquiring chlamydial infection is over 90% for 
women after five episodes o f vaginal intercourse and for men after six episodes. 
Therefore although Chlamydia trachomatis has a fairly short incubation period it does 
not take many episodes o f sexual intercourse before having a high chance o f acquiring 
the infection.
Figure 4.1. Probability of acquiring chlamydial infection if partner infected
0.9
0.7
0.5
0.2
Num ber o f  sexual acts
Men: Prob. o f  acquiring CT Women: Prob. o f  acquiring CT
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Applying the same calculations for an infection that the data suggests has a much 
lower probability of transmission per sexual act, such as HSV-2 (0.00015 for female to 
male transmission and 0.00089 for male to female transmission),(189) the chances of 
acquiring the infection within a partnership are greatly reduced (see Figure 4.2.). Based 
on the calculations above, the chance of a woman acquiring HSV-2 infection over a 
partnership is 5%.
Figure 4.2. Probability of acquiring herpes simplex virus type 2 if partner 
infected
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A number of limitations need to be borne in mind when interpreting these calculations 
and the data that informed them. In terms of the calculations, the level of infection is 
constant, that is one’s risk of acquiring an infection is the same for each subsequent act 
of sexual intercourse. This assumes that both the infectivity of the index patient and 
the susceptibility of the contact are constant. The duration of infectiousness is an 
important consideration as the stage of infection is a strong predictor of infectiousness. 
The peak transmissibility of HIV infection is soon after seroconversion of the index 
patient.(191) It is difficult to measure the duration of infectiousness of bacterial STIs 
because as soon as individuals become identified they should be treated.(187) 
Estimates for the infectiousness of untreated gonorrhoea and Chlamydia trachomatis
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range from around two to six months. Other factors that can influence the infectivity of 
the index patient include whether or not they have any other STIs, symptomatic versus 
asymptomatic infection and viral load.(192-194) Different subtypes may vary in their 
infectiousness. HIV subtypes have distinct geographical distributions, and the subtype 
most common in Thailand, for example, has a higher per contact transmission rate 
compared to subtypes found in other parts of the world.(191) The study used to 
provide HIV transmission data for My Way was from the prospective follow-up of 
discordant couples in Uganda.(192)
Examples of factors that can influence the susceptibility of the contact include whether 
or not they have any other STIs, and age. Younger women may be more biologically 
susceptible to STIs in comparison to older women because of, for example, lack of 
acquired immunity from past exposure, larger cervical ectopy and greater permeability 
of cervical mucus.(195)
As the aim of this work is the prevention of unplanned pregnancy, only studies looking 
at STI transmission amongst heterosexual couples were included. In reality, it is 
impossible to ascertain from the data collected if those who acquired an STI did so 
through vaginal rather than other forms of sexual activity, such as oral or anal 
intercourse. Other considerations that need to be borne in mind when examining the 
data, are the sensitivity and specificity of tests used to diagnose infection, and how 
samples are transported. How regular follow up is will also affect detection of STIs in 
contacts. Ho and colleagues, in their study of HPV infection in female college students 
in the US, describe how follow-up to test for HPV infection was conducted at six 
monthly intervals and therefore it is possible women could have acquired and lost the 
infection in this time.(195) This problem with follow-up would under-estimate the 
incidence of HPV infection and over-estimate the duration of infection.
2. Prevalence -  Probability of having vaginal sexual intercourse with an infected 
partner
Levels o f evidence
The ideal way to ascertain the prevalence of infection within the general population is 
through the use of a random probability sample.(196) The prevalence amongst specific 
target groups can then be compared to that within the general population. In reality
89
because of the cost and time taken to obtain information through this type of study 
design, surveillance data is the more usual way of obtaining prevalence estimates. 
However, the limitations of surveillance data include the dependence on the population 
under surveillance which may not be representative of the general population or the 
target group under investigation (such as young people with respect to MyWay). For 
example, in England STI surveillance is conducted by the collection of KC60 returns. 
These represent STIs diagnosed within GUM clinics and therefore there are 
limitations.(164) First, many people with asymptomatic infection not attending 
services for screening would not be detected and therefore remain undiagnosed. 
Second, STIs diagnosed in other settings, such as within community contraceptive 
services and general practice would not be included. For infections such as chlamydial 
infection, these two factors would mean that prevalence is greatly underestimated. 
However, other infections such as gonorrhoea, which are more often symptomatic, are 
more likely to be picked up in GUM clinics. Data from Natsal-2000 suggested that 
GUM attendance was highest amongst those with a history of gonorrhoea in 
comparison to other STI diagnoses, with over 90% of all men and women diagnosed 
with gonorrhoea reporting they had attended a GUM clinic in the past.(196) Data from 
cohort studies can also provide information on prevalence; however these data may be 
limited to the population under investigation and are not necessarily generalisable to 
the general population or other target populations.
For the purposes of data extraction for MyWay the evidence for STI prevalence was 
graded as the following:
1. Random probability sample
2. Surveillance data
3. Cohort
4. Expert opinion
Calculating probability o f STI acquisition within one year
In order to calculate the probability of STI acquisition we need to know the number of 
sexual partners an individual has within a year (nptr) and the chances of having sexual 
intercourse with an individual who has an STI. To do this we need to know the
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prevalence of infection within a given community (STI prevalence). The probability of 
STI acquisition within a one year (PSTI) is therefore calculated as:
pSTI= 1 -(1 -(pptr* STI prevalence))"1"
The best available evidence on the prevalence of chlamydial infection in the UK again 
comes from Natsal 2000.(187) Survey participants were asked to provide a urine 
sample, which was tested for genital Chlamydia trachomatis using urinary ligase chain 
reaction (LCR). The prevalence of undiagnosed chlamydial infection amongst 18-44 
year olds who reported at least one sexual partner was 1.5% (95% confidence interval 
[Cl] 1.1-2.1) for women and 2.2% (95% Cl 1.5-3.2) for men. The prevalence amongst 
women and men aged 18-24 was higher, 3.0% (95% Cl 1.7-5.0) and 2.7% (95% Cl 
1.2-5.8), respectively. Therefore the probability of acquiring chlamydial infection in 
one year for young men would be would be 1-(1-(1.0*0.03))1=0.03 (i.e. 3%) and for 
young women would be 1-(1-(1.0*0.027))1=0.027 (i.e. 2.7%). This is based on the 
assumption that an individual has a median number of partners of one in a year and the 
probability of transmission within a partnership is 1.0 (pptr). The probability of 
acquisition for each STI is provided in Appendix A.2. The data show that although an 
infection like gonorrhoea is highly infectious the chances of acquiring it are relatively 
small because prevalence is low, while the chances of acquiring HPV infection are 
relatively high as both the probability of transmission per partnership and prevalence 
are high.
Assumptions and Limitations
Nearly all the evidence to ascertain levels of prevalence came from UK studies or
surveillance data. The one exception was with regard HPV infection, which used data
from the United States.(197) STI prevalence data from other countries would be very
much-affected by different cultural norms with regards sexual behaviour and how
health services were delivered, including prevention and control interventions. Even by
trying to limit the data used to that from the UK will not take account of the
heterogeneity within the population. Where possible the data used were limited to
those relating to young heterosexual people (various age ranges), although this was not
always possible (see Appendix A.2.1. and A.2.2.). Generally STI prevalence is higher
amongst young people in comparison to the general population, predominantly due to
young people’s sexual behaviour and networks, and their poorer access to health
91
care.(193) By trying to use prevalence data from young people to calculate the 
probability of STI acquisition within one year, we were assuming that young people 
were having sexual intercourse with partners within a similar age range. Prevalence of 
STIs does vary between different age categories. Therefore, risk of STI acquisition will 
vary depending on partner difference age. Data from Natsal 2000 suggests that most 
men report first heterosexual sexual intercourse with a partner of similar age, while 
women report a mean age difference of 2.6 years older for their partners.(63) The other 
assumption made for calculating STI risk was that sexual partners are selected at 
random rather than through networks. There is increasing recognition of the 
importance of sexual networks and mixing in STI acquisition and transmission. (198- 
200)
Prevalence studies, like transmission studies, can be limited by detection problems. For 
example, our understanding of the epidemiology of HPV has been fairly limited 
because most infections are subclinical, there has been a lack of routine clinical tests 
for diagnosis and different studies have used different testing methods.(197;201)
3. The effect contraceptives have on STI acquisition
Levels o f evidence
For reasons already discussed, it would be unethical to randomly assign individuals to 
different contraceptive methods to assess the effect on STI acquisition and it would be 
difficult to get an appropriate control group. Prospective cohorts of monogamous 
discordant couples are likely to be the best level of evidence to assess the effect of 
contraception. The benefits and limitations of these types of study have again already 
been discussed. For example, in any prospective study, the investigators should 
counsel women on how to limit their risk of STI, and therefore the number of STIs 
diagnosed should be reduced. Prospective studies may also be prohibitively expensive, 
because in a relatively low risk population, large numbers of participants may need to 
be followed up for a long period of time to observe any difference between 
contraceptive methods.
Case-control studies may be more feasible to address the question of the effect of 
contraception on STI, but these studies also have their limitations that must be 
considered when interpreting results. For most STIs, it is not possible to determine the
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correct temporal association between contraceptive use and the time that STI 
acquisition occurred.(202) This problem should be reduced as the duration of 
contraceptive use increases. Caution should be paid to cross-sectional surveys for the 
same reason.
The levels of evidence to determine the effect different contraceptive methods have on 
STI acquisition were identified as follows:
1. Systematic review of prospective discordant couple cohort studies
2. Prospective discordant couple cohort studies
3. Case-control studies
4. Cross-sectional studies
5. Expert opinion
Increase or reduction in risk o f STI acquisition by contraceptive method 
The literature was searched to identify studies that investigated the effect use of 
different contraceptive methods have on the acquisition of STIs. Details of these 
studies are provided in Appendix A.2. Table 4.3. (see over) shows the risk ratios for 
acquiring chlamydial infection for each contraceptive method based on available 
literature or expert opinion. The risk ratios were then used to calculate the proportion 
of women who would acquire chlamydial infection within a year for each 
contraceptive method. This exercise found the method that the evidence suggested as 
the most effective in reducing the risk of chlamydial infection was the cap, which 
reduced the risk of acquisition by about 70%. Therefore 0.8% of young women using 
the cap would acquire chlamydial infection within one year. The evidence suggested 
that users of the pill may in fact have a slightly increased risk of chlamydial infection.
Assumptions and limitations
Studies that have investigated the effect of use of contraceptive methods on STI 
acquisition often report conflicting results. For example, Stephenson, in her systematic 
review on hormonal contraception and the risk of HIV transmission reported that the 
sparse data available from the methodologically strongest prospective cohort studies 
varied from a 90% reduction in the risk of seroconversion associated with oral 
contraceptive use to a 100% increase.(206) There are a number of methodological 
considerations that should be borne in mind when interpreting data on studies looking
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at the effect of contraception on STI acquisition and these may help to explain some of 
the variations observed across different studies.
Table 4.3. Calculated risk ratio (RR) for acquisition of chlamydial infection for
each contraceptive method
Contraceptive
method
RR for 
STI
acquisition Evidence for RR
Proportion 
acquiring an 
STI within 
one year1
None - - 2.7
Spermicides 0.88 Meta-analysis (WHO, 2001)(203) 2.4
Fertility awareness 1.0 Expert opinion 2.7
Cap/diaphragm 0.29 STI clinic attendees, US -  Cross-sectional 
study (Rosenberg et al, 1992)(204)
0.8
Withdrawal 1.0 Expert opinion 2.7
Condom (male) 0.97 STI clinic attendees, US -  Cross-sectional 
study (Rosenberg et al, 1992)(204)
2.6
Condom (female) 0.87 Expert opinion 2.4
Pill 1.04 STI clinic attendees, US -  Cross-sectional 
study (Magder et al, 1988)(205)
2.8
IUD 0.8 STI clinic attendees, US -  Cross-sectional 
study (Magder et al, 1988)(205)
2.2
Injectables 1.0 Expert opinion 2.7
Subdermal implant 1.0 Expert opinion 2.7
Notes
1 Calculated by multiplying the RR of STI acquisition for each contraceptive with the chance of STI acquisition if
no method was used.
As seen with pregnancy, the measurement of contraceptive use, in particular condom 
use, is often inconsistent and can therefore lead to an underestimate of their 
effectiveness in preventing STI transmission. There are even problems with some of 
the meta-analyses that have attempted to assess the effect of condom use of HIV 
transmission, such as comparing ‘some’ condom use with ‘no’ condom use.(207) This 
will underestimate the effect of condoms (as also observed for the relative risk of 
condom users acquiring chlamydial infection shown in Table 4.3.). In the meta­
analysis of condom effectiveness in reducing heterosexual transmission of HIV that 
provided the estimates for MyWay three categories of condom usage were compared: 
always-use (100% usage during vaginal intercourse), sometimes use (1-99% usage) 
and never-use (0%).(208) Condom effectiveness was measured by comparing always- 
use with never-use. There are some infections where condoms offer less protection 
even if they are used consistently and correctly. For example, it has been observed that
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condoms have a greater protective effect against HSV infection in women than 
men.(189) This may be explained by the location of the lesions. In men, lesions are 
typically on the shaft on the penis and therefore would be covered by a condom. In 
women lesions are more commonly found in the vulval or perianal areas. The evidence 
used for MyWay to determine the association between condom use and the viral 
infections HSV and HPV in women came from a random population-based cross- 
sectional survey conducted in Denmark and Greenland.(209) A slight decrease in risk 
of HSV infection was observed amongst women whose used barrier methods (i.e. 
condoms and the cap), but the association was non-significant (odds ratio [OR] 0.8, 
95% Cl 0.6-1.2). No association was found between users of barrier methods and 
HPV infection (OR 1.0, 95% Cl 0.7-1.5). However, a lack of observed association 
does not necessarily equate with no health benefit. Barrier methods, such as the 
condom and cap, may not be able to offer protection to ‘exposed’ areas that are not 
directly protected by the method itself, but they may offer protection for women in 
areas that are protected, such as the cervix. This may help to prevent the development 
of cervical neoplasia, and subsequent cervical cancer, associated with HPV.(210)
The under and over-reporting of contraceptive use will affect estimates of their 
effectiveness in reducing and increasing risk of STI acquisition. For example, 
Zenilman and colleagues comment how people’s perceptions of what health care 
workers or researchers expect or want to hear in terms of condom use may lead to 
over-estimates in the reporting of correct and consistent usage.(211)
Another problem with measurement is the length of time a contraceptive method has
been used. For the MyWay program data from a case-control study of female STI clinic
attendees were used to provide the relative risk of gonorrhoea, Chlamydia trachomatis
and trichomonaisis in users of condoms and the diaphragm.(204) In this study women
were asked about the single most used method over the last month. Not only may use
have been inconsistent, but the female cases may have been infected prior to use of the
contraceptive method. Another problem is that people often use more than one method
over a period of time or during an episode of sexual intercourse. Therefore, it is
difficult to attribute a risk increase or reduction to any one particular method. There
has also been suggestion of a synergetic effect of using more that one method. Austin
and colleagues conducted a case-control study to examine factors associated with
gonorrhoea infection in female GUM clinic attendees.(212) The use of spermicides
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alone reduced the risk of gonorrhoea by 10% and the use of condoms alone reduced 
the risk by 13%. However, amongst women who used both condoms and spermicides, 
there was a reduced risk of gonorrhoea of 59%.
The confounding between sexual behaviour and contraceptive choice can cause 
difficulties when trying to understand the relationship between STIs and contraceptive 
use. It is an individual’s behaviour, rather than the contraceptive method they are 
using, that is the risk factor. Stephenson observed in her systematic review of HIV 
infection and hormonal contraception that residual confounding may have been 
responsible for much of the association as studies with more extensive statistical 
adjustment for other risk factors tended to report lower odds ratios than studies with 
little or no adjustment.(206)
There are potential problems translating findings of studies from different countries 
with regards the effect contraceptive methods have on STI acquisition. For example, 
some of the evidence collected for use in the MyWay program came from studies 
conducted in Africa. Factors other than contraceptive method used may put some 
groups at increased risk of STI infection, such as impaired immunity in areas with high 
HIV prevalence and high levels of genital ulceration.
Despite these limitations, there are biological changes due to contraceptive use that 
may increase susceptibility to STI infection, particularly amongst the hormonal 
methods. Pill use is associated with cervical ectopy thought to be caused by higher 
levels of oestrogen.(202) Cervical ectopy is the extension of sensitive columnar cells 
from the cervix. These cells are more vascular than the squamous epithelium, and 
therefore may be more easily traumatised and vulnerable to STIs. An association has 
been found between cervical ectopy and chlamydial infection, although not with 
HIV-1 infection.(202;210) What is unclear is which came first: the ectopy or the 
infection, that is the ectopy through pill use leading to infection or the infection 
(confounded by pill use) leading to the ectopy. It has also been suggested that the 
ectopy may in fact make it easier to detect infections.(213;214) Expert opinion within 
the MyWay research team was that men whose female partners used the hormonal 
methods were at neither increased nor decreased risk of STIs. However, there has been 
some speculation that HIV infected users of hormonal contraception are more likely to
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infect their partners than other HIV-infected women as HIV DNA is more likely to be 
found in their cervical and vaginal secretions.(215)
Biological factors can also explain how some methods may (certainly in theory) 
protect against STI acquisition. Progesterone-releasing methods, either the combined 
pill or LARC methods, such as subdermal implants, IUSs and injectables, help prevent 
sperm penetration through the thickening of the cervical mucosa. This mechanism may 
also inhibit STI transmission. There was minimal evidence available to examine the 
effect of LARC use on STI transmission. Only one study was identified. This was a 
prospective study that followed up a cohort of HIV-negative sex workers to investigate 
risk factors associated with HIV seroconversion.(216) This study reported the use of 
DMPA injections was significantly associated with seroconversion (OR 3.7, Cl 1.4- 
3.4). However, these results should be treated with caution. This same study reported 
that there was also an association between pill use and seroconversion (OR 2.6, (Cl 
1.0-6.8), while the meta-analysis of the methodically strongest studies suggest that use 
of the pill has a protective effect, although this was not statistically significant (OR
0.3, 95% Cl 0.05-2.1).(206)
There is some suggestion that women may be more at risk of HIV infection during 
menstruation.(191) An increased risk has also been reported for men whose HIV 
infected partners are menstruating. It could be assumed therefore that methods that can 
increase the volume of blood loss, such as the IUD, or the frequency of blood loss, 
such as subdermal implants, could increase an individual’s risk of STI acquisition. 
Mati and colleagues found in their case control study comparing HIV seropositive 
women with HIV seronegative women that the former group of women had a slightly 
increased odds of being past IUD users, although this association was not statistically 
significant, (OR 1.2, 95% Cl 0.8-1.7).(202) Contrary to this was the cross-sectional 
survey of 1031 female STI clinic users in the US that found that there was a decreased 
odds of chlamydial infection amongst IUD users.(205) No evidence was found in 
terms of risk amongst men whose partners were using the IUD. Expert judgment 
within the research team was that we should assume the risk was the same as chance.
Sensitivity analysis
For the purposes of the initial development of My Way we tried to obtain data that
would represent outcomes in a typical young person. In the case of STI acquisition we
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assumed that the level of risk for My Way users would be ‘average’. However, it would 
be possible to identify young people who were ‘low’ or ‘high’ and then link them to a 
matrix with data that are more applicable to their risk behaviour or environment (such 
as if they were having sex with an individual from a target group where the prevalence 
of STI infection was high). Sensitivity analysis was conducted to assess the difference 
identifying an individual as low or high risk would have on the estimates of STI 
acquisition in one year. Data on from Natsal 2000 and studies relating to chlamydial 
transmission were again used to illustrate this process.
In order to investigate the effect of lowering or increasing the risk of STI within a 
partnership, the lower and upper ranges of transmission per sexual act of chlamydial 
infection provided by Katz were applied to the formulae pptr=l-(l-pact)n.(190) The 
probability of male to female transmission per sexual act was 0.395 (range 0.234 to
0.402) and 0.323 for female to male transmission (range 0.203 to 0.331). The lower 
and upper quartiles for number of sexual acts per partnership from Natsal 2000 data 
were applied (see Table 4.2.). Therefore the probability of acquiring chlamydial 
infection from an infected partner is estimated as:
Male to female
Lower risk transmission Pptr = 1 -(1 -0.234) = 1.0 
Higher risk transmission pptr = 1-(1-0.402)104 = 1.0
Female to male
Lower risk transmission pptr =l-( 1-0.203)10 = 0.90 
Higher risk transmission pptr= 1 -(1 -0.331 )104 = 1.0
Reducing or increasing risk of transmission per sexual act or the frequency of sexual 
activity within a partnership has little impact on transmission within a partnership as 
the chances of infection with Chlamydia trachomatis are already high. Transmission of 
this infection is likely to happen in the early stages of a sexual relationship. However,
impact of the sensitivity analysis will vary between infections and a difference will be
more notable with infections that have a lower chance of being transmitted during one 
sexual act, such as HSV.
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The sensitivity analysis had greater impact when the focus was risk of acquiring 
chlamydial infection in one year. Low and high scenarios were applied to the formula: 
pSTI=l-(l-(pptr* STI prevalence)nptr. Fenton and colleagues provide 95% confidence 
intervals around the prevalence estimates of chlamydial infection amongst 18-24 years 
in the UK: 3.0% (95% Cl 1.7 -  5.0) amongst women aged 18-24 years and 2.7% (95% 
Cl 1.2-5.8) amongst men aged 18-24 years.(196) The lower confidence limits were 
used to represent a low-risk scenario (i.e. low prevalence) and the upper limits a high- 
risk scenario (i.e. high prevalence). Natsal 2000 data provided the lower and upper 
quartiles for number of sexual partners in the last year (denominator those who had 
had vaginal sexual intercourse in the last year). The effect of condom use was applied 
to these estimates. Again the confidence intervals around the relative risk of infection 
obtained from the literature were applied. Estimates from the case-control study 
conducted by Rosenberg and colleagues were used for women.(204) As no estimates 
were obtained for the effect condoms have on men’s risk of chlamydial infection, it 
was assumed the risk would be the same as that for gonorrhoea (See Appendix A.2).
Male to female
Low risk PST= 1 -(1 -(1.0* 1.2))' = 0.012
Low risk pST with lower 95% Cl of condom relative risk = 0.6*0.012=0.0072 
High risk pST= 1 -(1 -(1 0*5.8))2 = 0.113
High risk pST with upper 95% Cl of condom relative risk = 1.57*0.113=0.177 
Female to male
Low risk p S T I= l-( 1 -(0.9* 1,7))'=0.015
Low risk pST with lower 95% Cl of condom relative risk =0.1*0.015=0.0015 
High risk PST =1-(1-(1.0*5.0))3= 0.143
High risk pST with upper 95% Cl of condom relative risk 1.13*0.143=0.162
The sensitivity analysis illustrates that changing the prevalence within a community 
and number of sexual partners does impact on an individual’s chances of acquiring an 
STI. In a low risk scenario a woman using condoms has a 0.7% chance of acquiring 
chlamydial infection in one year. For men using condoms it is 0.2%. In a high risk 
scenario the chance of acquiring chlamydial infection for a woman using condoms is
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17.7% and for a man it is 16.2%. The increased risk associated with condom use is 
likely to be confounded by other risks such as increased number of partners. As 
number of partners is already included in the modelling this risk is likely to be an over­
estimate. In the high-risk scenario, it has also been assumed that there is the same 
number of sexual acts within each partnership. Garnet and Andersson have noted that 
as people increase their number of partners, there is a reduction in the number of 
sexual acts per partnership.(217) As described above this is unlikely to have a great 
impact on the transmission of chlamydial infection due to the high probability of 
transmission, but this may have an impact on acquisition of other STIs.
4.2.4. Side effects
Levels o f  evidence
RCTs are the gold standard in measuring ‘treatment’ effect. In non-RCT studies it is 
difficult to attribute any side effects to the contraceptive methods themselves. For 
example, weight gain in women may be due to lifestyle changes rather due to use of 
contraception.
The levels of evidence used to identify studies that that investigated the side effects 
associated with contraceptive methods were:
1. Systematic reviews
2. Randomised or clinically controlled trials
3. Prospective cohorts
4. Case control studies
5. Cross-sectional surveys
6. Expert opinion
Data
Data from the literature were collected for the following potential side effects for
contraceptive methods: weight gain, acne, nausea, no periods, heavy periods and
thrombosis. These outcomes had been identified by young people in qualitative work
(previously conducted by RF) as side effects that would be likely to influence a young
person’s adoption and continuation of a method. As side effects are subjective, where
possible, definitions were set. For example, no periods or amenorrhoea is defined as no
menstrual bleeding lasting for more than 90 days. Belsey and colleagues analysed the
menstrual histories of over a 1000 healthy, normally menstruating women aged 15-49
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years (contributing to 6375 women years) to provide baseline data with which the 
menstrual patterns of women using contraception could be compared.(218)
Attributable probability of experiencing the identified side effects, rather than overall 
probability, was entered into the matrix. So for example, the probability of weight gain 
was obtained from a US study women aged 15-49 years with moderate acne where 
participants were randomly allocated to receive either the oral contraceptive or 
placebo.(219) The probability of self-reported weight gain at six months was 0.022 
amongst the pill users and was 0.021 amongst those taking the placebo, so the 
attributable risk was estimated to be 0.001. For some side effects, this meant there 
were negative values. The estimate used for acne amongst pill users (p=0.05) was less 
than the estimate of acne for amongst 16 year-old women in general 
(p=0.03).(220;221) As the My Way program was designed for all values in the matrix to 
be 0 to 1.0 the program would not accept negative values. Therefore, 0 was entered for 
any minus values. This was something that the team realised would have to be 
addressed in the future refinement of the program, but it was felt this would be 
acceptable for the pilot. Acne was the only side effect where some contraceptive users 
had a reduced risk attributable to the method they were using.
Assumptions and limitations
Nearly all of the side effects related to the hormonal methods. Therefore, for the most 
part, the chance of having the identified side effects whilst using any of the non- 
hormonal methods was assumed to be none. The exception was that menstrual changes 
were also investigated for IUD users.
Most of the evidence came from studies of women of reproductive age. Morbidity 
outcomes may be very different in young people, such as their reduced risk of 
thrombosis relative to older women.(222) Weight gain will be different amongst young 
women. It is important that young women realise that it is normal to gain some weight 
and percent body fat during their teens.(223) Young women are also likely to 
experience great variability in there menstrual cycle between menarche and the age of 
19 years, in particular episodes of infrequent bleeding, which is completely 
normal.(218)
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The extent to which some side effects are ‘bad’ enough to lead to discontinuation of a 
method will be subjective. There are, for example, cultural variations in how bleeding 
patterns are viewed. A systematic review of implantable contraceptives found that 
women in developing countries were far less likely to report discontinuation because 
of menstrual changes in comparison to women in developed countries.(224;225) Little 
is understood about young people’s views on changes in bleeding patterns caused by 
some contraceptive methods and how this affects method acceptability and 
continuation of use. Other factors, such as the influence of population programs and 
whether or not women have to pay for contraception, may influence the ‘acceptability’ 
of methods used. It is viewed as good practice that women should be counselled about 
possible side effects, although interestingly a systematic review found that there was 
little evidence to suggest that enhanced counselling improved contraceptive adherence 
or continuation.(226)
Many of the studies followed women up for less than one year. For some side effects, 
such as nausea, which normally settles after two to three months,(227) shorter follow- 
up will not be too much of a limiting factor. However, other contraceptive side effects, 
particularly bleeding patterns, can take a much longer time to settle.(224)
4.3.5. Bother factors
The ‘bother’ factors associated with contraceptive methods that young people had 
identified in the earlier qualitative work included:
1) having to go to a clinic to obtain supplies,
2) having to remember when to take or use the method,
3) having to have an invasive procedure,
4) the effect on sexual intercourse.
‘Bother’ factors are even more subjective than side effects. For the pilot, probabilities
for each of these factors were estimated by the research team. For example, for the
attribute “bother getting” we assumed that this would be 100% (i.e. 1.0) for the cap as
a user would definitely have to access a health service to obtain the cap, while for male
condoms it would be 25% (i.e. 0.25) as these are more widely available and a user does
not necessarily need an appointment at a health service and for withdrawal there would
be ‘no bother’. Other probabilities were even more arbitrary, for example the ‘bother’
of not using any contraception during sexual intercourse was estimated at 0.25 as it
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was felt there may be some anxiety in relation to the risk being taken. Details o f the 
probabilities assigned to bother factors for each method are provided in Appendix A.2 
(See Table A2.16).
A limitation is obviously what the research team constitutes to be or not to be a bother 
may be very different from what young people feel is or is not a bother. There is also 
likely to be wide variation between young people and bother may be influenced by 
external factors, such as accessibility o f local sexual health services.
4.3. Site structure and design
The team at LSHTM led by Prof. Jack Dowie, in collaboration with Lorenzo Gordon 
from the UK web programming company Orange Ideas, led on the development of the 
underlying decision analysis model and its presentation through a purpose-built 
website that functions as an interface for the model. The whole team contributed to the 
text for the site. Other websites about sexual health targeted at young people were 
reviewed by members of the UCL team to inform style and layout. A designer was 
employed to create a site that would appeal to young people using information 
collected from the website review. The logo image chosen to identify the MyWay site 
is illustrated below.
Figure 4.3. My Way logo image
maw ci y
103
There were four main sections to the site that were presented to users:
■ Questionnaire (for research purposes, See Chapter 5. Section 5.2.5.)*
■ Demo (Choice of two demonstrations: 1) choosing a friend to go on 
holiday with or 2) choosing a boyfriend/girlfriend)
■ Using the software
- Options
- Attributes
- Importance: The weighting box 
Results
■ Documentations
- FAQs (Frequently asked questions)*
How Tos*
- Glossary*
Credits (i.e. research team details)
Documents marked with an asterisk are shown in Appendix 3.
MyWay program was web-based. This gave it the future potential of being accessed 
from any location in the country, or indeed world. Using an Internet-based program did 
cause problems in the early stages as the NHS system did not allow access to sites 
outside the NHS network and the MyWay was hosted on a commercial server. This 
problem was solved by organising access to the IP (Internet Protocol) address of the 
commercial server on some of the clinic computers.
The MyWay software used a variety of computer technologies to achieve its objective. 
The software needed to be web enabled. Data entered by users had to be captured via a 
central database, irrespective of the location of the user. A web-capable relational 
database package was used to build and maintain data storage, which was stored on the 
commercial web server hired specifically for this purpose. It had to work with existing 
software. The MyWay team leased some Java softwarelv, which provided the weighting
iv The original “Rator Box” software was developed by Michael Kirschner.
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box and the decision analysis calculation code. The graph software was purchased 
from a commercial company (CORDA). Orange Ideas then substantially modified the 
working of the Java software in order to create something sufficiently dynamic for 
MyWay use.
The questionnaire and the option/attribute decisions made by the user were captured 
using a combination of web programming. This code had to correctly capture the data, 
and ensure that though a user could move freely about the system, they could not 
accidentally overwrite their data. In addition, because it was important to capture the 
data at a specific time, a login system had to be written to prevent unauthorised access 
contaminating the data set. The data were stored on relational database on the web 
server.
Whilst maintaining the user’s anonymity, we had to link the questionnaire with the 
recorded software data, and at the same time allow the user to change rooms between 
answering the questionnaire and using the software, or taking a break if necessary. We 
used a User identification (ID) number, which was an anonymous number, but allowed 
a returning young person who had not completed their software use to enter their ID 
and resume from the point where they had left off.
Terminology relating to the decision analysis process, such as ‘weighting’ and 
‘scores’, and the options and attributes were defined in pop-up boxes. These came up 
when the cursor was placed across the word the user wished to look up.
A site map was also included to help users navigate the non-software sections of the 
site, and get an overview of the information available.
An underlying matrix contained the probabilities collected for each option and 
attribute. The MyWay program was designed so that a library of alternative rating 
matrices (i.e. tables of probabilities), reflecting the different probabilities for the 
various outcomes and attributes that were likely to apply in different locations or 
population groups, could be installed and selected for use. An important feature of 
MyWay was the control ‘administrators’ could have over the data used within the 
program. It was felt that, ultimately, different sites, such as clinics, could have their 
own matrices, which could include local data. The only proviso would be that
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justification would have to be given as to why data were changed. Matrices could also 
be easily updated as new research results became available, ensuring that MyWay need 
never be out of date. Users were given the option to access the matrix data being used 
to generate their scores after they received their score.
An important consideration in relation to the matrix is the focus adopted in relation to 
outcomes. If a particular outcome is experienced by only one party in a sexual 
partnership, such as women in the case of heavy periods, then her rating for this event 
may be different from that of men. (Indeed men may be less likely to select it as a 
relevant attribute.) Conceptually a matrix may therefore be female focused, male 
focused or dual focused, the latter being one in which it is assumed that an outcome 
experienced by either is experienced by both. For the purposes of the pilot the 
outcomes were rated from either partner’s perspective (i.e. a ‘dual’ focus). Therefore 
the bother of getting the cap would still be 100% for a male MyWay user. In situations 
where data were applicable to both women and men, the highest probability was 
selected. For example, a young man’s risk of obtaining chlamydial infection was 
estimated to be higher than the risk for a woman if no contraception was used. 
Therefore the risk for men was entered into the dual matrix.
4.4. How the program works
4,4.1. How to use the program?
Young people were to be introduced to the program during their consultation with the 
contraceptive nurse or doctor. Demos were designed to be a simple introduction to the 
concepts behind the MyWay program. There were two demos to choose from. The first 
was “Boyfriend/Girlfriend” where users were asked to weight attributes they would 
look for in a potential partner. These attributes were being well-off, faithful, kind, 
outgoing and sexy. The second was “Holiday friend”, which asked the user to weight 
the attributes lively, adventurous, independent, funny and reliable to select a friend to 
go on holiday with. Young people were presented with a list of fictitious names. The 
gender of the first names used for the options were purposively ambiguous so that they 
would be applicable to both young women and men. Each name had probabilities 
assigned to each of their attributes, for example the probability that Gerry would be 
faithful was 0.2, but the probability s/he would be well-off was 0.8. Unlike the data 
used in the underlying matrix for the main contraceptive element of the program, the
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data on the attribute probabilities for the demonstrations were made up by the LSHTM 
team as this was purely as ‘academic’ exercise to help young people understand how 
the program worked.
The user was presented with a box made up of segments each labelled with an 
attribute. Using a cursor, the user could then increase or decrease the relative areas 
inside the box to assign their individual values to each of these attributes. These values 
were then quantified for use in the underlying decision analysis model by calculating 
the proportion of the total area each attribute is given. The values would always equal 
100% and the weights are all relative to one another. Therefore, if the user increases 
the size of one area within the box the software automatically adjusts the size and 
assigned weight of the other attribute areas. A bar chart showed the ranking and rating 
of fictitious boyfriends/girlfriends or holiday friends, by combining the user’s weight 
given to each attribute with the rating of the friend for that attribute. Details on how the 
scores are calculated are provided in the next section.
Once the young person had gone through the demos, they were then to move onto the 
section on contraceptive methods. The same principles as seen in the demos applied. 
Instead of the fictitious friends, the user was presented with a list of contraceptive 
options. These included: none, cycle awareness, withdrawal, condom (male), condom 
(female), cap/diaphragm, spermicides, the pill, IUD, injectables, subdermal implants 
and Double Dutch (condom and pill). They could choose up to eight options. It was 
felt that selection of more than eight options would be too complicated for the 
underlying decision analysis calculations. Once they had done this, they were 
presented with a list of attributes, which included pregnancy, and different STIs, side 
effects and ‘bother’ factors. Again they could select up to eight attributes. They 
assigned weights to each of the attributes and a bar chart then showed the ranking and 
rating for each of the contraceptive options chosen by the user, with the highest bar 
showing the option most consonant with the best available evidence and the user’s 
value weights.
The MyWay program also positively encouraged users to carry out ‘what i f
explorations by manipulating the weighting box to see how changing the weights
placed on the different attributes affects the scores given to each contraceptive method.
This exploration was not intended to be used to manipulate the program in order to see
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how a pre-preferred option could emerge as the recommended one. It was only 
available after the user has confirmed that they were satisfied with their weights and 
had been provided with the recommendation based on these weights.
4.4.2. How is a score calculated?
The Boyfriend/Girlfriend demo is used to provide further explanation on how a score 
is calculated. Figure 4.4. shows the attributes someone may consider when choosing a 
boyfriend or girlfriend. This box was presented and the respondent was instructed to 
use the cursor to move the borders and so increase or decrease the areas within the 
weighting box to represent the importance they placed on each of the attributes. Figure
4.5. shows an example o f assigned weights given to each of the attributes. In this 
example, being well-off was given the greatest relative importance at 46%.
Figure 4.4. Weighting box for Boyfriend/Girlfriend Demo
Click hero to save end se e  Option scores
Figure 4.5. Example of assigned w eights for Boyfriend/Girlfriend Demo
Play with area sizes to se e  effect on Scores
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In the Score Bar Chart below (Figure 4.6.) we can see that Gerry scored best when the 
user entered the weights above and these were combined with the supplied ratings for 
each friend and each attribute (see Table 4.4). The tallest bar (i.e. the one with the 
highest score) identified the ‘best’ option based on the evidence and the user’s values. 
This bar was always identified in yellow.
Figure 4.6. Score Bar Chart
Pat Gerry J o s sSam Chris
If the user were to click on the Show Score Breakdown button, they could see that 
Gerry scored 0.64 (Figure 4.7.).
Figure 4.7. Score breakdown
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To see why Gerry scored 0.64 we need to refer to the matrix for Boyfriend/Girlfriend 
(Table 4.4.). The ratings for the friends’ characteristics were assigned by the team, for 
example Gerry had the highest rating for being well-off at 80%.
Table 4.4. Ratings matrix: Probability of ‘friends’ having defined characteristics
Kind Outgoing Sexy Well-off Faithful
Sam 0.8 0.2 0.5 0.4 0.6
Chris 0.2 0.8 0.2 0.6 0.4
Pat 0.4 0.6 0.8 0.2 0.5
Gerry 0.5 0.4 0.6 0.8 0.2
Joss 0.6 0.5 0.4 0.5 0.8
Each option (friend) was scored in the way illustrated for Gerry in Table 4.5. The 
ratings for each attribute appear in the first row. In the second row the attribute weights 
from the Weighting Box are entered. The attribute weights and ratings are then 
multiplied to get the figures in the final row. Adding sideways across all the attributes 
provides Gerry’s score of 0.63 (a slight difference to score in the bar chart due to 
rounding up). All other options (friends) are scored the same way. This way of 
calculating a score differs from the decision trees described in Chapter 2 (Section 
2.3.4.), but the same decision analysis principles apply.
Table 4.5. How a score is calculated
Gerry Kind Outgoing Sexy Well-off Faithful Total
Rating 0.5 0.4 0.6 0.8 0.2
Weighting 0.12 0.08 0.27 0.45 0.06 1.0
Rating x 
Weight 0.06 0.032 0.162 0.368 0.012 0.634
When calculating the scores for the contraceptive options, we had to take account of 
the fact that the attributes were negative or undesired characteristics (unlike the 
Demo’s positive attributes). Because we wanted a higher score to be better, we entered 
the complement of the rating for each attribute. For example, instead of using the 
probability of getting pregnant whilst using the pill when calculating scores, we used 
the probability of not getting pregnant whilst using the pill. The program can function
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with either positively or negatively orientated attributes, but all attributes must be 
orientated the same way.
The phase I pilot was an opportunity for both young people and providers to give 
feedback on the structure and design of the program, as well as for investigating the 
feasibility of using the program in a clinical setting. The pilot’s design and findings are 
described in the next chapter.
4.5. Key points
• The computer-based program, MyWay, was developed to help young people with 
their contraceptive decision-making and was to be used during their consultation 
with doctors or nurses in a sexual health clinic.
• Data on the effectiveness of different contraceptive methods in preventing 
conception, the risk of STI acquisition for each contraceptive method, and other 
outcomes and factors affecting the attractiveness of each method, i.e. possible side 
effects (e.g. weight gain) and ‘bother’ considerations (e.g. having to remember to 
take method) were collected from available scientific evidence for the program’s 
underlying decision analysis model. Data collected referred to the probability of an 
event occurring within one year (e.g. the probability of weight gain in a year when 
using injections).
• Evidence was selected in terms of study methodology and its appropriateness to the 
target group. Where evidence was not available from the published literature, 
opinion was sought from experts in the sexual health field.
• The MyWay program was presented through a purpose-built website that 
functioned as an interface for the model.
• Young people were first given some demonstration exercises (e.g. choosing a 
friend to go on holiday with), designed to be a simple introduction to the concepts 
behind the program.
• They were then presented with a list of contraceptive options and attributes to 
select. They were asked graphically to weight how concerned they were about each 
of their selected attributes. The program then provided a ranking and rating for 
each of the contraceptive options chosen by the user. The scores for each method 
were calculated by combining the probability of events occurring from the
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scientific evidence with the weight young people placed on their selected 
attributes.
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Chapter 5. The pilot: MyWay in a clinical setting
5.1. Introduction
The ultimate goal was to conduct an RCT comparing the MyWay program to usual 
contraceptive care within clinical consultations to assess its effect on selection and 
continuation of contraceptive methods (a measure of acceptability) and on subsequent 
rates of pregnancy and STI diagnosis (a measure of effectiveness). Distinguishing 
which components within a complex intervention are responsible for its effectiveness, 
or lack of it, can be challenging. In trials of complex interventions simply focusing on 
primary trial endpoints, such as biological outcomes, will provide little understanding 
of how the intervention is working.(228;229) In order to understand the process, multi­
method evaluations need to be adopted. In behavioural interventions the mechanisms 
are social and psychological, unlike clinical trials where they are biological, which can 
make measuring effect more complicated. Understanding the context and how 
stakeholders interact with the intervention needs to be examined.(230) Before an RCT 
could be undertaken exploratory work was needed to give young people and health 
care staff an opportunity to provide feedback on both the program and the research 
tools designed to measure effect. The phase I pilot provides the opportunity to assess 
the feasibility of using the MyWay program within consultations in a young person’s 
sexual health clinic, its acceptability amongst young people and staff, and its potential 
in helping young people make contraceptive decisions. It also helped to identify 
methodological factors that would have to be addressed when designing an RCT.
The objectives of this chapter are:
- to describe the methodology used in the phase I pilot study of the MyWay program
- to report the pilot findings
5.2. Pilot methods
5.2.7. Aim and research questions
The aim of the phase I pilot was to access the feasibility, acceptability and potential 
effectiveness of the MyWay program in a young person’s sexual health clinic.
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The following questions were to be addressed in this exploratory stage:
1. Can the MyWay intervention be introduced during young people’s 
consultations with doctors or nurses in a sexual health clinic -  from a 
technological perspective and a health service delivery perspective?
2. Is the MyWay program presented in a way that is acceptable to young people, in 
terms of language and visual presentation, and is the program easy to use?
3. Is the use of the program within consultations acceptable to the health care 
providers?
4. Are the data collection instruments designed in a way that they collect data on 
the process and outcome measures of interest?
5. Does a decision aid based on expected utility theory have the potential to 
improve contraceptive uptake and continuation, i.e. how acceptable is the 
method recommended by the MyWay program to young people? How do they 
feel it informed their choice of contraception?
6. To what extent is there agreement between the young people, the health care 
workers and the MyWay program as to what is considered the ‘best suited’ 
contraceptive method?
In the anticipated RCT the MyWay intervention would be compared to usual 
contraceptive care and management delivered to young people in a sexual health clinic. 
It was deemed unnecessary to have a control group in this exploratory phase I stage.
5.2.2. Study population and setting
The target group was young men (n=10) and women (n=15) attending the designated 
young people’s service and the contraceptive clinic at a London sexual health clinic. 
Twenty-five was thought to be a sufficient number of young people to include in a 
feasibility study, and a number possible to recruit in the timeframe available.
Young people were eligible for inclusion in the study if they were:
❖ aged 1 3 - 2 1  years (initially it was intended to limit the age group to 13-17 
years, but staff explained that the men seen at the young people’s clinic tended 
to be slightly older than the young women).
❖ having or planning to have vaginal intercourse
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❖ not wanting to get pregnant (or their partners to become pregnant) at the time 
of consultation or in the near future
5.2.3. Recruitment
Recruitment started at mid-January, 2005 and finished mid-May, 2005. The designated 
young people’s clinic and the contraceptive clinic each ran sessions once a week. 
These sessions were a combination of appointment slots and drop-in. Not all sessions 
were covered by members of the research teamv and during March there was no 
recruitment because the clinic contraceptive nurse was away.
Posters advertising the study were placed in the waiting rooms and information sheets 
about the study were handed out at reception when young people booked in. When 
young people were initially seen by the doctor or nurse the reason for their visit was 
established. Any young woman and man who met the selection criteria were invited to 
take part in the pilot by the doctor or nurse they were seeing. Information was 
collected on the number of people approached, the numbers eligible, and the numbers 
declining to take part. The reasons young people were not invited to take part or the 
reason they declined was also noted. Those agreeing to participate were asked to see 
the researcher before continuing with the consultation. Some of the young men invited 
to participate were attending the clinic for reasons not directly relating to contraception 
(for example they wanted an STI screen). In these cases the reason they were attending 
the clinic was dealt with first, and then they were to come and see the researcher for 
consenting.
Written consent was sought from the young people. This also applied to young people 
under 16 years, as it would not be appropriate to request additional parental consent for 
this age group, as this would be in breach of their confidentiality attending a sexual 
health service. Whether or not young people had the maturity to understand the nature, 
purpose and likely outcome of the work was assessed by the researcher. A list of 
relevant helplines and websites, such as Childline and the fpa (Family Planning 
Association), was also provided.
v Two researchers were involved in the fieldwork: Rebecca French and Makeda Gerressu
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The information sheet, consent form and the list of helplines and websites are all 
shown in Appendix A.3.
5.2.4. Intervention process
The consultation process and the use of the intervention amongst those young people 
who agreed to participate is outlined below:
1. Sexual history taken by the doctor or nurse
2. Young person uses the MyWay program on their own (although the 
doctor or nurse could go through the program with the young person if 
the young person preferred this).
3. Doctor or nurse discusses the program outputs with the young person.
4. Continue with consultation and contraception provided as required
5.2.5. Research process
How the pathway through the clinic and the intervention process for those eligible 
young people who agreed to take part was integrated with the research process is 
illustrated Figure 5.1. (see over). Boxes in blue highlight the parts of the consultation 
that were observed by the researcher. The outcomes measures and the research 
instruments used to obtain the data are discussed in Section 5.2.7.
5.2.6. Pilot process and outcome measures and research instruments
Decision-making, itself, can be measured in a number of ways, including collecting 
data on attitudes, preferences, intention, motivation and perception of risk.(97) In order 
to assess all aspects of decision-making on which the MyWay program was to act 
upon, the pilot was designed to measure impact on utilities (i.e. the measurements of 
individual values and attitudes towards choices available rather than the outcome of 
the decision) and affect (e.g. increased satisfaction or reduced anxiety with the 
decision made). As we were not following up the young people it was not possible to 
collect measures on the impact that MyWay had on health behaviours (e.g. the use of 
chosen contraceptive methods).
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Figure 5.1. Young person’s pathway through the MyWay intervention and the 
research process
Young perso n ’s pathw ay th ro u g h  R esearch process
the clinic and  the  in tervention  process
Consultation: reason for their 
visit established by the doctor 
or nurse
Sexual history taken by the 
doctor or nurse
Young person’s exit 
interview with researcher
Young person uses MyWay 
program
Young person books in at 
reception
Young person self - 
completes CAPI 
questionnaire
Young people eligible for 
the study sent to the 
researcher for recruitment 
and consent
Health care worker 
completes Facilitator Sheet 
on how they viewed the 
consultation process
Data on selected options, 
attributes and assigned 
weights collected within 
program
Health care worker 
documents contraceptive 
method they think would be 
best suited based on the risk 
assessment
Doctor or nurse discusses 
MyWay output.
Continue with consultation. 
Contraception provided as 
required
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Studies of interventions that look at decision-making need to include a range of 
process and outcome measures.(95;231) Therefore when assessing the effect of 
MyWay in this pilot study a number of factors needed to be studied, such as the effect 
the program has on the relationship between the health care worker and the young 
person, how best to present the intervention, the expectations of the young person (and 
their partner), what factors influenced choice, how incorporating user values altered 
decision-making, the impact the program has on the delivery of health care, and the 
outcome of the care provided.
Table 5.1. Research methods used to collect process and outcome data
Research Instrument Process measures Outcomes measures
Self-completed CAPI 
questionnaire for 
young people
•  Effect o f  program  on young 
p eop le’s contraceptive 
choices: pre-intervention 
m ethod o f  choice
Facilitator (staff) 
sheet
•  Im pact o f  intervention on 
staff/young person 
interaction
•  Effect o f  program  on s ta ff 
assessm ent o f  young 
peop le’s contraceptive 
needs: pre and post­
intervention m ethod o f  
choice
Observation •  Tim e taken to  use program  
and participate in the 
research
•  U sability  o f  the program
•  Im pact o f  intervention on 
staff/young person 
relationship
•  Feasibility  o f  introducing 
MyWay w ithin consultations 
-  benefits and barriers
Individual program 
outputs
•  Selected contraceptive 
options
•  Selected contraceptive 
attributes
•  C ontraceptive option scores 
(and ‘b est’ m ethod)
Exit interview with 
young people
•  U sability o f  the program
•  Im pact o f  intervention on 
staff/young person 
relationship
•  Feasibility  o f  introducing 
MyWay w ithin consultations 
-  benefits and barriers
•  Intervention acceptability
•  Effect o f  program  on young 
peop le’s contraceptive 
choices: post-intervention 
m ethod o f  choice
Staff feedback •  Feasibility o f  introducing 
MyWay w ithin consultations 
-  benefits and barriers
•  Intervention acceptability
118
A variety of research tools were used to collect data from the young people. All of the 
research instruments cited below are provided in Appendix 4. Table 5.1. identifies how 
research methods and instruments were used to obtain the pilot’s process and outcome 
measures.
Questionnaire
A self-completed questionnaire was designed to collect data from the young people in 
the following areas:
■ demographic characteristics
■ reason for their current visit to the sexual health service
■ attitudes towards contraception
■ sexual and contraceptive history
■ individual perception of pregnancy and STI risk
■ individual level of concern with regards pregnancy, STIs, and side effects and 
‘bother’ factors associated with contraceptive use
Validated questions were used where appropriate, for example questions on sexual 
behaviour were taken from Natsal 2000 and questions on attitudes towards 
contraception were from the TPSE tracking survey. Skips were used to ensure that 
young people did not have to answer sections that were irrelevant, for example young 
people who had not yet had vaginal sexual intercourse were not presented with 
questions about experience of pregnancy.
The anonymous and confidential questionnaire was computer-based and part of the 
MyWay program. A combination of text boxes and radio buttons were used for young 
people to report or indicate their responses. Each young person using the program was 
allocated an ID numbervl. This made it possible to link up data provided in the 
questionnaire with other program-related data (such as data on the user’s selected 
attributes, the assigned weights and outputs), while at the same time protecting user 
anonymity. Young people were asked to complete the questionnaire after the doctor or 
nurse had taken a sexual history. After they had completed the questionnaire they went 
straight into the MyWay demo and contraceptive program.
"  There are gaps between participant ID numbers (see Table 5.5) because each time a member o f the 
research team accessed the program they were allocated an ID number.
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Program data
The following output data for each user were obtained from the program: the 
contraceptive options they selected, the attributes they selected, the relative weightings 
they placed on their selected attributes and the scores for each option.
Facilitator sheet
A facilitator sheet was designed for completion by the nurse or doctor doing the 
consultation. It asked:
■ what was their favoured contraceptive option after their initial risk assessment, 
but prior to the young person’s use of the program;
■ what was their favoured contraceptive option once they had discussed the 
MyWay outputs with the young person; i.e. to see if the MyWay output was 
consistent with their assessment or had changed it.
■ how the young person’s use of MyWay affected the consultation.
Researcher observation
Researchers (MG and RF) observed the consultations. Notes were documented on pre­
designed observation sheets. Areas covered included the young person’s understanding 
of the program and its output, ease of use, and interaction with the facilitator. The time 
it took to complete the questionnaire, go through the program and do the exit- 
interviews were recorded.
Exit interviews
A topic guide was developed for brief semi-structured exit interviews with young 
people after they had finished their consultation. Information was collected on what 
individuals thought of the program in terms of ease of use, language and usefulness as 
well as information about the program’s effect on the consultation and its outcome. A 
combination of note-taking, and taping and transcription of interviews was undertaken.
Staff training and feedback
Two doctors and two contraceptive nurses were trained to use and interpret MyWay. 
The training was completed in one session and lasted three hours. Topics covered 
included:
■ The rationale behind MyWay
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■ An explanation of intermediate decision technology
■ The research process, i.e. pilot methodology and its application in the 
clinic
■ MyWay Simulation: Demo and program
■ Site map-Description of website pages and locations, e.g. glossary
Role play exercises were used as a way describing how the program would be used 
during the consultation. Each member of staff participating in the training was given a 
manual which contained all of the text within the program (such as the FAQs and the 
glossary of terms), details of how a score was calculated within the program and all the 
research documentation.
The initial findings from the pilot were reported back to clinic staff at a team meeting. 
Staff were asked to comment on the research process and pilot findings. Specifically, 
they were asked their views on the most appropriate setting and target group for 
MyWay, and how the MyWay process compares to the way they make decisions about 
what is the most appropriate contraceptive method for young people they see. This 
session was taped so that the discussions could be transcribed.
5.2.6. Analysis
Quantitative data analysis was conducted to assess the appropriateness of the survey 
questions and to assess the practicalities of linking up individual survey data with 
individual outputs from use of the MyWay program. For the purposes of the pilot the 
analysis was limited to descriptive statistics, such as frequencies. The analysis was 
conducted in SPSS Version 12.0.(163)
Analysis of process data allowed an initial assessment of the program from three 
perspectives. These included:
1. The user: e.g. whether young people found it to be a useful tool, whether it 
addressed their concerns when choosing a method of contraception and whether it 
made a difference to their previous attitudes and beliefs.
2. The health care worker: e.g. whether providers found it a useful tool, whether it 
assisted with the contraceptive consultation
3. The service: e.g. space and time required
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Using the first stages of ‘Framework’, a thematic analysis was conducted allowing the 
classification and interpretation of the qualitative data.(232) Data from each participant 
was coded with the My Way ID number and data from transcripts and field notes were 
entered into Excel spreadsheets. Qualitative and quantitative data were linked to allow 
further exploration.
5,2,7, Funding and Ethics
A grant of £20 052 was received from the North Central Thames Primary Care 
Research Network (NoCTeN) to conduct the pilot study. The award covered the some 
salary costs towards a research fellow (Makeda Gerrussu), the consultancy fee for 
Orange Ideas Ltd and consumable costs, such as printing. Ethics committee approval 
for the pilot was granted from the Joint UCL/UCLH Committees on the Ethics of 
Human Research.
5.3. Results
In this section, the characteristics of the young people participating in the study are 
described, followed by presentation of data on their selected options and attributes, the 
program weightings and the level of agreement between the young people, staff and 
the program. Vignettes of two users are then provided to illustrate in more detail how 
the program worked. Findings focusing on the process are presented in the final part 
of this section (5.3.4.)
5,3,1, Characteristics o f young people
Twenty-five young people participated in the pilot (15 young women and 10 young 
men). During the recruitment period 56 young women and 74 young men were eligible 
and were invited to participate in the pilot. The most common reasons given by young 
people who declined were insufficient time, lack of interest and lack of remuneration. 
Many of the young people had friends with them who were not keen to hang around.
The demographic and behavioural characteristics of the sample that were reported in 
the computer-based questionnaire are presented in Tables 5.2. and 5.3., respectively.
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Table 5.2. Demographic characteristics of My Way Users (n=25)
Age in years, mean and range 18(15-22)
Employment status, n
At school 1
At college/university 15
Paid employment 3
Unemployed 3
Other 3
Ethnicity, n
White 8
Black-Caribbean 9
Black-African 2
Black-Other 1
Indian, Pakistani, Bangladeshi 0
Other 5
Religion, n
Catholic 5
C of E, Other Protestant 4
Muslim 3
Other 5
None of these 8
All of the young people, with the exception of one young woman, reported that they
had had vaginal intercourse.
Table S3. Sexual Behavioural Characteristics of My Way Users
Male (n=10) Female (n=14)
Age at first intercourse, median (range) 15.7(14-18) 15.8(14-18)
Use of contraception at first sex, n 
Number of sexual partners in last year, n
7 12
1 3 2
2 3 3
3 or more 4 7
Not answered - 2
Unprotected sex in the last 4 weeks, n 3 6
Current regular partner, n 6 12
Past pregnancy (or known pregnancy with partner), n 3 4
Ever STI, n 3 2
Twenty-two young people reported that they (or their partner) had used condoms in the 
past, 15 reported pill use, nine withdrawal, three injectables, one implants and one the 
patch. Ten of the young women and three of the young men reported that they or their 
girlfriend had used emergency contraception in the past.
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Table 5.4. Participant contraceptive choices pre and post-intervention and My Way recommended choice
ID Demographic characteristics Contraceptive method pre-intervention MyWay ‘Best’ Choice4 Contraceptive method 
post-intervention
Gender, Age, Relationship status,1 Young person’s method of choice1 Health care worker3 Health Care Worker*
103 Female, 18, Regular partner Pill Double Dutch Double Dutch Pill
104 Female, 17, Regular partner Pill Condoms Condoms Condoms
105 Female, 22, Regular partner Pill Pill Pill Pill
106 Male, 18, No current partner Condoms N/A Condoms N/A
107 Female, 17, Regular partner Patch Patch Pill Patch
108 Female, 17, Regular partner Spermicides N/A Double Dutch Undecided
109 Female, 17, No current partner Pill Double Dutch Condoms Pill & condoms
115 Female, 18, Regular partner Implant Patch Program error Pill
119 Female, 15, No current partner Pill Pill Implant Pill
120 Female, 17, Not reported Pill Double Dutch Pill Pill & condoms
124 Female, 17, Regular partner Implant Implant Implant Implant
125 Male, 16, No current partner Condom N/A Double Dutch Condom or nothing
126 Male, 19, Regular partner Condom Double Dutch Implant Double Dutch
127 Female, 17, Regular partner Pill Double Dutch Implant Pill
128 Male, 16, Regular partner Condom Double Dutch Condoms Double Dutch
129 Female, 16, Regular partner Injection Double Dutch Double Dutch Injection
136 Male, 20, Regular partner Pill Pill Pill Pill
143 Female, Regular partner Pill Pill Double Dutch Double Dutch
144 Female, 19, Regular partner Injection Pill Double Dutch Double Dutch
145 Male, 22, Regular partner Condom Double Dutch Pill Double Dutch
146 Male, 19, Regular partner Condom Double Dutch Pill Double Dutch
147 Female, 16, Regular partner Patch Pill Pill Pill
152 Male, 20, No current partner Condoms Condoms Double Dutch Condoms
153 Male, 18, Regular partner Condoms Condoms Pill Condoms
155 Male, 19, No current partner Condoms Condoms Pill Condoms
Notes
1 Source: Questionnaire data 2 Source: Observation data 3 Source: Facilitator sheet data 4 Source: Program data
to
Reasons for attendance at the clinic are listed below. Some people had more than one 
reason for attending.
■ STI screening or treatment (8 male, 2 female)
■ HIV test (2 male, 0 female)
■ Contraceptive advice (2 male, 4 female)
■ Starting a new method or needing a repeat prescription (1 male, 8 female)
■ Picking up condoms (3 male, 2 female)
■ Emergency contraception (2 female)
■ Pregnancy test (5 female)
5.3.2. Selection o f contraceptive options and attributes and program output
Options
Only two young people reported in the questionnaire that they were currently not using 
any contraception. Young people were asked which method they would use if they were 
thinking of starting or changing a contraceptive method. Most reported the condom 
(n=10), followed by the pill (n=9) (see Table 5.4)
Table 5.5. illustrates that the male condom and the pill were the most frequently 
selected contraception options in the program. None of the young people were 
interested in the IUD. A few young people expressed interest in the patch, but this 
option was not available on the list within the program.
Table 5.5. Young people’s selected contraceptive options in the MyWay program1
S elected  M eth o d s F em ale  n=15 M ale  n=10
N othing 1 3
W ithdraw al 4 7
C ap/diaphragm 0 2
Sperm icides 1 2
Condom  (m ale) 2 1
C ondom  (fem ale) 14 10
Pill 13 9
Injectables 5 1
IUD 0 0
Subderm al im plants 3 1
Double D utch (condom  & pill) 12 7
Notes
1 Each young person could select up to eight contraceptive options.
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Many of the young people explained during the exit interviews that knowledge of 
methods other than the pill and condoms was often poor. They explained that decisions 
about contraception were often based on their friends’ experiences and peer norms.
Attributes
In the questionnaire, young people were asked, if they were changing to a new 
contraceptive method today how concerned would they be about pregnancy, STIs, side 
effects and ‘bother’ factors. Pregnancy (identified by 12 young women and 7 young 
men) and STIs (identified by 10 young women and 9 young men) were outcomes of 
concern for many of the young people. Only two of the young women and one of the 
young men felt they were at risk of pregnancy, and one of the young women and four of 
the young men felt at risk of STI acquisition. Most of the young people were concerned 
about potential short-term side effects (13 young women and 9 young men) and long­
term effects (9 and 12, respectively). The women were asked in the questionnaire to 
report how likely they would be to discontinue a method if they experienced any of the 
pre-defined short-term side effects. The numbers of women who would be very likely or 
likely to discontinue for the following side-effects were 13 for acne, 11 for weight gain, 
10 for nausea, seven for headaches, seven for heavy periods and five for no periods.
When the young people were presented with the list of attributes to chose from in the 
My Way program, nearly all selected pregnancy as something they would be concerned 
about when thinking about contraception (n=24) (See Table 5.6.). Data collected from 
the relative weightings young people assigned to the selected attributes showed the 
mean weight women placed on pregnancy was higher that the men’s mean weight, 
49.2% versus 38.7%, respectively. Table 5.6. illustrates that HIV was the most 
commonly selected STI in the list of possible attributes to select. In terms of ‘bother 
factors’, half of the women selected having to have an invasive procedure or having to 
remember to take contraception, while the most frequently selected ‘bother factor’ for 
men was the effect on sex. Weight gain was the most frequently selected side effect for 
women, although the side effect given the most weight by women was heavy periods.
In the exit interviews, many of the young people thought that their risk of STIs or 
pregnancy was low, particularly those in a regular relationship. However, despite 
perceptions of low risk, many expressed great concern about STIs and pregnancy. Some
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of the men commented that they had found it interesting to think about the attributes 
from their girlfriend’s perspective. One of the young men explained that he had selected 
no period as a concern because, if his girlfriend had no periods, it might mean she was 
pregnant.
Table 5.6. Selection of attributes and their average weighting
n
Female
Mean 
weighting % 
(range)
n
Male
Mean 
weighting % 
(range)
Pregnancy 14 49.2(18.4-93.9) 10 38.7 (8.6-58.7)
STIs
Gonorrhoea 12 10.5(1.0-44.1) 4 6.6(1.9-12.5)
Syphilis 5 8.5 (5.3-17.7) 1 0.9
Chlamydia 10 8.8 (0.8-16.0) 4 9.6 (3.8-12.7)
Trichomoniasis 2 8.0 (8.0) 0 -
Genital warts 3 3.7 (0-5.7) 3 5.4(1.1-13.2)
Genital herpes 7 5.0 (0.9-9.0) 3 19.6(11.3-40.3)
HIV 13 13.2 (6.0-26.7) 10 16.1 (7.3-33.2)
Bother
Bother getting 2 2.8 (0.9-4.7) 4 7.1 (0-10.7)
Invasive 5 4.8 (0-8.6) 2 9.0 (8.1-10.0)
procedure
Bother
remembering 5 9.1(1.1-17.4) 5 7.1 (2.2-9.0)
Effect on sex 4 6.3 (0.6-10.6) 8 10.2 (7.3-19.7)
Side effects
Weight gain 12 8.7(0.9-19.4) 4 13.4 (7.2-19.4)
No periods 3 6.9(1.2-10.7) 2 5.4 (3.6-7.3)
Heavy periods 4 9.7(1.1-16.6) 6 8.1 (3.1-11.1)
Acne 5 5.8(3.2-12.4) 4 5.5(1.3-12.4)
Nausea 6 8.7 (3.8-13.3) 0
Thrombosis 7 7.1 (1.3-13.2) 5 8.8(1.3-25.0)
Notes
The numbers and percentages in bold are the highest for each category.
Methods recommended by My Way
The contraceptive method recommended for each individual, based on the weights they 
assigned to their selected attributes, is shown in Table 5.4. Overall the pill was the 
method recommended the most (9 times), followed by Double Dutch (7), implants (4) 
and condoms (4). One user did not have a recommended method as the program crashed 
before she reached this point.
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Levels o f  agreement
One of the objectives of the research was to assess the level of agreement between the 
method young people said they would be most likely to use, the method the facilitator 
thought to be the most appropriate based on the young people’s risk assessment and 
history, and the method which came out as the best option in My Way. In the 
questionnaire, the methods young people reported that they would currently be most 
interested in using were: pill (n=10), condoms (8), subdermal implant (2), injectables 
(2), Evra patch (2) and spermicides (1). We were then able to compare the young 
people’s preferred choice before use of My Way with the best option based on their 
selected options and attributes. We excluded the two women who chose the Evra patch 
as this method was not available on My Way. The computer crashed before one young 
person was presented with My Way's ‘best choice’. Therefore of the remaining 22 
participants, there was agreement with My Way's option on six occasions and 
disagreement on 16 occasions (See Table 5.5.). None of the young people said they 
would want to use Double Dutch (pill and condom) and this method was recommended 
on seven occasions by the program. Other discrepancies can be explained by young 
people’s lack of knowledge of all methods prior to using the program, and methods that 
are more effective in preventing pregnancy, such as subdermal implants, were more 
likely to come up best in the program in those who had placed greater weight on 
pregnancy being a concern. Unfortunately we were unable to investigate the difference 
between the facilitator’s choice of most appropriate method with the young person’s 
and MyWay's ‘best’ choices as none of the consultations were with regular clinic staff. 
Although staff recruited young people onto the study and provided the usual 
contraceptive care and management, they did not have the time to go through and 
discuss the My Way program with the young people participating in the study (this 
problem is further discussed Section 5.3.4. Process). The nurse (DG) who was part of 
the research team went through the program with the young people, took sexual 
histories and made an assessment on the ‘best suited’ method (which she identified on 
the Facilitator Sheet) when she conducted the consultation. Three of the young men did 
not have a risk assessment taken as they were seen by only one of the researchers (they 
had either come into the clinic to collect condoms or had already seen the doctor). The 
most frequent method recommended by DG for the young people was Double Dutch. 
Agreement between DG and the My Way program occurred for seven of the twenty 
young people she assessed.
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During the presentation of findings to the clinic staff, there was some discussion about 
how decisions about contraception are made. The staff were very interested in the extent 
to which there was agreement in the “choice” methods between My Way, the young 
people and the facilitator (i.e. the research nurse). They felt many young people attend 
the clinic having already made a decision about what method they want. However the 
staff acknowledged that there is a need to improve continuation and adherence of 
contraception. They also thought it was important that staff should be questioned about 
how they make decisions. One person commented that it was important for staff to look 
at their own prejudices. Another staff member explained how decisions are often 
subjective, and factors such as how busy the clinic is and appointment times will play a 
role “i f  i t ’s the last patient at 7 o 'clock you may not be so thorough anymore going 
through all the methods". It was mentioned that contraindications to some methods 
were not factored into the program, and this could account for some inconsistencies 
between the program and the research nurse’s recommendations.
5.3.3. Vignettes
Two vignettes are used to describe the MyWay experience in greater detail. Data from 
the questionnaire, the program outputs, observations and the exit interviews are used to 
describe the two young people’s background and experience of MyWay. The names of 
each participant are fictitious.
Vignette 1 (ID 136)
Michael was aged 20 years, and studying at university. He had started seeing a new 
girlfriend three weeks ago, and during that period had been using condoms consistently. 
He had had no other sexual partners in the last year. He had no history of STIs or 
pregnancies. The reason for his attendance was for an STI check up as his girlfriend was 
going to start taking the pill.
Michael went through the program with one of the researchers (RF) after he had seen 
the doctor. He was computer literate and used the Internet everyday. He tried the 
holiday friend demo and this gave him a good grasp of what the program was trying to 
achieve. He was interested to know about the data for the demo. He went through the 
instructions by himself and felt the wording was appropriate. He chose seven 
contraceptive options (see Figure 5.2.) The attributes and weights he assigned to them
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are shown in Figure 5.3. He did not feel he was at risk of pregnancy or STIs, although 
he reported that he was very concerned about both these outcomes. He was also very 
concerned about what his partner thought. He found the process of assigning weights to 
his selected attributes a useful exercise:
I t ’s interesting actually, because you don 7 quantify risks in your head. You 
don 7 do it on such a form al basis. It ’s quite weird because you are concerned 
about all these things really, and i t ’s quite weird saying what are you more 
worried about, getting your girlfriend pregnant or getting HIV, and that is like 
woo, so its weird. I t ’s quite educational to be forced to do that, and you are 
never going to be able to express statistically how they are feeling with their 
emotions and stuff and I know tha t’s not what you ’re trying to do. You are trying 
to gauge w hat’s best in terms o f  what type o f  contraception is good for them. I t ’s 
not definitive the things you choose in terms o f  what way you give them, it is 
educational, i t ’s just reminded me o f  how many STDs (sexually transmitted 
diseases) there are which is probably quite good, so yeah.
Figure 5.2. Michael’s selected attributes and weights
Play with area sizes to see  effect on Scores
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Figure 5.3. Michael’s score b ar chart
Z _ _ L /
i  I 1 I 1 I r
None | Cycle awareness | Condom (female) | Pill
Withdrawal Cap /  Diaphragm Condom (male)
He was pleased the pill came up as the ‘best’ option as this confirmed the decision he 
and his girlfriend had already made. He also explained it was useful to think about 
contraception from a female perspective:
It hasn 7 changed my perspective or anything because like I say, I came here 
today to get the pill. But yeah I mean, I think i t ’s good for men certainly because 
a lot o f men and I know a lot o f  my friends don 7 give any thoughts to ... they let 
their girlfriends handle contraception, which I think is really out o f  order. They 
have to take responsibility, in fact this is interesting everyone likes playing 
around with bars and everything, then hopefully a lot o f men would log onto it 
and learn a lot more about it. You should make it clear at the start that men can 
do it as well, i f  the questions seem to apply just to women then you answering on 
your perspective o f  your girlfriend cos, when it came up “How do you consider 
your risk o f getting pregnant? ” you don 7 really know, but, yeah its good for  
men just as much as for women.
He also described how it was useful to be able to adjust weights to see what affect this
had on the scores bar chart:
Yeah, I mean, I ’d  say any process where there are plenty o f different options 
and there’s this kind o f balance between people having very strong opinions and 
very strong feelings o f  what they want and what they don 7 want. And also the 
fact that there is lots o f  different information and options that they might not be 
aware of. But I think that the whole problem o f quantifying things is you can 7 
always express exactly what you think. It's very good that you get the choice to
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move these (the weighting box segments) around after, i f  it just came up this is 
your best choice then I  think that wouldn ’t be very good at all. This is very good 
because you can stop to compare you know exactly, you know, how you can 
make a difference, and what kind o f other things are you thinking o f using it for.
Michael explained how the MyWay program could be particularly beneficial to young 
people who may feel uncomfortable seeking advice from a health care professional:
I have never discussed contraception with a nurse. My girlfriend has, but I 
haven’t. And i t ’s good that you can do this because I don’t know i f  I  would 
discuss contraception with a nurse or a doctor. I  would now, I  think, now that 
I ’m in a long-term relationship. But before then, when things were like casual 
and i t ’s just, I  didn ’t feel so comfortable with myself, I  wouldn’t have. I would 
have been embarrassed coming here to have a test or anything like that, and I  
think there is a lot o f  shyness and nervousness about talking about these issues. 
And so, the fact that people can do this, perhaps instead o f going to see a doctor 
or a nurse is very good, perhaps especially for men who aren’t necessarily 
comfortable speaking about it, like, with someone in public. So yeah, I  can 7 say 
how it compares, but i t ’s definitely a good thing.
Vignette 2 (ID 124)
Anna was aged 17 years and studying at college. She first had sexual intercourse aged 
16 years. She reported 10 sexual partners in the last year, two of these in the last four 
weeks. She had a regular boyfriend of four months. She currently had a subdermal 
implant in situ. Despite this she was attending the clinic for a pregnancy test. Previous 
contraceptive methods used included the pill, condoms and withdrawal. She has used 
emergency contraception twice in the past. She described the problems when making 
decisions about contraception:
With most young people contraception doesn't go with their way o f life, you do 
have to think about it, worry i f  you've forgotten and go out o f  your way.
She had no history of pregnancy or STIs. She used the Internet everyday.
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She went through the program as part of her consultation with the nurse. She did not 
want to use the demo and went straight to selecting the three contraceptive options she 
was interested in: the pill, implants and Double Dutch (i.e. the condom and pill).
Anna’s selected attributes and weights are shown in Figure 5.4. She did not feel at risk 
of pregnancy, STIs or HIV, although she stated she was very concerned about these 
outcomes. She explained that she was mainly interested in HIV in terms of infection, 
"because it can't be treated, if  caught early enough, the others can be treated." Other 
factors that she was very concerned about included long-term side effects and having to 
remember to take contraception. She reported that if she experienced nausea, headaches 
or acne she would be very likely to discontinue a contraceptive method. Her concern 
with thrombosis was due to family history on her mother's side. She thought acne and 
nausea were "the worst side effects o f contraception" and explained that she selected 
weight gain because "I have problems with my weight anyway
Figure 5.4. Anna’s selected attributes and weights
Ray with area sizes to see effect on Scores
During the exit interview Anna commented that she was surprised that Implants came 
up as the ‘best’ option as she felt that she had given HIV much importance and had 
expected Double Dutch to score the highest (Figure 5.5).
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Figure 5.5. A nna’s score bar chart
Pill Im plant ouble Dutch (p il l .
The researcher (MG) conducting the interview explained that in the weighting box she 
had only given HIV a relative importance of 6%. The greatest importance had been 
given to pregnancy and implants were the most effective in preventing this outcome. 
Anna described how she had found the process useful:
I think it is good ‘cause, if  you are concerned, it doesn't just tell you about the 
methods, but it takes account what you actually want from it.
It's not just about finding a safe method or the method that works best but 
finding one that suits. ..It made me think whether this is the method I want to 
use.
However, although she would access a program like MyWay on a computer at home, she 
still felt conversations with health care providers would be more informative.
5.3.4. Process
A summary of the strengths and weaknesses of the MyWay program used in 
consultations within a clinical setting which were identified through the pilot process 
are summarised in Table 5.7.
134
Table 5.7. Summary of strengths and weaknesses identified through the pilot
Strengths
Popular with young people
♦ The potential to access on demand as 
circumstances change if  available on the 
Internet
♦ Demo helped to introduce concept
♦ Opportunity to look at different contraceptive 
options
♦ Young people liked the fact that outputs were 
personalised
♦ Program viewed as non-judgmental, less 
embarrassing and less pressurised than 
consultations with health care workers
♦ Educational, although not an information site
♦ For some men it was the first time they 
thought about contraception from the 
perspective o f their partner
♦ Liked the fact that it was not just pregnancy 
and disease orientated and took account o f 
‘bother factors’
♦ Liked the fact that it was visual and 
interactive
♦ Design generally liked
♦ Some young people felt there would be more 
consistency in outcome in comparison to 
those from health care workers
♦ Thought provoking. Ability to see how 
change o f  values affects options
Weaknesses
♦ Many participants had already made their 
decision or wanted the doctor nurse to make it 
for them
♦ Men who were not in long-term relationships 
found it less useful
♦ Time pressure -  from user perspective. Some 
had already had to wait for a while. Pressures 
to go from friends/partners who were with 
them
♦ Not used during the consultations with regular 
clinic staff
♦ Some young people said they would prefer 
human interaction
♦ Some technical problems, e.g. system crashed 
when user tried to return to previous pages
♦ Time pressure -  from staff perspective due to 
short appointment times and often large 
number o f  patients waiting to be seen
♦ Requires internet access
♦ M yW ay did not ever change the preferred 
option o f  the facilitator, although only one 
nurse involved
♦ Young people trust opinion o f  doctor/nurse 
over that o f  a computer program
♦ When more options are chosen difficult to 
move borders -  fiddly
♦ Some young people found it difficult to put in 
context -  e.g. risk o f STIs___________________
The mean time it took young people to participate in the research, including completion 
of the questionnaire, use of the program and have their exit interview was 34 minutes 
(range 1 9 - 5 0  minutes). This time represents an underestimate of an individual young 
person’s time spent participating in the research as it excludes time taken during 
recruitment and consent.
Design
All of the young people said they liked the colour scheme and layout of the program. 
The young people liked the fact that the program was interactive; this was a criticism of 
other websites that target young people.
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When you go on the web you get loads o f things, bumbling along about 
anything. With this you just read what you need to know and then i t ’s simple. 
You don’t get annoyed. I t ’s straightforward. I t ’s not telling you about what you 
don 7 really want to know about. You don’t have to read. (Female, Age 17, ID 
109)
Generally, the weighting box and the score bar chart were the popular sections in the 
site. However, some found it fiddly moving the boxes with the cursor to assign weights 
to the attributes they selected. This was more evident when they had selected the 
optimum number of eight. A couple felt there was too much text and some found some 
of the terminology difficult to understand, e.g. ‘attribute’. One of those interviewed felt 
more pictures, for example of different contraceptive methods, would improve the site. 
Most liked to use of pop-up boxes for definitions. When observing the young people, 
many found it easier to be talked through the ‘instructions’ rather than have to read 
them.
Some young people found it difficult to understand why, when they altered their 
weights, there was little change in the heights of the score bar chart. This is the 
mathematical consequence of the fact that many probabilities are very low and the 
absolute differences between them tiny. This was particularly evident for an outcome 
like HIV, where the probability of acquisition for the ‘average’ teenager based on the 
evidence used is so low, therefore even giving greater weight to HIV is going to make 
minimal difference to the ‘best’ contraceptive options provided by MyWay. Although 
young people had access to all the probabilities used in the program, few looked at 
these, and of those who did, these data were for the most part meaningless in their 
tabular form.
Young people’s views on the MyWay experience
During the exit interviews young people were asked how using MyWay compared with 
speaking to a doctor or nurse. Many of the young people described how they liked the 
anonymity of MyWay and how they could obtain personalised information without fear 
of judgement.
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[MyWay] allows you to be yourself. No need to lie since you'd only be cheating 
yourself (Male, Age 18, ID 106)
Never discussed contraception before. I  would rather do this. I  don't like to talk 
about it with people. (Male, Age 16, ID 128)
Prefer this because it can answer questions, so the nurse doesn't have to make 
judgement. It's useful because it will be consistent for every person using it. 
(Female, Age 20, ID 127)
It's a computer, not really a human being. It's easier to talk to, easier to relate to 
because talking to a doctor about contraception. It might be a woman, i t ’s 
uncomfortable talking to them. I f  it's a computer, I  find  it easier. (Male, Age 19, 
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It's easier cause sometimes you don't really want to talk about it. I f  embarrassed 
you don't really want to tell the truth. (Female, Age 16, ID 147)
Normally when you come to a clinic they deal with what you ’re there for and 
then you ’re out the door again. With this i t ’s information and i t ’s there for you. I  
would never think that they would have something like this. I t ’s a good idea. I t ’s 
about real things. (Female, Age 17, ID 109)
There were others who preferred going to see a health professional, particularly those 
who had already decided on the contraceptive method they wanted.
Personally I  would go and see a doctor cause I  kind o f know. But say you were 
younger than me., say 15 or 16.. this would be better i f  you were embarrassed 
about asking about these kind o f things. I t ’s easy. Anyone has access to the 
Internet nowadays. I t ’s much easier. (Male, Age 19, ID 155)
When talking you get feedback. You can ask questions, With a computer you 
have less choice. (Female, Age 18, ID 115)
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However, one young person felt the comparison of MyWay with a consultation with 
health care worker was not a fair one, as they were not necessarily exclusive of one 
another:
It made me think about finding out information for myself rather than having a 
doctor or nurse, or someone explain to me. It was useful in a different way. I  
wouldn't be able to say it was better or worse because it is too different to 
compare. (Female, Age 17, ID 108)
Young people liked the individual focus of MyWay:
It's different, shows you things you wouldn't think about but that you need to 
think about. (Female, Age 15, ID 119)
It focuses on you, not on things that are not important to you. (Female, Age 17, 
ID 120)
It tells me from my personal perspective what to do, giving me information 
about myself using a formula to give me answers. (Male, Age 19, ID 126)
Some young people described how MyWay provided them with more choices and 
increased their awareness of methods they had little knowledge of.
.. you've got different choices. You might have tried one or two choices before 
and this could help you choose a different one. ..It’s your choice. Things that you 
think are important to you are not what other people think are important. 
(Female, Age 16, ID 129)
It definitely gets your brain working. It makes you think about things that you 
don 7 normally think about. I  normally wouldn 7 think about things other than 
the pill. (Female, Age 17, ID 109)
For others, they had already made their decision and MyWay had little, if any, affect.
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The pill is the easiest way and the more normal way, i f  you know what I  mean. 
(Male, Age 19, ID 155;
However, even those who had already made up their mind described using MyWay 
helped either to validate their decision or to think about aspects of contraception they 
previously had not thought about:
It was useful doing it. I  have been using the pill for a while and I'm a bit scared 
o f trying anything else and it (the pill) came up best. (Female, Age 19, ID 144)
It hasn’t really changed my opinion about it. I  will still continue to use condoms 
or my partner to use the pill. So.. I  guess I didn 7 really know anything about 
these things. The effect on your partner. Cause they ’re female things. I  guess 
that helps m e” (Male, Age 19, ID 155)
MyWay was not too helpful to me since I  have already discussed it with the 
nurse. So I'd thought o f the effects o f  the pill but it was good to give order o f  
importance to bother. (Female, Age 17, ID 104)
One young women described how MyWay had introduced a new option she had not 
previously considered, but she was still undecided about MyWay's recommendation:
I  was going to start using a spermicide alongside condoms. My plan is to use 
more than one form o f contraception, whether it ’s with the pill or not, I ’m not 
too sure yet. I  need to take away the information first. (Female, Age 17, ID 108)
Some of the men described how using MyWay helped think about contraception, 
particularly from their partner’s perspective:
I  really think men should know more, it broadens your mind.... Sadly yes, I  did 
know very little before I came here. (Male, Age 22, ID 145)
Most of the young people said they would recommend this type of site to a friend. Only 
two said they would not as their friends would be more likely to access information 
through sources such as magazines and television, or they do not use computers.
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Target group, timing and setting
The program worked best with young people who were literate, whose first language 
was English, and those competent using computers. Amongst the male users, the 
program was felt to be more relevant to those in a relationship than those who were 
single. It was suggested during the interviews that MyWay may be more appropriate for 
younger people who had not yet formulated any opinions on different contraceptive 
methods and prior to visiting a health service:
It's good for younger people who do not know what to do. For those who want to 
have sex, but don't know what to do, not for those who already know. It adds no 
information because you would have already discussed everything when you 
first got your method. (Female, Age 17, ID 107)
The fact that the program was web-based was popular as it had the potential to be easily 
accessible. Four of the 25 young people reported in the questionnaire that they learnt 
about sexual matters from the Internet. Only two of the young people reported that they 
did not have access to the Internet. Sources of Internet access included home (n=10), 
school or college (n=13) and cyber cafes (n=9). Nine young people reported that they 
used the Internet every day, five said they used it at least once a week, three once a 
month and five less than once a month. The most popular settings for MyWay access 
suggested by the young people were schools and youth clubs.
Most times yo u ’ve got girls having sex under age. And they don 7 like coming to 
clinics and stuff like that. They get embarrassed. ... A lot o f people do go onto 
computers at schools. It would be good information to have. I f  you 're young and 
embarrassed you don 7 really want to ask questions. When I was young I didn 7 
ask about contraception. I  wasn’t even thinking about it. I f  there was a website 
you could go on and just play about with things it would be great. (Female, Age 
17, ID 109)
The pilot found that there were problems introducing MyWay within consultations at the 
clinic (see section on consultations below). Clinic staff, like the young people, felt the 
program would be more useful prior to the consultation.
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Incorporating MyWay into a consultation is hard but it would be extremely 
useful for before the consultation to help thinking and increase awareness. It 
could include myths and dispel them. (Staff member)
However, the staff felt that there was still a role for MyWay within the clinical 
environment and they felt that the program would be best accessed in the waiting room, 
so that young people could use it prior to their consultation. It was suggested that young 
people could print off their personalised output and then discuss it with the doctor or 
nurse. Having computers based in the waiting rooms would have resource and security 
implications.
Recruitment
Generally one to two young people were recruited at each session (it would not really 
have been possible to recruit more than two at each session due to the time needed to go 
through the program and the different components of the research).
The research team found that it was often easier to recruit young people prior to their 
consultation as taking part in the pilot was something for them to do while they were 
waiting to be seen. Once they had seen the clinic doctor or nurse they wanted to leave 
quickly and many had friends in the waiting room, who would text participants to see 
how much longer they were going to be. The research nurse (DG) was able to take 
sexual histories and conduct consultations, which helped with the recruitment. It took 
longer to recruit young men as they often felt a program about contraceptive decision­
making was not relevant to them.
Consultations
It had been the intention that MyWay would be used as part of the consultation with the 
doctor or nurse. In reality, the program was either used before or after the young 
person’s consultation with one of the researchers (MG and RF) or the contraceptive 
research nurse (DG) incorporated use of the program in her consultation with the 
participants. The reasons the clinic staff did not get actively involved in facilitating use 
of the program were discussed during a meeting to present the pilot findings. The 
reasons included:
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The large numbers attending each of the clinics meant that staff were keen to ensure 
there were no further delays and felt that time going through the program would 
slow them down.
Staff felt it was more appropriate for young people to use the program prior to the 
consultation.
It ’s more useful to have it before you make your decision as an information tool 
which will influence your decision. But to incorporate it into a consultation I  
think it ’s quite a challenge. (Staff member)
The mean time it took a young person to go through the MyWay program (excluding 
time spent on the questionnaire) was 10 minutes (range 5-15 minutes).
Technical issues
There were a couple of occasions when the program crashed. For one young person this 
meant that they were unable to obtain their MyWay output.
Using a variety of languages and codes meant much work to ensure the integrity of the 
data as they passed from one section to another. Issues with the Java Virtual Machine 
and Java’s handling of the graphics code meant that some situations arose with the 
interface that were not ideal, such as being unable to click on an area’s border if the user 
had made the area too small.
Research instruments
The computer-based questionnaire was completed by young people prior use of the 
program. The mean time to complete the questionnaire was 14 minutes (ranging from 7 
minutes to 30 minutes). Those who were less confident using computers did take longer. 
The questionnaire was designed with skips to omit questions that were not relevant. 
Those who had experienced pregnancy had more questions that added to the time it took 
to complete the questionnaire. Young people also had some comments on question 
wording and the relevance of some questions. A couple of young people commented 
that they found the questionnaire too long.
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Individual questionnaire data were linked with data collected on selected contraceptive 
options and attributes (along with the assigned weights), as well as with the data from 
the observations and exit-interviews. Interestingly information on sexual behaviour and 
attitudes to contraception provided in the questionnaire were not disclosed during the 
consultation.
The research also provided the opportunity to pilot the observation sheets and topic 
guide for the exit-interviews with young people. These instruments worked well and 
provided the opportunity triangulate data from different sources.
The phase I pilot study provided an opportunity to investigate how the MyWay 
intervention worked, the feasibility of delivering the intervention within a clinical 
situation, its acceptability and potential effectiveness, and how the research instruments 
functioned. In the next chapter I discuss the interpretation and implications of the pilot 
findings, and the areas for further development.
5.4. Key points
• The aim of the phase I pilot was to access the feasibility, acceptability and potential 
effectiveness of the MyWay program in a young person’s sexual health clinic.
• Twenty-five young people (15 women and 10 men) attending a London sexual 
health clinic participated in the pilot.
• A multi-method approach was used to collect data, including 1) a computer-based 
questionnaire for self-completion by the young people; 2) program data on young 
people’s selected options and attributes, the relative weights placed on their selected 
attributes and the scores for each selected contraceptive option; 3) facilitator sheets; 
4) researcher observation, 5) exit interviews with young people; and 6) staff 
feedback.
• Condoms and the pill were the methods most commonly selected by young people.
• Nearly all young people (n=24) selected pregnancy as an attribute they were 
concerned about when selecting contraception. HIV was the most commonly 
selected STI. There was variation in the other attributes selected by participants and 
the weights they placed n these attributes.
• The methods recommended by MyWay included the pill (recommended to 9 users), 
Double Dutch (7), condoms (4) and implants (4). There was agreement between the
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method recommended by MyWay and the young person’s original preferred option 
on six occasions.
• Benefits of the program identified by young people included its non-judgemental 
and personalised approach, its inclusiveness of young men, that it was not just 
focused on ‘disease’, and it was interactive and educational.
• Weaknesses included problems using the program within consultations because of 
time pressures, some young people had already made their decision or wanted the 
doctor to make the decision for them, and there were some technical problems.
• The young people suggested that it would be beneficial to have access to the 
program at a younger age before they had started having sex and that schools would 
be an appropriate setting to introduce young people to the program.
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Chapter 6. Lessons learnt and where next
The pilot study confirmed the MyWay program was popular with young people, and 
sexual health staff felt as a tool it has great potential in helping young people with 
contraceptive decision-making. The particular strengths identified included its 
individual focus, the provision of skills to aid contraceptive decision-making, its 
potential accessibility to young people who are either too nervous or too embarrassed to 
seek advice from sexual health services and being inclusive of men. Both staff and 
young people felt the program acted as an information source as well as a decision aid, 
although this had not been the main aim of the research team. The phase I pilot study 
provided useful information on how to refine the program, where and how it could be 
applied and how it should be evaluated.
The objectives of this chapter are:
■ to provide a summary of the key findings from the exploratory phase I pilot 
study of the MyWay program’s use in consultations within a young people’s 
sexual health clinic.
■ to examine the strengths and limitations of the MyWay intervention and the pilot 
study.
■ to identify areas for further application and research
6.1. Key findings from the phase I study
6.1.1. Feasibility
The study did illustrate that there were difficulties in introducing the program within 
consultations in a young people’s sexual health clinic. The service which provided the 
setting for the pilot study is an extremely busy open-access clinic. Staff are under great 
pressure to see large numbers of young people, who are often presenting with complex 
sexual health needs, in a relatively short period of time. An intervention that requires an 
additional 10 minutes (the mean time it took for the young person to go through the 
MyWay program) will affect service capacity. This could potentially have negative 
consequences by reducing the numbers of young people able to be seen by health care 
staff.
The feasibility of implementing decision aids within consultations in health care settings 
has been identified as problematic in other studies, predominantly because of the need
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for high productivity and time constraints.(97;129) It has been suggested that decision 
aids may be better made available to consumers outside of the clinical consultation and 
the use of sites, such as the Internet, need further exploration.(129) Bekker and 
colleagues note in their systematic review of interventions designed to assist decision­
making that consumers need to be given some time to reflect on decisions.(97) Sexual 
health consultations usually allow insufficient time for this process.
6.1.2. Acceptability
The program itself was popular with both young people and staff (although with the 
staff, their views were based on the idea of the program rather than actual experience of 
using the program within a consultation). Young people liked the individual value 
focus, and the fact that it was interactive and non-judgmental. There was also agreement 
amongst both users and staff about its acceptability within the clinical consultation in 
comparison to other possible settings. Most of those interviewed did not feel the 
decision aids should replace support provided by health care staff. They felt its role 
should be as a pre-clinical aid, with many of the young people suggesting that the 
MyWay program should be first introduced in schools (see Chapter 7.).
The general consensus amongst the young people participating in the pilot was that the 
MyWay program would be more appropriate for a younger age group (the average age 
of participants was 18 years). The majority of young people explained that they had 
made their decision on what method of contraception they wanted prior to coming to the 
clinic. This decision was usually based on peer norms or previous experience using 
different contraceptive methods. The young people attending the designated young 
people’s service are not necessarily representative of the general teenage population. 
The self-reported data from the small number of participants showed relatively young 
age at first sexual intercourse, high numbers of sexual partners and poor sexual health 
outcomes in comparison to a general population sample of the same age group.(7)
Embarrassment and the fear of being judged have been identified by young people as 
important factors when discussing their sexual behaviour.(75) These emotions could 
lead to young people providing responses they feel are considered socially acceptable 
and what a health care provider would want to hear. For example, young women may 
feel uncomfortable admitting pregnancy is their preferred option (or even feeling 
ambivalent towards pregnancy). Some of the young people taking part in the MyWay
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pilot study did disclose that they were more likely to respond ‘honestly’ to a computer 
than to a health care worker. This work also highlights the fact that pressures within 
sexual health services may limit the time spent with young people discussing the 
context of their contraceptive use, eliciting their values and identifying how these may 
impact on their contraceptive decision making and ultimately on risk of pregnancy 
and/or STIs. How assistance with contraceptive choice is delivered is crucial to their 
acceptability to young people.(75) Research commissioned by Brook showed that 
young people wanted a service that was tailored to their needs and they wanted advice 
and support on contraception that was ‘suitable’ to them.(179) Not investing the time to 
discuss these matters with young people to save time may be a false economy if the end 
result is more young people with unplanned pregnancies and STIs.
6.1.3. Potential effectiveness
The rationale behind MyWay was that if young people’s values were considered when 
they were selecting and initiating contraceptive methods, effectiveness would increase. 
Although the young people participating in the pilot were concerned about poor sexual 
health outcomes, their perception of risk was often low, particularly those in regular 
relationships. The pilot showed that the young people found MyWay a useful tool to 
either validate the decision made prior to coming to the clinic or as a method of thinking 
about aspects of contraception they had not previously thought about. We were not able 
to ascertain what impact MyWay had on subsequent behaviour, in particular use of 
contraception and length of continuation, or on final endpoints (pregnancy or STI 
acquisition) as this was beyond the scope of the exploratory phase I pilot. However, it 
was apparent that although young people assigned relatively large weights to pregnancy 
and STIs, and therefore methods such as subdermal implants and Double Dutch came 
out as the ‘best’ option, the condom and pill (used separately) remained the methods 
most likely to be used. Those young people who spent time playing with the program to 
see how changing their values impacted on their ‘best’ method appeared to gain most at 
an educational level. O’Connor and colleagues in their systematic review of decision 
aids comment that people who are more uncertain about their options and do not have 
prior preferences may be the ones who would benefit the most from decision aids.(122) 
This supports the comments made by some young people in the pilot that MyWay 
should be first introduced at a younger age in school settings, i.e. before becoming 
‘established’ on a method of contraception.
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My Way's impact on contraceptive decision-making may have been greater if the 
inclusion criteria had been limited to those who were wanting to start or were thinking 
about a new method of contraception. This group may be more likely to be at a stage 
ready for change. Those who were already established on a contraceptive method or 
those attending the service for non-contraceptive reasons (the majority of men were 
attending for an STI screen only) may have been more likely to have been in the pre- 
contemplative stage.
6.2. Strengths and Limitations
6.2.1. Strengths o f the MyWay Program
Benefits o f a computer-based intervention
There is much strength in having MyWay as a computer-based intervention. Although 
most of the young people participating in the pilot did not see it as a replacement to 
doctors and nurses, they did feel that they would be more honest in their responses to a 
computer program as fears about being judged were no longer a concern.
Another strength of computer-based interventions is that they have the potential to be 
used and revisited at one’s own pace and convenience.(233) This would have the added 
benefit of increasing the duration and intensity of the intervention, factors which have 
been identified as key to intervention effectiveness^ 112) MyWay was set up to be 
accessible via the Internet. A national study investigating Internet use among young 
people aged 9-19 years published in 2004, found that 75% had Internet access at home 
and over 90% at school.(234) Over 80% of users accessed the Internet at least weekly. 
A quarter of this group used it for personal information and advice, and of these, 22% 
reported searching for advice on sex, contraception or pregnancy. By creating a web 
version of the software it would be possible to track use of MyWay as each user has 
given a unique ID number. This would allow an assessment of the intensity of the 
intervention (i.e. the ‘dose’effect).
In their systematic review of information included in decision aids, Feldman-Stewart 
and colleagues comment that information critical to decision-making was frequently not 
included within decision aids.(124) While accuracy and completeness of information is 
paramount, overloading patients or consumers with too much information could also 
have negative consequences.(124;235) Computer-based programs can be designed to
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provide layers of information which users can access further depending on need or 
interest. For example, in the MyWay program there were pages providing a definition of 
the different contraceptive methods or pages providing links to helplines.
Value focus
The novel feature of MyWay is that it is value-focused rather than information-focused. 
It elicits a young person’s relative valuations of the attributes and outcomes they feel are 
relevant to them, and then combines these valuations with evidence-based ratings of the 
degree to which alternative contraceptive methods produce these attributes and 
outcomes. The scores produced by combining the ratings and weightings result in a 
recommendation based on the underlying decision analytic principle of maximising the 
person’s expected utility. It is therefore a decision aid rather than an information aid, the 
latter typically providing information which the young person is assumed to be able to 
take into account in making their choice, leaving their valuations to be introduced and 
processed implicitly rather than explicitly. Decision aids on the other hand allow 
sophisticated and individual decision modelling to be made available to users in a more 
accessible format.(236)
A strength of MyWay was the simple way users were asked to assign weights to their 
selected attributes, that is by increasing or decreasing the area size of boxes representing 
the attributes. The young people did not appear to have difficulties in understanding the 
idea of weighting their values. The only problem was that users sometimes found it 
fiddly changing the size of the boxes, particularly when the full limit of eight attributes 
had been selected. This problem has been rectified for the new program by use of bar 
charts to assign weights (see Section 6.3.). Other studies of decision aids have found 
that users have experienced difficulties in utility assessment.(236) Although it is argued 
that this problem is more to do with insufficient instructions rather than difficulties with 
the concepts behind decision analysis.
Data used in underlying matrix
Clinicians and young people were able to access the data used in the underlying 
decision analysis if they wished. This ensured transparency and could allow clinicians, 
in particular, to question the appropriateness of the data and their applicability to 
clients.(144) As already discussed, some of the evidence used in the underlying matrix 
may not necessarily be generalisable to UK residents attending an inner city sexual
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health clinic. Enkin and Jadad comment “it would be reasonable to expect that 
sometimes our knowledge of the individual patient, the clinical setting, or our own 
expertise may override the more generalized evidence even from the best formal 
studies.” (p. 964).(237) For example, a clinician may be aware the prevalence of 
chlamydial infection in their local area is much higher than the estimate provided within 
the MyWay program. The program was designed by the team at LSHTM to ensure that 
it would be possible to add different matrixes to inform the decision analysis. Matrixes 
could be developed for different areas, different target groups or be up-dated as new 
evidence becomes available. It would be possible to create a library of matrixes; the 
only stipulation would be that changes would have to be justified to maintain 
transparency.
Trade-off
Another benefit of the MyWay program is that it provides a comparison of different 
contraceptive methods and allows the user to see the trade-off between these methods. 
For example, Sheeran and colleagues comment how often our focus has been on 
condom versus no condom (i.e. method versus no method) rather than acknowledging, 
as discussed in Chapter 1, that the decision to use a condom may involve weighing the 
advantages and disadvantages of condom use against the alternative contraceptive 
options.(57) The use of the MyWay program is not a one-off process. The values that 
shape the weight we place of different attributes and the relative trade-offs we are 
willing to make will be dependent on changing circumstances. Therefore the 
contraceptive method the program identifies as the ‘best’ option may vary over time, as 
influences on values, such as length of a relationship, change.
Dual focus
An unforeseen strength of the program was the benefit some men gained by thinking 
about contraception from a dual perspective (i.e. from both their and their partner’s 
perspectives). The role young men can have in contraceptive decision-making is often 
ignored. As Pyper and Freely highlight there is a need for a dual focus when addressing 
poor (and healthy) sexual health amongst young people, “we tend to forget when we’re 
talking in broad terms about the importance of reproductive choice is that it takes two to 
make a baby” (p. 94).(238)
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6.2.2. Limitations o f  the MyWay Program
Introducing the MyWay intervention into a clinical situation enabled the research team 
to ascertain how it worked in ‘real life’. This process identified some limitations of the 
program. Most of these problems would be relatively easy to address in future 
development. As discussed in Section 6.2.1. overloading patients or consumers with too 
much information may hinder effective decision-making. Therefore any potential gains 
resulting from additions to the program, as described below in this section, would have 
to be weighed up against the potential reduction in accessibility these additions might 
cause.
Contraceptive options
The MyWay program did not include all contraceptive methods available to young 
people in the UK in the list of options. For example, Evra (the contraceptive patch) was 
not available during My Way's development phase, yet by the time of the pilot study it 
was. Some of the young women who participated in the pilot expressed an interest in 
this method. The IUS was not included as the research team felt this was a method that 
would not be made available to most young people, particularly those without children. 
However, National Institute for Health and Clinical Excellence (NICE) guidelines on 
contraceptive provision for young people report that the IUS can be offered to 
nulliparous women.(239) Emergency contraception (either the progestogen-only pill or 
the copper IUD) was not included as an option. The reason for its exclusion was that 
data on risk of events, such as pregnancy or side effects, were usually collected at one- 
year follow-up rather than looking at risk per episode of vaginal sex. We also assumed 
emergency contraception use was a responsive act to potential risk of an unwanted 
pregnancy rather than an active decision to use it as one’s method of choice.
Abstinence from vaginal sexual intercourse and having oral or anal intercourse to 
prevent pregnancy were not included as options as they were viewed as behaviours 
adopted to avoid pregnancy rather than as methods of contraception. It was also 
assumed young people had already made the decision to have vaginal intercourse (either 
currently or in the future). If abstinence was to be included as an option young people 
would need to trade-off the pros and cons of having sexual intercourse with the pros and 
cons of not having sexual intercourse.
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Contraceptive attributes
The contraceptive attributes listed in the program had been identified through previous 
qualitative work with young people. The attributes that affect decision-making 
identified in this work are similar to those found in a study by Grimley and colleagues 
conducted in the early 1990s with psychology students in the US.(240) The study 
examined the cognitive and motivational aspects of contraceptive decision-making at 
various stages of change with respect to adoption of contraceptive methods. Pros and 
cons associated with contraception were identified. The authors report that their work 
suggested “interventions designed to increase the use of contraceptives to prevent 
pregnancy and disease will be more effective if the pros of engaging in their use were 
more salient to users” (p.468). For the most part, the attributes identified by young 
people used in MyWay tended to focus on the negative effects of contraceptive use or 
failure, such as an unplanned pregnancy or a negative side effect. In MyWay the 
attribute “effect on sex” was assumed to be negative, such as the use of condoms or 
diaphragms interrupting the spontaneity of sexual intercourse. Young people 
participating in the pilot appeared to view “effect on sex” this way as well. However, as 
Grimley and colleagues point out contraceptive use can be viewed to have a positive 
effect on sex, for example being more relaxed during sexual intercourse because you 
know you are protected against pregnancy and/or STIs. Conversely, contraceptive non­
use may have a positive effect in that unprotected sex may be viewed as more exciting. 
In any future application of MyWay, the attribute “effect on sex” would have to be more 
clearly defined.
There are also many other non-contraceptive benefits that perhaps the consumer should 
be made aware of when they are trying to make a decision. For example, the non­
contraceptive benefits associated with pill use include more regular menstrual cycles, 
less dysmenorrhoea, and protection against endometrial and ovarian cancers.(210) 
Young people were also less likely to identify potential long-term risks associated with 
contraceptive use, such as the increased risk of cervical cancer amongst pill users. 
Therefore, although it was key that young people were involved in identifying the 
contraceptive attributes important in their decision-making process, attributes they may 
be less aware of, but potentially useful to decision-making, should also be included.
It is also worth noting that the young people who participated in the original focus 
group work, where the attributes for MyWay were identified, all came from the same
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area of London (although they were recruited from a variety of clinical and non-clinical 
settings). It is possible that work with young people in other areas may identify different 
attributes. For example, cost of contraception was not highlighted. In parts of the 
country where it is more difficult for young people to access free condoms, cost may be 
an important influence in decision-making.
The final point about attributes that needs to be highlighted is that of consequence of 
outcomes that may follow from contraceptive use (and non-use). These will be often 
incomplete. For example, in MyWay if a user selected HIV acquisition as an attribute 
they were concerned about the probability of this event happening and the relative 
weight they placed on it would be used in the underlying decision analysis model to 
calculate the best contraceptive option for that individual. The effect of HIV on life 
expectancy is not directly addressed in the model. However, these consequences may 
affect the weight we place on the selected attributes.
Contraindications
Most contraceptive methods are not contraindicated on the grounds of age. Despite 
some concerns about the decrease in bone mineral density amongst young users of 
progestogen-only injectables, particularly DMPA, current Faculty of Family Planning 
and Reproductive Healthcare Clinical Effectiveness Unit guidelines state the benefits of 
these methods, may outweigh the risks.(82) However, these guidelines do recommend 
against use of any hormonal method prior to menarche.
The MyWay program did not ask young people about their own or their family’s 
medical history. Therefore it is possible MyWay could recommend a contraceptive 
method that would be contraindicated. For example, current UK Medical Eligibility 
Criteria for Contraceptive Use (UKMEC) guidance recommends against combined oral 
contraceptives (including the combined pill and the patch) for women who had a first 
degree relative with a history of venous thromboembolism (VTE) under the age of 45 
years, unless other contraceptive methods are unavailable or not acceptable to the 
user.(241) As the pilot was in a clinical environment and hormonal contraceptive 
methods have to be prescribed, this was not thought to be problematic. However, it 
would be feasible to introduce a set of medical history questions to identify 
contraceptive methods that may be contraindicated for an individual user, and then 
remove any contraindicated methods from their list of options. It has been shown that
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there is a high level of agreement between women’s and provider’s assessment of 
contraceptive risk factors.(242;243).
Presentation o f  Evidence
Attempts were made to ensure that the underlying decision analysis in MyWay was 
informed by the best available evidence. However, there are still many gaps in our 
understanding of the risks and benefits of contraceptive use. As already discussed in 
more detail in Section 4.2.3. many assumptions had to be made, in particular when 
trying to calculate risk of STI acquisition when using different contraceptive methods. 
However, as Dowie comments, “the necessity for a decision does not disappear just 
because there is little or no good evidence of a clinical sort.”(p.l80)(132). Where no 
evidence is available, anecdotal evidence provides the best, and in the fact the only, 
source of evidence to inform decisions. A couple of the clinical members of our 
research team provided estimates when required. This level of evidence could be 
strengthened if estimates were gathered from a larger group of those working in 
reproductive and sexual health, so a consensus of opinion could be reached. Although 
the data used in the underlying decision analysis were made available to interested 
clinicians and young people, they had no means of judging its quality as no information 
was provided on their source. Although it may not be appropriate to include details of 
all the studies used for estimates (as seen in Appendix 2.), it is important there is 
sufficient transparency so that an assessment can be made of the evidence included 
within the program. In any future development of MyWay, grading the hierarchy of 
evidence (from example data from meta-analysis of RCTs through to anecdotal 
evidence) could be considered as a way of helping both providers and consumers 
understand the strengths and limitations of the included data. Some decision aid studies 
have provided easy systems to help users interpret the quality of the evidence, such as 
the use of gold, silver and bronze medals.(124) Currency of information could also be 
clearly identified by providing citations of the included studies.
The vast majority of young people participating in the pilot study did not look at the 
data used in the underlying matrix. This may have been due to lack of time within the 
consultation or lack of interest. The data in the matrix consisted of probabilities of 
events, such as pregnancy, occurring within a year whilst using each of the 
contraceptive options. Those accessing the matrix would have had difficulty interpreting 
the data, and ways of presenting the data in a more user-friendly way would need to be
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addressed in fixture development of MyWay. The fpa commissioned some research to 
find out the most effective way to report contraceptive efficacy in their information 
leaflets to consumers.(102) One hundred women and men aged 16-45 years were 
interviewed. Interviewees found positive messages more reassuring, while negative 
messages could put people off using contraception. The majority of the sample 
preferred contraceptive efficacy presented as a percentage. Those who were less 
numerate preferred numbers. Some found it difficult to understand when failure rates 
were less than 1% as they could not see how you could have less than one person. The 
recommendation from this research is that efficacy should be presented as a percentage 
followed by the number of women who will become pregnant after one year of use. For 
example, injectables are 97% effective. If 100 women use injectables for a year, 3 of 
them will become pregnant.
Whilst evidence from the literature was sought for probabilities of pregnancy, STIs and 
side effects, the probabilities for ‘bother’ factors were estimated by the research team. It 
would be a fair assumption that a young person would have to attend a clinic to have a 
subdermal implant fitted (this attribute being assigned 1.0 in the underlying matrix). 
However, the assumptions made for other contraceptive attributes are more subjective. 
For example, the probability of condoms’ effect on sex was 0.5 (See Appendix: Table 
A2.17.). It may be more appropriate for some of the ‘bother’ factors for the user to 
assign the probabilities. This, like the assignment of values, could be done through 
visual means. It would also be an interesting intellectual exercise to ask users to assign 
their own probabilities to the other attributes, such as what they think the probability is 
of becoming pregnant whilst using the pill. The evidence-based matrix could be 
available afterwards for them to compare their ratings with those from the scientific 
literature.
There was much uncertainty around some of the estimates included in the program. For 
example, Stephenson’s systematic review of contraception and HIV acquisition risk 
estimated that the odds of HIV acquisition amongst women who used the pill was 0.3,
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but the lower and upper limits of the 95% Cl were 0.05 and 2.1, respectivelyvll.(206) 
Where there is uncertainty in the literature, for example illustrated by wide confidence 
intervals around an estimate, the lower and upper limits can be used in sensitivity 
analyses.(125) Sensitivity analysis could be conducted to determine high risk and low 
risk scenarios and different matrices could be developed to reflect these different 
scenarios. This would allow further exploration of how altering the probability of 
different outcomes for selected contraceptive methods altered would affect the 
contraceptive option ‘recommended’ by MyWay, even if user values remained the same.
The other consideration when presenting the evidence is that of ‘rounding up’ the 
estimates. If one selected the contraceptive options the male condom and nothing and 
HIV as the only attribute, both options would rate equally and score 1 (i.e. the 
probability of remaining free from HIV infection in one year would be 1.0 when 
rounded up to the nearest decimal point). The chance of HIV acquisition in one year 
amongst a general female population of 15-19 year olds in England using the male 
condom is estimated at 0.000002 or two in a million, but the chance without any 
protection is estimated 0.00003 or 30 in a million (see Table A2.9.). The percentage 
reduction is impressive, but the baseline number is so small that the 
difference disappears when we take both numbers away from 1 and round to two 
decimal places. If the condom is to score the highest in this situation more decimal 
places are needed. This example illustrates the important difference between relative 
and attributable risk; the increased attributable risk is negligible despite a large 
increase in relative risk.
Self-efficacy
A systematic review of the qualitative research on factors that influence young people’s 
sexual behaviour has shown the importance of sexual partners in this context.(120) In a 
paper that examines the role of emotional factors in predicting STI risk, Whitten and 
colleagues comment that a problem with social cognitive theory is that it demands 
increased interpersonal self-efficacy in order to reduce sexual risk taking.(245) As
v" A large African multi-centre study following up a cohort o f women aged 18-35 years who were HIV 
negative at recruitment has found no association between combined oral contraceptive use and HIV 
acquisition (hazard ratio 0.99, 95% Cl 0.69-1.42). Therefore as studies such as this one conducted by 
Morrison and colleagues are included any subsequent meta-analyses,(244) greater precision around the 
estimates will be observed.
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described above, a strength of MyWay is that it can look at contraceptive decision­
making from both an individual and partnership focus. When making decisions from a 
partnership focus, for example, a young woman may take account of or be influenced by 
the values she thinks her boyfriend would place on the effect contraceptive use may 
have on sex. For some young people, a partner’s values may dominate decision-making 
within a relationship, which can potentially cause conflict. MyWay aims to improve 
young people’s contraceptive decision-making and their understanding of how their 
values affect the decisions they make. It was never seen as My Way's role to improve 
user self-efficacy. This highlights the need for a number of different approaches to 
improve young people’s sexual health.
6.2.3. Strengths o f the Phase I  Pilot
The piloting phase was in line with MRC guidance for the development and evaluation 
of complex interventions. As Campbell and colleagues explain the framework is not 
about having a stepwise approach where each component is conducted in 
sequence.(246) Instead there needs to be flexibility. Defining the problem and context, 
intervention development, and development and refinement of the evaluation may be 
done simultaneously.
A major strength of the phase I pilot was the multi-methods approach used to collect 
data and the use of quantitative (the computer-based questionnaire and program data) 
and qualitative (observation of consultations, facilitator notes, in-depth interviews with 
young people and staff group feedback) techniques. This allowed triangulation of the 
data to provide a greater understanding of how the program was working at an 
individual level and within the setting it was being used. For example, analysis of data 
obtained from the observations, in-depth interviews and staff feedback provided insight 
into process of introducing MyWay into clinical consultations -  what worked and where 
the barriers were. At an individual level, we were able to link the program inputs and 
outputs (young people’s selected contraceptive options and attributes, attribute weights 
and final scores) with the survey responses, which provided information on their 
demographic characteristics and sexual behaviour. In a larger scale study this would 
allow analysis of factors that influence young people’s contraceptive risk assessment 
and values. From an intervention perspective, this will provide us with a greater 
understanding of how the intervention is working, making specific links between 
thoughts, beliefs, values, decisions and behaviour. Hesie comments that research needs
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to pay more attention to how contraceptive choices are made, “The challenge of 
elucidating the ‘black box’ of contraceptive decision-making is a task of theoretical 
import.” (p. 12).(54) A synthesis of reviews looking at interventions aimed at reducing 
teenage pregnancy concluded that a lack of understanding of what works (i.e. the ‘black 
box’) have been limitations of previous interventions.(47)
6.2.4. Pilot Considerations
Bias
A number of biases need to be considered when interpreting the pilot findings and these 
would need to be addressed in any future study of the MyWay intervention. The 
development of the intervention and the pilot to assess its feasibility, acceptability and 
potential effectiveness were managed by the same team. Therefore the exploratory study 
was not independent and the team would not have been impartial. This may have led to 
an over-estimation of the positive impact on the intervention. This problem would be 
reduced in an RCT of the MyWay intervention, where allocation to the intervention or 
control group could be blinded to both clients and researchers. Although there would be 
obvious problems blinding clients and researchers to the intervention itself and when 
collecting process data, it would be possible to conduct the outcome analysis blinded.
A high proportion of young people attending the clinic who were invited to participate 
in the pilot study declined to take part. No information was collected on the 
characteristics of these individuals. It is possible that those agreeing to use the MyWay 
program and take part in the pilot are not representative of young people attending 
sexual health clinics. Information about non-responders would have to be collected in 
any future study of MyWay.
Structural problems
It was not possible to see what impact MyWay had on uptake as some of the methods 
identified as possible options, and some methods recommended by the program were 
not available on site. So those young women, who may have wanted to have a 
subdermal implants fitted, for example, would have to have been referred to other 
contraceptive service. This may have been a factor that acted as a barrier to the uptake 
of some methods.
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Determining effect size
Campbell and colleagues in their paper updating the MRC’s framework for the design 
and evaluation of complex interventions recommend that in order to calculate the 
sample size for the main trial the exploratory phase should be randomised to allow an 
assessment of effect size.(246) The ultimate goal of the MyWay program was to 
improve correct and consistent contraceptive use through use of methods acceptable to 
the user, and thereby reducing unplanned pregnancy. It was beyond the scope of this 
phase I study to follow up young people and therefore collect data on potential effect 
size. However, in any future pilot it would be worth using other variables relating to the 
decision-making process to inform sample size calculations for trials (see Section
7.3.1.).
Outcome measures
A trial of MyWay would need to be designed to collect measures of effectiveness and 
acceptability. A phase II study would be designed to collect the same outcome measures 
as those to be collected in a future trial (see Section 7.3.3.). For example, there are a 
number of ways contraceptive acceptability could be measured. In the phase I pilot we 
asked the young people what their method of choice was before and after using the 
MyWay program. Whether or not the option MyWay recommended was the preferred 
option was a hypothetical question. Unfortunately the evidence suggests that we are not 
good at predicting actual contraceptive preference from hypothetical scenarios.(54) In 
trials method uptake and continuation are often used as markers of acceptability. The 
phase I study provided the opportunity to identify appropriate measurements of 
acceptability, which could be investigated in further evaluation phases. Ways of 
measuring decision-making would also need to be explored. Decisional conflict scores 
and scales have been developed to measure internal perceptions of ability to make a 
decision, factors contributing to uncertainty and the extent to which people are satisfied 
with the decision they have made (95;135;247;248). Further exploratory work could 
also aim to develop and validate some specific contraceptive decision making scales.
6.3. Areas for future application and research
The focus of this section is to explore areas for the further application of MyWay within 
a clinical setting and other potential areas of research identified during the phase I pilot. 
The description of the proposed work to implement and pilot MyWay in school settings
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(phase II) and to conduct preparatory work for a cluster RCT (phase III) is the focus of 
Chapter 7.
The phase I pilot provided the research team with information to refine the intervention. 
A generic decision analysis program, called Annalisa, has subsequently been developed 
(by Jack Dowie and Lorenzo Gordon).(249) The underlying decision analysis principles 
remain the same, but the program has been made more user-friendly. For example, 
much of the text in the original program has been removed and the method of utility 
assessment has been made easier. The user is now presented with bar charts, with each 
selected attribute represented by a bar, rather than having segments within a box.
MyWay was developed for young people who were having or planning to have vaginal 
sexual intercourse. The program could easily be developed for other target groups, for 
example heterosexual adults or gay men, and could include other behaviours that affect 
fertility or STI/HIV risk, such as oral or anal intercourse. In further studies the 
principles of the intervention would remain the same but the mechanisms in terms of 
delivery may vary, depending on the target group and the setting.
6.3.1. Using MyWay as a pre-consultation tool
The idea behind MyWay developed because of concerns that young people’s values 
surrounding their use (or non-use) of contraception were often not being addressed 
during clinical consultations. The pilot study suggested that it was not feasible to use 
MyWay in consultations. However, the reasons for this were for the most part related to 
structural barriers rather than any indication that MyWay would not be effective or was 
not acceptable. Young people’s values and the context of their contraceptive use still 
need to be addressed during consultations. Staff felt that it may be easier for young 
people to use MyWay prior to their consultation with a doctor or nurse. My Way's 
recommendations and their basis could then be discussed within the consultation.
Target group and setting
Brook Advisory Centres have expressed interest in using MyWay as a pre-clinical 
decision aid for young women and men attending their clinics. Brook is a charitable 
organisation that provides sexual health services to young people aged under 25 years.
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Intervention
The MyWay program would be accessed by young people prior to their consultation 
with the doctor or nurse. Computer access is already available in some Brook waiting 
rooms. The process would be the same as in the original intervention set within the 
clinical consultation, that is the young people would first do the introductory 
demonstration exercise and then they would go on to the contraceptive section of the 
program to select the contraceptive options and attributes they are interested in and 
assign weights to the attributes. This information, along with the expected utilities for 
each contraceptive option and the option with the highest score, would be made 
available as a printout for the young person to then discuss with the doctor or nurse. 
Future access to the program and previous outputs could also be made available to 
young people via the Internet, so decision support is also available outside of the 
clinical environment.
6.3,2. Areas for further research
The development and piloting of MyWay identified areas that warrant further research, 
identified in brief below. It would be possible to address some of these gaps in further 
research of the MyWay program.
How contraceptive use affects STI transmission and acquisition
The review of the evidence to inform the MyWay program showed that more research 
into the effect contraceptive method use has on STIs and the interplay with sexual 
behaviour is needed. We know, for example, that progestin-only contraception prevents 
sperm penetration by thickening the cervical mucosa.(210) The extent to which this 
action is protective against STIs is unknown.
At a population level, patterns of contraceptive use will impact on STI prevalence. The 
calculation of the reproductive ratio is a way of determining the sustainability of an 
infection at a population level by providing the average number of secondary cases 
generated by a primary case.(217) The reproductive ratio (Ro) is calculated by 
combining the probability of transmission with a sexual partnership (P), the length of 
time someone is infectious (D) and the number of new sexual partners the infected has 
had within a defined period of time (c), [Rcr= PDc]. The spread and subsequent 
persistence of an STI occurs when Ro is equal to or greater than 1.0. Contraceptive 
methods affect or are associated with p and c, therefore patterns of contraceptive use at
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a population level need to be considered when determining whether an infection is on 
the decline or spread.
Perception o f risk and value assignment
Little is understood about how young people estimate their perceived risk of pregnancy 
and/or STIs. Getting young people to assign probabilities to these events would be a 
way of improving of understanding, particularly if these data could be linked to other 
data relating to demographic characteristics (e.g. age), educational level (e.g. 
qualifications), sexual behaviour (e.g. age at first intercourse) and context (e.g. stage of 
relationship). The highly numerate tend to draw more affective meaning from 
probabilities and numerical comparisons than do the less numerate.(139;140) Validated 
questions to assess individual numeracy could also be included to assess if this has any 
impact on contraceptive risk-taking behaviour.
Although the number of young people participating in the exploratory pilot of MyWay 
was small, there was wide variation in the values assigned to the different selected 
contraceptive attributes by different individuals. Further research is needed to 
investigate the association between young people’s demographic characteristics, their 
beliefs, values and behaviour in relation to contraceptive use, and how these vary 
between individuals and within an individual over time.
Provider decision-making
Discussions with staff working in sexual health illustrated that how professionals make 
decisions about contraception is not necessarily evidence-based. There is little research 
on what basis professionals make decisions about what they consider the most 
appropriate contraception, and how their decisions compare with young people’s 
decision making. The values that inform young people’s decision-making may conflict 
with values held by providers. A postal survey of 169 doctors and 148 nurses working 
in general practice found there was great variation in the contraceptive methods these 
professionals thought were ideally suited to women depending on their personal 
characteristics.(250) For example, 87.2% (95% Cl 83.5-90.9) reported that condoms 
would be ideally suited for a 19-year old woman with no children and who had casual 
partners. For a 17-year old woman with one child and no regular partner, 76.1% (95% 
Cl 71.4-80.9) of the professionals thought condoms would be ideally suited. How
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providers influence young people’s contraceptive choices, either directly or indirectly,
also warrants further investigation.
6.4. Key points
• The pilot study of MyWay's use in consultations within a sexual health service 
found acceptability was generally high amongst the young people using the program 
and that as a tool it has potential in helping young people with contraceptive 
decision-making. However, the study also suggested that there may be practical 
barriers to introducing MyWay within clinical consultations.
• Strengths of the MyWay intervention included the non-judgemental approach, its 
potential accessibility, its value focus, and the transparency of what data were used 
in the underlying matrix.
• The pilot study did identify some areas where the program could be improved. The 
list of contraceptive options and attributes needed to be expanded and the non­
contraceptive benefits of different methods could be included, such as reduced 
dysmenorrhoea amongst pill users. Ways of presenting the data in a more user- 
friendly format needs to be addressed, including ways of presenting risk of 
outcomes and study quality.
• The phase I pilot was in line with MRC guidance for the development and 
evaluation of complex interventions. The adoption of a multi-method approach 
ensured a good understanding of how MyWay was working at a user level and in 
consultations within a sexual health service.
• Further exploratory work would be required for the calculation of the sample size 
needed in a definitive trial and for the development and validation of specific 
contraceptive decision-making scales and effectiveness outcomes.
• Although there were problems introducing MyWay within the consultation, its 
application as a pre-consultation tool to be used within services warrants further 
investigation.
• Other areas of research identified through the development and pilot process worth 
pursuing included: the relationship between use of different contraceptive methods 
and STI transmission and acquisition, the basis on which providers make decisions 
about contraceptive provision, and young people’s perception of pregnancy and STI 
risk and value assignment.
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Chapter 7.0. MyWay in schools: Phase II
7.1. Introduction
Introducing the MyWay program in schools was one of the recommendations suggested 
by the young people taking part in the phase I pilot study. Evidence from the research 
literature supports this view. School-based lessons are young people’s main source of 
information about sexual matters, in particular for young men.(41;251) Data from 
Natsal-2000 found that 39.2% of men and 30.1% of women aged 16-19 years reported it 
as their main source.(251) Most of the SRE provided within schools is covered within 
Personal Social and Health Education (PSHE) lessons. Natsal-2000 data also showed 
that over a third of young people wanted more information about STIs and a quarter 
wanted more information on contraception. Young people still complain that SRE is too 
biological and does not meet their needs, and that the psycho-sexual topics should be 
included. Ways of engaging young people and putting sex in context are needed. As 
illustrated in Chapter 3, young people are increasingly using school-based services to 
gain contraceptive advice.(252)
Just under a third of young men and just over half of young women in the UK have first 
intercourse before their 16th birthday.(7) This group is significantly less likely to use 
contraception at first and subsequent sex than those who wait under after they are 16 
years of age.(7;55) Therefore targeting an intervention at 13-14 year olds to help them 
improve their skills for future contraceptive decision-making would seem appropriate. 
Stone and Ingham found that less than half of those who delayed access to a sexual 
health service until after first (and subsequent) intercourse had been using contraception 
consistently prior to seeing a provider.(253) Some of the men who had not accessed a 
health service provider had obtained condoms elsewhere. They had not considered using 
a service or had not felt it necessary to seek help. Therefore the rationale for introducing 
interventions to improve future contraceptive use at an age when the majority of young 
people have not yet had sexual intercourse would seem justified.
A review of interventions aiming to reduce teenage pregnancy found there was evidence 
of the effectiveness of school-based programmes.(47) Interventions in this setting also 
have the potential to reach a wide population. Process evaluations of sexual behavioural 
interventions in the UK have suggested their implementation within school settings are 
feasible.(254-257) The main barriers have been problems of fitting the intervention into
164
an already tight timetable and questions relating to the ethics in obtaining parental 
consent for their children’s participation in the evaluation.
The application of the MyWay across PSHE and Mathematics lessons has been an area 
that I have been interested in exploring. There are a number of reasons which support 
this integrated approach. Learning about probability is part of the Mathematics National 
Curriculum for 13-14 year old pupils. Informal discussions with Mathematics teachers 
have suggested that introducing sexual health into Mathematics lessons would be a way 
of engaging young people by applying the subject of probability to an area that is 
relevant and likely to affect young people in the future (or already doing so for a 
particularly vulnerable minority). The goal of the MyWay program when used in the 
clinical consultations was to provide sexually active young people with their ‘best’ 
contraceptive option given the scientific evidence and their current values, which would 
lead to improved contraceptive use and ultimately to better sexual and reproductive 
health. Introducing a decision analysis intervention within a school setting provides 
more opportunities for young people to learn about probability and how their values 
affect judgments and to improve their decision-making skills in general as well as in 
relation to their sexual health. Using an integrated Mathematics and PSHE approach 
will encourage young people to understand the concept of risk, including that associated 
with sexual behaviour and contraceptive use, as well as how their values affect decision­
making. This integrated approach fits in with the philosophy of national programmes, 
such as Every Child Matters and the National Healthy Schools Standards. (258;259)
The objectives of this chapter are to:
- to describe a proposed phase II pilot study of MyWay in schools and the preparatory 
work for a clustered RCT.
The definite trial would be designed to compare schools implementing the MyWay 
intervention plus their usual SRE programme against control schools just providing 
their usual SRE programme.
7.2. Aims and objectives
The aims of the proposed work for the next phase II study would be to adapt and pilot 
an intervention designed to improve contraceptive choice using a computer-based
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decision analysis program {MyWay) in Mathematics and PSHE lessons, and to carry out 
preparatory work for a cluster-RCT.
The specific objectives related to the intervention development and implementation 
would be to:
1. adapt the MyWay computer-based program to a school setting using the 
Annalisa program, a generic decision analysis program.(249)
2. develop and deliver facilitator training for Mathematics and PSHE teachers 
involved in the implementation of MyWay.
3. deliver an intervention using the MyWay program to pupils aged 13-14 years 
across Mathematics and PSHE lessons.
4. develop and test process evaluation tools to assess if the intervention is 
delivered as intended.
5. evaluate probability assessments of young people pre and post intervention.
6. investigate the association between young people’s demographic 
characteristics, their beliefs, values and behaviour in relation to 
contraceptive use, and to determine how young people make decisions 
around the contraceptive choices available to them.
The specific objectives related to development of the definitive trial would be to:
1. assess recruitment of young people to the intervention and retention of 
participants.
2. determine the feasibility and acceptability of the intervention in schools 
through process evaluation.
3. estimate the likely variability between schools to use in the definitive trial 
sample size.
4. estimate likely prevalence of sexual health primary endpoints for the 
definitive trial, including contraceptive use, pregnancy and STI acquisition.
7.3. Methods
7,3.1. Study population and sampling
Setting
Two secondary inner city schools would be recruited to take part in the pilot. These 
would be comprehensive, mixed sex, non-selective schools. Both schools would
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implement the MyWay intervention (plus usual SRE). As the purpose of this pilot is 
primarily to pilot the implementation of the MyWay intervention and other UK trials 
have already addressed the collection of outcome and process data in secondary schools 
who are implementing their usual SRE programmes, (255-257;260) there would be no 
control schools.
The MyWay intervention would be delivered across Mathematics and PSHE lessons. 
Target group
All 13-14 year old male and female pupils (year 9) would be invited to participate.
Written consent would be obtained from young people participating in the pilot. Written 
information about the research would be provided and sufficient time would be allowed 
to consider participation. Contact details of a member of the research team and relevant 
helplines, such as Childline and Sexwise, would be provided with the information sheet. 
Participants would be informed that they are free to withdraw from the pilot at any stage 
without having to give a reason for their decision. Parents or guardians of pupils would 
be informed that the research is taking place, what it involves and that written consent 
would be sought from their children to participate. Parents would retain their right to 
withdraw their children from these classes. An opt-out policy regarding parental consent 
has been adopted in previous sexual behavioural trials in UK schools and this appeared 
to be acceptable to both parents and schools.(255;260)
Mathematics and PSHE teachers delivering the intervention would contribute to the 
process evaluation. Their written consent would also be obtained.
Sample size
Assuming around 5% of pupils are absent, and 2% of parents do not give consent, 
(based on the RIPPLE study [Randomised Intervention trial of Peer (Pupil)-Led sex 
Education])(260), it is estimated that at least 200 pupils would participate at each 
school, giving a total of 400 in the study. This would allow the mean change in ability 
(see Section 7.3.3. Analysis) to be measured within 10% of the standard deviation of 
changes seen, and allow an initial assessment of how such changes are linked to 
demographic or behavioural characteristics.
167
7.5.2. The intervention
The first stages of the phase II study would involve the adaptation of the original phase 
I intervention and then its delivery with Mathematics and PSHE lessons. A gant chart 
illustrates the timescale for this process (Table 7.1.).
Adapting the original (Phase I) intervention
Generic decision analysis software Annalisa would replace the original software used in 
the previous MyWay program in the clinical setting.(249) The principles behind the 
program and the users’ pathway through it would remain the same as the original 
program. The main differences would be in how it is delivered and the additional 
emphasis on educating young people about the wider principles of decision analysis.
An updated literature search (from 2002) would need to be conducted to obtain more 
recent epidemiological evidence on pregnancy, STI risk and side effects associated with 
the different methods and to include data on contraceptive options and attributes 
omitted from the original program, such as inclusion of data on the Evra patch. A new 
matrix holding this evidence would be incorporated into the program. Information about 
the studies, including an assessment of their quality, would also be made available 
within the program.
During the initial stages of development meetings would be held with the schools to 
discuss the delivery of the intervention (and the research process, for example pupil 
recruitment logistics). A workshop with a group of sixth form pupils would be 
conducted to get their advice on the program, including input on ideas for 
demonstration examples and how to illustrate study quality.
A one-day training workshop for Mathematics and PSHE teachers involved in the 
implementation of the MyWay program would be developed and implemented to ensure 
standardisation in the delivery of the intervention. The workshop would cover the 
principles of decision analysis and its application to contraception, how the program 
works and delivery of the intervention. Advice and support about the required training 
would be provided by the recently formed PSHE Association, based at the National 
Children’s Bureau.
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Delivering the intervention
The plan would be for the program to be introduced over three lessons, with each lesson 
around one hour in length. Lessons involving use of the MyWay program would be 
conducted in computer labs to ensure each pupil had direct access. Each young person 
would be provided with a unique ID number and would have to create their own 
password to gain access to the program.
The agenda for each lesson is provided below:
Lesson 1- Introduction to basic principles underlying decision analyses, using a 
wide range of social, financial, health and other examples, and discussion about 
the different ways of making decisions. This would be run jointly by 
Mathematics and PSHE teachers.
Lesson 2 -  Introduction to MyWay, class exercise using decision analysis to, for 
example, chose a friend to go on holiday with (i.e. young people would be asked 
to assign relative weights to characteristics, such as fun, reliable, and talkative, 
to fictitious friends to see who would be their best holiday friend). Young people 
would then be allowed to use the contraceptive element of the program on an 
individual basis. This session would again be run jointly by Mathematics and 
PSHE teachers.
Lesson 3 -  Small group work to explore how values affect decisions related to 
sexual behaviour and contraceptive use (and life in general), and what pupils felt 
they learnt from the program (including about decision making in general). The 
group work would be led by the PSHE teacher.
The program would be made available to young people via the Internet so they could 
continue to access the program as and when they needed through use of their ID number 
and password. This would also allow access in settings outside school, for example at 
home, in libraries or in Internet cafes. This ongoing access could be monitored by the 
research team.
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Table 7.1. G ant chart for proposed phase II study
Stage 1: Development phase
Update evidence
Adaptation of decision analysis software
Development of research instruments
Establishing partnerships with selected schools
Ethics approval
Staff training programme
Stage 2: Collection of baseline data and implementation of 
the intervention
Baseline survey and probability exercise
Implementation of MyWay
Monitoring of intervention implementation
Repeat probability exercise
Semi-structured interviews and focus groups
Tracking use of MyWay
Stage 3; Follow up
Follow-up questionnaire, probability exercise and focus groups
Analysis and writing up
Preliminary analysis
Final analysis 
Proposal development for clustered-RCT 
Writing up and dissemination
Year 1 Year 2
Q uarter 3 Q uarter 4 Quarter 1 Q uarter 2 Q uarter 3 Q uarter 4Q uarter 1 Q uarter 2
Figure 7.1. Pupil pathway through the MyWay intervention and the research process 
•  ►
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INTERVENTION
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Introduction to and 
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Lesson 3: Small 
group work
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7.3.3. The research process
The interaction between the intervention delivery and the research is illustrated in Figure
7.1. and the timescale is provided in Table 7.1. During the time the intervention is being 
developed, research instruments from the original phase I pilot study would be adapted, and 
where appropriate new tools developed. These tools would collect data for both the 
outcome and process elements of the study, and are described below. Process evaluation, 
alongside the evaluation of outcomes, can help with the interpretation of findings through 
the examination of how the intervention has been implemented, the context of its delivery 
and its acceptability.(257;261)
Questionnaire
Pupils would complete the computer-based questionnaire within the My Way program in the 
school computer labs. They would each be allocated their own computer. The questionnaire 
would provide baseline data prior to the introduction to the My Way intervention and at final 
follow-up nine months later.
Data would be collected on the pupils’ demographic and sexual behavioural characteristics. 
The questionnaire would also collect data on the following intermediate outcome measures 
to allow for an assessment of the intervention’s impact:
• Knowledge and attitudes (e.g. knowledge of different contraceptive 
methods, attitude towards teenage pregnancy)
• Intentions (e.g. intended method of contraception)
• Behaviour (e.g. levels of sexual activity, correct and consistent contraceptive 
use)
• Biological (e.g. self-reported pregnancy and STIs)
Questions would be used from validated sexual attitudinal and behavioural surveys where 
appropriate (i.e. Natsal-2000, RIPPLE and the tracking survey for the Teenage Pregnancy 
Strategy Evaluation).
Data on biological events would be self-reported. In the future trial this could be supported 
with routine pregnancy data. Previous school-based trials of SRE interventions have shown
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it is feasible to link trial data at a cluster or sub-group level (e.g. leaving school before 16 
years versus staying on at school) with routinely collected data on births, miscarriages and 
abortions.(256;260)
Probability exercise
This exercise has a dual purpose: to gain a better understanding of young people’s ability to 
assign probabilities and to form part of the assessment on what they have learnt from the 
intervention (i.e. the skills obtained).
Software called Prober has been developed by members of the research teamvl". It basically 
works by inviting the user to assess whether a given statement is correct. Young people are 
asked to assign a probability to measure the extent to which they agree with a statement. 
Statements can be a combination of general knowledge (e.g. “London is the capital of 
England”) and sexual health knowledge (e.g. “A woman has to be over 16 years before she 
can be prescribed the pill”). Data on educational and cognitive outcomes could also be 
collected from this exercise for research purposes. Two key dimensions of ability can be 
examined in this context: discrimination and calibration (See Section 7.3.4. Analysis).(132) 
The probability exercise, like the questionnaire, would be within the computer-based 
My Way program. This will allow the linkage of data at an individual level from other 
sources (e.g. the selected contraceptive options and attributes in the MyWay program). The 
exercise will be conducted at baseline, immediately after the intervention (i.e. after lesson
3) and at final follow-up.
Program data
Data would be collected from each pupil using the program at Lesson 2 on the following 
outputs: selected contraceptive options and attributes, assigned weights to the selected 
attributes and their option scores.
vni Jack Dowie, Lorenzo Gordon and Mark Clements
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Tracking use o f My Way
Each young person will be allocated a unique ID and password when first introduced to the 
program. As the program will be Internet-based young people would be able to access 
My Way for a nine-month period following their introduction to the program. The research 
team would be able to monitor the number of occasions the program has been accessed and 
link this to other data collected at an individual level.
Observation and monitoring
Standardisation of a complex intervention can be increased through the training and 
monitoring of those involved in its delivery.(262) Monitoring can be achieved by regular 
supervision and feedback, or by observing or even videotaping of some of the classroom 
sessions. Ideally this would be done by independent assessors.
The phase II study would provide the opportunity to assess the recruitment rate and level of 
retention likely in a subsequent trial. Campbell and colleagues note that problems of 
follow-up can be further complicated in clustered studies as there are two levels at which 
drop-out can occur; the cluster level or the individual level within a cluster.(246) The 
RIPPLE and SHARE (Sexual Health And Relationships, a teacher-led intervention) studies 
suggest the level of retention of clusters and individuals in school-based studies can be 
good.(256;260) Ways of increasing follow-up would be explored during the phase II study, 
including use of new ways to improve communication about the study, such as through the 
use of internet media.
Focus groups with pupils
Two focus groups (one with young men and the other with young women) would be 
conducted in each school. Participants would be purposively sampled to ensure a range of 
educational abilities. The focus groups would explore the young people’s experiences of 
the intervention, how the intervention has affected their decision-making skills, and assess 
its acceptability, including the acceptability of an integrated Mathematics and PSHE 
approach.
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In-depth interviews with teachers
Face-to-face semi-structured interviews would be conducted with the school staff involved 
in the implementation of the My Way intervention (n~6-8). The in-depth interviews will 
explore staff experiences of the intervention and views on its feasibility and acceptability.
7.3.4. Analysis
The analysis plan would follow the same approach used for the analysis of the 
questionnaire data and the qualitative data in the phase I pilot study in the sexual health 
service (see section 5.2.6). Again linkage of the different sources would allow data 
triangulation.
The two additional analysis components to this phase II study would be the analysis of the 
probability exercise and the analysis to inform the sample size needed for a future clustered 
RCT.
Data from the probability exercises would be used to assess the student’s overall ability to 
assign appropriate probability measures of their certainty in the truth of statements 
presented to them, from 0 (certain statement is false) to 100% (certain statement is true). 
Whilst this ability can be assessed with a single overall figure using the Brier Score, it is 
instructive to look at two key dimensions of ability in this context. The first is 
discrimination, which is concerned with the extent to which students differentiate correctly 
between the true and false statements. This would be measured by the difference between 
the average probability assigned to true and false statements. The second dimension is 
calibration, which is the extent to which the student’s assessments of their certainty match 
the proportions of statements that are in fact true, for example whether all those they assign 
as 0% are all false, half of those they assign as 50% are true, and all those they assign as 
100% are true. This is measured by the distance between each assigned probability and the 
corresponding percentage of statements that are correct. These dimensions are distinct and 
can be very different for the same student. For example a student may assign very different 
and higher probabilities to true statements about condoms compared with those they assign 
to false statements and therefore show considerable discrimination, but the probabilities 
themselves may not be at all in line with the frequency of correctness at each probability.
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The primary analysis would describe the distribution of discrimination and calibration 
ability across pupils in the two schools at baseline and describe the change observed 
between baseline and each of the two follow-ups. These descriptions would be based on 
figures and summary statistics, such as mean change in ability, together with confidence 
intervals. Statistical testing (with conventional 5% significance level) would address 
whether there has been change in the two ability measures. Standard parametric tests such 
as the ‘t-tesf (or non-parametric tests if required) would be used to test the associations 
between demographic and behavioural factors collected in the study questionnaire and the 
ability measures. Furthermore, linear regression would be used to assess how multiple 
factors are associated with the ability measures.
Data from the questionnaire would be collected to estimate likely prevalence of sexual 
health primary endpoints for the definitive trial to inform the sample size calculations for a 
trial. Clustering can cause a reduction in the effective sample size, but this can be addressed 
when planning the study design and in the analysis. The sample size in clustered RCTs 
usually has to be larger than in trials of individual randomisation because of the correlation 
between individuals in the same cluster, that is those within a cluster (such as a specific 
school) are more likely to be similar than different. The degree of correlation within 
clusters is called the intracluster correlation coefficient. Stephenson and colleagues describe 
the factors required to calculate the sample size for their clustered trial, RIPPLE, where the 
main outcome was abortion,(260) and a similar approach would be used for trials of 
My Way:
1) the expected incidence rate of abortion in the absence of any intervention;
2) the variability in the abortion incidence rate between schools (i.e. the intracluster 
correlation coefficient)
3) the number of participating pupils in each school
4) the magnitude of effect of the intervention on abortion incidence that the trial 
intends to detect
5) the desired degree of certainty (i.e. statistical power) with which an effect on 
abortion is to be detected.
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7.4. Outputs
The main phase II school study outputs would be:
1) An intervention, including facilitator training, ready for full-scale evaluation in 
schools (as well as health care settings) based on the principles of decision analysis 
to help young people with contraceptive decision-making.
2) A comprehensive quantitative dataset linking information collected on demographic 
and sexual behaviour characteristics, selected contraceptive options and attributes, 
relative weights assigned to the attributes, utility scores for selected contraceptive 
options, and number of occasions the program is accessed. This would provide us 
with an understanding of how the intervention is working, making specific links 
between thoughts, beliefs, values, decisions and behaviour (i.e. opening up the black 
box’).
3) A process evaluation of the development of a decision analysis intervention, and use 
an integrated approach in the intervention delivery.
4) The design and research tools for a definitive clustered-RCT.
The definitive trial would be developed to meet the standards outlined in the Consolidated
Standards of Reporting Trials (CONSORT) checklist.(68;263)
7.5. Key points
• The case for introducing interventions into schools to improve young people’s 
understanding and skills around contraceptive decision-making is strong.
• A phase II study where the My Way intervention would be adapted and implemented 
to 13-14 year old pupils in Mathematics and PSHE lessons is proposed.
• The development of the definitive clustered-RCT would also form part of this work.
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Chapter 8. Conclusions
This thesis has described the development and piloting of a computer-based decision 
analysis intervention to help young people with their contraceptive decision-making. This 
process has followed the initial phases of the framework outlined by the MRC for the 
development and evaluation of complex interventions.(91;264) It can often be problematic 
trying to find the resources for the development and early piloting of interventions, 
however these phases are an absolute requirement to ensure good quality interventions and 
their evaluations.(92)
Campbell and colleagues explain how a complex intervention will be influenced by 
interacting components,(246) including:
• the ‘disease’ or health outcome (e.g. pregnancy and STIs),
• the ‘patient’ or the ‘consumer’ (e.g. their lifestyle and beliefs),
• the professionals (e.g. prescribing patterns and accessibility),
• health services (e.g. availability and setting),
• policy (e.g. policies on preventive services)
• social context (e.g. attitudes to teenage pregnancy)
The barriers to an intervention working at an individual level can be cognitive and 
behavioural, and at the wider level, organisational, socio-cultural and financial. Each 
decision we make is unique, with these decisions based on a combination of our 
background, knowledge, circumstances, values and our assessment of the probability of the 
consequences resulting from the decision. Sexual behaviour must be seen within the social, 
cultural and environmental context. As Wight comments, ‘the behavioural outcome is 
frequently the result of a complex interaction of social factors .... and is rarely the subject 
of explicit decisions’ (p. 17).(265) One of the key findings from this work with young 
people, even within the small sample, was the wide variation in the values they placed on 
contraceptive attributes. Free argues in her paper about providing sexual health advice for 
young people that the constraints on, or the facilitators of, contraception need to be 
considered when trying to understand contraceptive use and should be incorporated into 
models of contraceptive use.(59) One of the good practice points from the Faculty of 
Family Planning and Reproductive Health Care (FFPRHC) Guidance on contraceptive
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choices for young people states: “A young person should be assisted in making 
contraceptive choices by considering her (sic) individual needs and wishes as well as other 
factors relating to lifestyle and risk of pregnancy or STI.” (p. 240).(82)
However, the approach adapted by health (and education) services still tends to focus on a 
“top down” medical model. Lack of time during a consultation, information overload (in 
particular the ‘pill talks’) and use of a ‘medical’ approach are young people’s criticisms of 
current contraceptive service delivery.(75) Frewer and colleagues comment that innovative 
methodologies to incorporate people’s values are needed in health care, but are critical of 
current practice; “at present there is a problem with identifying methodological approaches 
which take account of both the need for patients to express preferences and concerns 
regarding treatment options using their own terminology, and the considerable intra­
individual variation in treatment preferences which may explain why some treatments are 
successful for some patients but not for others.” (p i54).(266) This is a problem that is 
likely to affect contraceptive choices as well as treatment choices.
Although there were questions about the feasibility of introducing decision aids, such as 
My Way, within consultations, the fact that consumer values may not being elicited in health 
care consultations does need to be addressed. It may be more time consuming going 
through a program like My Way (which will have resource implications), but if the program 
increases acceptability of the contraceptive method used, continuation of this method will 
hopefully increase and the risk of unplanned pregnancy reduced. Sonnenberg and 
colleagues conclude in their paper on the costs and net health effects of contraceptive 
methods that even a modest increase in the use of effective contraception will improve 
health and reduce costs.(18) In their analysis methods that require less than daily action, 
such as injectables and implants, are both more effective and less costly than methods that 
require daily action. The costs associated with methods that require daily action, such as 
condoms and the pill, were even greater amongst younger women because the effectiveness 
in preventing pregnancy in this group is lower, explained by lower compliance.
In the pilot phase I study, the pill was the method most likely to be used or selected by the 
young people and it was the method most likely to be recommended by the My Way 
program when the evidence and young people’s values were combined. Since the
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publication of the NICE guidelines on LARC methods,(239) there has been a push to 
ensure their availability within health services. However, it is important that the focus on 
pregnancy prevention is not at the expense of STI prevention. An increase in STI 
prevalence amongst young people will have negative financial and health costs associated 
with, for example, PID, infertility and ectopic pregnancy. Until methods that are more 
effective at preventing both pregnancy and STIs are developed, and there is no indication of 
their development in the near future, our focus must be on improving interventions that 
tackle both these outcomes.
Sex and decision analysis theory would not immediately be seen as natural partners. Sex is 
often unplanned and emotional, and not a time for ‘rational’ decision-making. However, 
although sex may be unplanned, contraceptive use can be planned. Poor decisions can be 
wrong because of ignorance, but they are not necessarily ‘irrational’. While most young 
people do use contraception, predominantly the condom, as first intercourse, this is not 
necessarily maintained for subsequent sexual activity. Therefore it is appropriate to look at 
how interventions can help young people understand risks and decision-making to ensure 
they are protected against unplanned pregnancy and STIs prior to sexual intercourse taking 
place whether this is within casual or more long-term relationships. Simply providing 
young people will information about the risks associated with sexual activity, in particular, 
sexual activity without the use of condoms and/or other contraceptive methods, has had 
limited success. Young people need to be given the skills to support the accurate processing 
of information. Over 30 years ago Fishbein was recommending that contraceptive research 
needed to establish the relative weights for different behaviours and for different 
populations.(267) This knowledge, to help us understand individual’s perceived 
consequences of a behaviour and the subjective values of the consequences, is still needed 
to inform the development of effective interventions.
The National Strategy for HIV and Sexual Health recommends the adoption of new 
technologies, such as the Internet, to improve sexual health.(5) Internet interventions have 
the potential to be more cost-effective than face-to-face interventions because of the large 
numbers of people that can be reached. Jadad and colleagues argue “The Internet could 
benefit evidence-based decision-making by giving decision-makers cheap, fast and efficient 
access to up-to-date, valid and relevant knowledge at the right time, in the right amount and
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in the right format.” (p. 362).(268) The Internet can be used as a way of reaching young 
people, particularly those who may not be accessing sexual health services.(269) These 
types of interventions should be viewed as enhancements to more traditional care rather 
than a replacements.(270)
Sexual health interventions that focus on young people not only address the immediate 
consequences of risky sexual behaviour, but also future consequences as adolescent risk 
behaviour strongly predicts health problems in adulthood.(103) With the poor sexual health 
of Britain’s young people still being of great concern, the role of decision aids in reducing 
unplanned pregnancy and STIs warrants further investigation.
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Abstract Purpose: To describe young people's knowledge and use of contraceptive services over initial
stages of England’s Teenage Pregnancy Strategy, and to investigate factors associated with use of 
different services.
Methods: A random location sample of young people aged 13-21 years (n = 8879) was inter­
viewed in 12 waves over 2000- 2004. Individual data were analysed to investigate factors associated 
with knowledge and use of contraceptive services and to observe trends over time. Area-level data 
were analyzed to explore differences in key variables.
Results: In all, 77% of young women and 65% of young men surveyed knew a service they could 
use to obtain information about sex. Amongst those who had had vaginal sexual intercourse, the 
most common source of contraceptive supplies was general practice for young women (54%) and 
commercial venues for young men (54%). Young women’s use of school-based services to obtain 
supplies increased significantly from 15.4% in Year 1 to 24.4% in Year 4, p  <  .001. Young men’s 
use of the commercial sector declined significantly over the same time period (60.3% to 50.6%, p  
= .002), while their use of general practice and family planning clinics increased (from 8.9% to 
12.4%. p — .008. and 21.2% to 29. 1%, p ~  .054, respectively). Use of family planning clinics and 
designated young people’s clinics was associated with first vaginal intercourse before the 16th 
birthday and living in a deprived area.
Conclusions: Young people’s patterns of contraceptive service use have changed since implementation 
of the Strategy; although no increase in overall service use was observed. The contribution of school- 
based services needs further exploration. © 2007 Society for Adolescent Medicine. All rights reserved.
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In the U nited K ingdom  (U.K.), a sharp decline in teenage 
pregnancy rates was observed during the 1970s. It was 
during this decade that contraception becam e freely avail­
able to all wom en, irrespective o f marital status or ability to 
pay [1]. H ow ever, w hile rates in other W estern European 
countries continued to decline, the m om entum  was not 
sustained in the U.K. [2,3]. The relatively high U.K. rates 
have been attributed to deprivation and w idespread inequal-
1054- 139X/07/$ -  sec front matter ©  2007 Society for Adolescent Medicine. All rights reserved, 
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ities. Yet there is evidence o f o ther factors having contrib­
uted to lower rates in other European countries, including 
good access to sexual health services [2]. Young people in 
the U.K. have com pared unfavorably w ith peers from  other 
W estern European countries in term s o f  use o f contracep­
tion at first sexual intercourse and use at the last episode of 
sexual intercourse 14]. This w ould suggest that im proving 
young people’s know ledge o f how  to access services prior 
to first sexual intercourse is warranted.
In 1999, England em barked upon a 10-year Teenage 
Pregnancy Strategy w ith a desire to tackle social exclusion 
faced by teenage parents and their children, who are m ore 
likely than their peers to be living in poverty, lack formal 
education and be unem ployed [3]. A program m e was 
launched w ith two main aims: 1) to halve the conception 
rate am ong individuals in E ngland under 18 years by 2010 
(with an interim  reduction target o f  15% by 2004); and 2) to 
increase the participation o f  teenage m others in education, 
training or w ork to 60%  by 2010 to reduce the risk o f 
long-term  social exclusion.
The Teenage Pregnancy Unit (TPU) was established within 
the Department o f Health (now based in the Department for 
Education and Skills) to implement and co-ordinate activities 
related to the Strategy at a national level. Teenage P reg­
nancy Co-ordinators, predom inantly  from  youth work, ed ­
ucation or health prom otion backgrounds, w ere em ployed at 
a local top-tier authority level to  m anage Strategy im ple­
m entation. There are 148 local top-tier authorities in England. 
Their purpose is to provide public services to their local 
population in liaison w ith the N ational Health Service. 
There is w ide variation in their boundary sizes and in the 
dem ographic and health characteristics o f  those living in 
these areas, including the conception rates for individuals 
under 18 years old.
The com ponent o f the Strategy that aim ed to prevent the 
causes o f teenage pregnancy included better sex and rela­
tionship education (SRE) both in and outside o f  school 
settings, a national inform ation cam paign that targeted 
young people and provided support for their parents, im ­
proved access to contraception and the targeting o f  “at-risk” 
groups. A local im plem entation fund was provided to  sup­
port integrated and innovative program m es and the appli­
cation o f new health service criteria  for effective and re­
sponsible contraceptive advice and treatm ent for young 
people. This fund was larger in areas w ith  h igh rates o f 
teenage pregnancy. F u rther in fo rm atio n  about the p ro ­
gram m e are p rov ided  on the T P U ’s w ebsite  (www. 
everych ildm atters .gov .uk /teenagep regancy /).
A team o f academ ic and social researchers carried out an 
independent evaluation o f the T eenage Pregnancy Strategy 
(TPSE). The aims o f this article are to describe young 
people’s know ledge and use o f  contraceptive services over 
initial stages o f the Teenage Pregnancy Strategy (2 0 0 0 -  
2004), and to investigate factors that are associated with 
young people’s use o f  d ifferen t types o f service.
Methods
As part o f  the TPSE a national tracking survey was 
carried out w ith the aim  o f m onitoring progress tow ards the 
S trategy’s goals. A random  location sam ple o f  young peo­
ple aged 13-21 years was interview ed in 12 waves at 
4-m onth intervals betw een O ctober 2000 and June 2004. 
Y oung people living in the random ly selected geographical 
areas (enum eration districts w ith on average 150 house­
holds) rather than the sam e individuals w ere interview ed at 
each wave. F ieldw ork was spread across 200 sam pling 
points in England, and to increase fieldwork efficiency, 
areas w ere chosen w ith a higher representation o f 13-44- 
year-olds. H ousehold screening interviews were conducted 
on the doorstep to  ensure inhabitants were eligible w ith 
regard to age group. The sam ple included only young peo­
ple living in a fam ily hom e or those who were living 
independently. W ritten consent was obtained from all par­
ticipants. For young persons aged 17 years o r less and not 
living independently, w ritten perm ission was sought from  a 
parent o r guardian. Face-to-face m ulti-m edia com puter- 
assisted personal interview s (CAPI) were conducted by 
trained interview ers at the young person’s home. Interviews 
were not timed, but lasted around 40 minutes. The more sen­
sitive questions, relating to sexual experience and experience 
o f pregnancy, were contained within a self-com pletion sec­
tion, to  afford privacy. As well as collecting inform ation 
about young peop le’s aw areness o f Strategy m edia cam ­
paigns, the survey m onitored changes in young peop le’s 
know ledge, attitudes and behaviour over time. This in­
cluded data on their know ledge and use o f contraceptive 
services. W ith regards to know ledge o f contraceptive avail­
ability, young people w ere asked, “Can you think o f a clinic 
or place in your area you could visit if  you wanted advice 
about sex? (for exam ple, advice on contraception or infec­
tions passed on by sex).” They also w ere asked to report 
w hether the follow ing statem ents were true or false (or that 
they d id  not know): 1) contraceptives are available to ev ­
eryone, free o f  charge; 2) people o f any age can get free 
condom s from  a Fam ily P lanning Clinic; and 3) a girl under 
16 can be prescribed contraceptives w ithout her parents 
knowing.
The young people w ere provided with a list o f services 
and sources, and asked 1) if  they had ever accessed any o f 
the places for contraceptive advice and 2) if  they had ever 
accessed any o f these places for contraceptive supplies. 
Young people could select as many responses as applicable. 
The follow ing responses or categories were examined: 
school-based services; general practice (either general prac­
titioner [GP] or practice nurse); com m unity contraceptive 
services (fam ily planning clinics o r youth advisory centres/ 
Brook A dvisory centers); retail (pharm acies or vending m a­
chines, w here supplies have to be purchased). Data were 
also collected to explore variations in key variables at a 
local authority level. These included the following. First,
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postcodes of contraceptive services identified from  the 2004 
Sex wise database (a source that provides inform ation on all 
contraceptive services for young people in the UK). Post­
code data were used to calculate how far individuals lived 
from  their nearest contraceptive service. The distance from  
services was calculated as a population w eighted average of 
the road distance (in km) from  w ard centroids to the nearest 
service (for all services and also young person specific- 
services). Second, deprivation scores w ere collected. These 
scores are a m easure o f  m ultiple deprivations at a small area 
level. A num ber o f dom ains are used to derive these, in­
cluding measures o f incom e, em ploym ent and crim e [5]. 
Third, Strategy-related “effort” scores w ere obtained. The 
TPU  provided the “effort” scores. These w ere derived from  
regional panel assessm ents o f  Teenage Pregnancy Partner­
ship Board reports. The panels w ere m ade up o f profession­
als whose rem its related to the Strategy, including represen­
tatives from  the N ational H ealthy Schools Program m e and 
from  Strategic Health A uthorities. The effort that had been 
put into sexual health services at a local authority level was 
scored as “very good,” “good,” “satisfactory” o r “poor.” 
Individual panel m em bers w ere asked to provide scores and 
then a  consensus was reached. T hese data w ere used as a 
m eans o f rating som e o f the m ore intangible activities at a 
local level. Fourth, the level o f S trategy expenditure each 
local authority was allocated by the TPU  to im plem ent the 
Strategy was sought. For the purpose o f  analysis expendi­
ture was divided into quintiles.
A merged dataset was created to link data from  individ­
ual survey respondents w ith corresponding area-level data. 
Analysis was conducted in SPSS (V ersion 12.0) [6J. Survey 
data w ere w eighted by social grade. D ata from  respondents 
on know ledge and use o f  services were analysed at yearly 
intervals to observe trends over the 4 years o f the evalua­
tion. U nivariate analyses o f  individual and area-level factors 
by gender associated with overall know ledge and use o f 
services were conducted. The analysis o f  use o f services for 
contraceptive supplies was confined to those who reported 
previous vaginal sexual intercourse. In this paper sexual 
intercourse refers to vaginal sexual intercourse, as the focus 
o f our analysis is use o f  services to obtain contraceptive 
advice or supplies to avoid pregnancy. W e used x 2 tests for 
significance testing of trends over tim e and the univariate 
analyses. Statistical significance is considered at p  <  .05 for 
all analyses.
Results
Characteristics o f respondents
Interviews were achieved w ith 8879 young people across 
the 12 waves o f the tracking survey. R espondent character­
istics are presented in Table 1. There w ere no significant 
variations in these characteristics over the course o f  the 
evaluation.
Table 1
Characteristics o f all survey respondents
Total Men Women
4418(49.8) 4461 (50.2)
Age at interview, years 
13-15  
16-17 
18-21
Living in most deprived quintile 
Had heterosexual intercourse before 16 
years*
Average distance to any sexual health 
servicet
<  1 km
1- <  2 km
2 -5  km
>  5 km
Average distance to designated young 
people’s sexual health service
<  1 km
1- <  2 km
2-5  km
>  5 km
Data are n (%).
* Denominator =  respondents aged 16 or over.
+ Includes mainstream sexual health services and designated young 
people’s services, but excludes general practice. Services identified though 
the Sexwise database.
Knowledge o f contraceptive services
In all, 77%  o f young w om en and 65%  o f young men 
interview ed betw een 2000 and 2004 knew o f a clinic or 
place they could visit if  they wanted advice about sex (Table 2). 
Proportions w ere higher am ong young w om en and men who 
reported sexual intercourse (89%  and 75% , respectively) 
(data not shown). N o significant increase was observed over 
tim e in young w om en’s know ledge o f contraceptive ser­
vices or availability; how ever, young m en’s aw areness that 
contraception is freely available increased significantly 
(Table 2). Young people aged under 16 years had poorer 
know ledge o f contraceptive availability com pared to those 
aged 16 and over (data not shown). F or exam ple, 47%  o f 
young women under 16 were aware that contraceptives were 
available free o f charge com pared to 70% o f those 16 and over 
(p  <  .001) and 40%  of young men under 16 were aware, 
compared to 61% o f those 16 and over (p <  .001). This 
association rem ained after controlling for whether or not re­
spondents had experienced sexual intercourse.
Use o f contraceptive services fo r  advice
N early tw o thirds o f all young wom en and nearly half o f 
all young m en (including those who had not yet had sexual 
intercourse) reported  that they had accessed a service to 
obtain contraceptive advice (Table 3). The m ost frequently 
cited service accessed for advice by young wom en was 
general practice and for young men was school-based.
1497 (33.9) 1531 (34.3)
1400 (31.7) 1369 (30.7)
1520 (34.4) 1561 (35.0)
1000 (22.7) 1158 (26.0)
778 (27.1) 846 (29.1)
1276 (29.0) 1339 (30.1)
1510 (34.3) 1540 (34.6)
1226 (27.8) 1187 (26.7)
391 (8.9) 387 (8.7)
827 (18.8) 879 (19.7)
1218 (27.7) 1275 (28.6)
1634 (37.1) 1604 (36.0)
724 (16.4) 695 (15.6)
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Table 2
Knowledge of contraceptive services and contraceptive availability by year and gender (denominator =  all respondents)
Year 1% Year 2% Year 3% Year 4 % p  Value 
for trend
All years n (%)
Women
Place to get information 79.5 74.5 77.7 78.0 .422 3445 (77.4)
Contraceptives free o f charge 59.4 62.2 63.9 62.4 .110 2759 (62.0)
Any age can get free condoms 68.0 70.6 74.6 70.3 .051 2922 (71.1)
Can get contraceptives without parent’s knowledge 62.9 63.7 64.6 63.6 .379 2837 (63.7)
Men
Place to get information 65.4 65.1 65.2 64.3 .957 2859 (65.0)
Contraceptives free o f charge 50.9 52.8 56.2 55.9 .003 2378 (53.9)
Any age can get free condoms 55.9 56.9 64.2 61.1 <  .001 2420 (59.8)
Can get contraceptives without parent’s knowledge 55.1 53.3 58.6 54.4 .509 2441 (55.4)
There were significant increases over the period of the observed in use o f fam ily planning clinics for advice over
evaluation in the proportion o f young wom en accessing the 4-year period.
school-based services and using the identified phone help­ The proportion o f  young people who had experienced
lines and websites for advice. S ignificant decreases were sexual intercourse and reported obtaining contraceptive ad-
Table 3
Use of different services for contraceptives advice and supplies by year and gender
Services accessed for advice1 Year 1 % Year 2 % Year 3 % Year 4 % p  Value 
for trend
All years %
Women: AH (n =  4116)
Any service 63.1 61.1 67.7 65.1 .054 64.3
School-based services2 18.8 21.6 28.5 26.9 <  .001 24.4
General practice 36.5 33.8 34.5 33.4 .250 34.4
Family planning clinics 31.7 31.3 25.2 29.2 .043 29.2
Designated young people’s clinics 8.5 7.3 7.5 7.8 .710 7.7
Pharmacies 8.6 9.7 9.0 9.4 .771 9.2
Identified phone lines and websites3 5.3 5.7 8.2 9.6 <  .001 7.4
Men: All (n =  4054)
Any service 43.0 43.1 51.2 43.0 .333 45.3
School-based services2 22.8 22.1 29.7 23.2 .190 24.6
General practice 11.6 9.7 12.9 10.7 .814 11.2
Family planning clinics 13.9 13.8 12.6 11.0 .030 12.7
Designated young people’s clinics 5.4 6.4 3.8 3.6 .004 4.7
Pharmacies 5.2 7.1 6.3 7.3 .168 6.6
Identified phone lines and websites3 5.3 7.0 7.5 5.4 .936 6.4
Services accessed for supplies
Women: Reporting sexual intercourse (n =  1801)
Any service 90.4 91.3 91.7 92.3 .304 91.5
School-based services2 15.4 15.0 23.2 24.4 <  .001 19.8
General practice 53.7 56.0 52.9 53.2 .616 54.0
Family planning clinics 49.9 51.2 44.3 52.4 .870 49.5
Designated young people’s clinics 9.4 7.8 9.6 10.7 .301 9.4
Commercial4 39.4 40.2 38.4 38.5 .652 39.1
Men: Reporting sexual intercourse (n =  1713)
Any service 77.2 78.0 79.0 79.3 .442 78.5
School-based services2 22.5 20.7 27.2 22.2 .537 23.2
General practice 8.9 6.9 13.8 12.4 .008 10.7
Family planning clinics 21.2 28.7 26.5 29.1 .054 26.8
Designated young people’s clinics 5.8 7.3 7.4 5.6 .760 6.6
Commercial4 60.3 57.2 51.0 50.6 .002 54.3
1 Respondents could report multiple services.
2 School-based services =  teachers, school nurses or school-based clinics.
3 Identified phone lines and websites Sexwise helpline, Contraceptive Education Service, ruthinking website (promoted in TPU media campaigns) and 
the NHS Direct phone line and website.
4 Commercial =  pharmacies or vending machines.
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Table 4
Individual-level factors associated with use o f different types o f service for contraceptive supplies [%)] (Denominator =  respondents reporting sexual 
intercourse)
Any School-based General Family planning Designated young Commercial %
service % clinic % practice % clinic % person’s clinic %
Women
Age at interview (years) p <  .001 p  =  .001 p  <  .001 p  =  .046 p  =  .332 p  =  .001
<  16 (n =  157) 83.4 40.1 30.6 43.3 13.4 32.5
16-17 (n =  615) 89.9 25.2 45.9 48.1 8.6 35.3
>  18 (n =  1029) 93.7 19.8 62.4 51.2 9.2 42.4
Age at first intercourse (years) p  =  .264 p  <  .001 p  =  .317 p  =  .001 p  -  .004 p  =  .684
<  1 6 (n = 922) 92.4 23.0 53.1 55.3 11.3 39.9
>  16 (n =  852) 90.8 15.8 55.5 43.2 7.3 39.0
Deprivation p  =  .136 p  =  .326 p  =  .385 p  =  .083 p  =  .001 p  <  .001
Least deprived (n =  1292) 92.1 20.4 54.6 48.2 8.0 42.7
Most deprived (n =  506) 89.9 18.4 52.4 52.8 12.8 30.0
Men
Age at interview (years) p  =  .001 p  =  .001 p  =  .012 p  =  .037 p  =  .006 p  <  .001
<  16 (n = 132) 70.5 37.1 8.3 24.2 9.8 39.4
16-17 (n =  554) 75.8 28.9 8.1 23.6 8.3 50.2
>  18 (n =  1026) 81.0 18.4 12.4 28.8 5.3 58.5
Age at first intercourse (years) p  =  .458 p  =  .091 p  =  .629 p  =  .048 p  =  .016 p  =  .002
<  16 (n =  836) 78.3 25.0 11.2 29.1 8.1 51.2
>  16 (n =  828) 79.8 21.5 10.5 24.8 5.2 58.6
Deprivation p  =  .056 p  =  .699 p  =  .495 p  =  .214 p  <  .001 p  <  .001
Least deprived (n =  1273) 79.5 23.6 10.4 26.0 5.1 57.6
Most deprived (n =  430) 75.1 22.6 11.6 29.1 11.2 44.4
vice prior to first sexual intercourse declined over the 4 
years o f the evaluation, from  49%  o f young w om en in Year 
1 to 41% in Year 4 (p =  .052) and from  67% of young men 
in Year 1 to 52% in Y ear 4 (/? =  .006) (data not shown). 
Overall young men and w om en w ho reported sexual inter­
course before 16 years o f age w ere less likely to have 
obtained contraceptive advice prior to first sexual inter­
course than those who had experienced first sexual inter­
course at 16 years or above (for wom en: 36%  vs. 54% , p  <  
.001, and for men: 49%  vs. 64% , p  <  .001, respectively). 
Young men living in m ore deprived areas were less likely to 
seek advice before first sexual intercourse com pared to 
those from more affluent area (50%  vs. 58% ./? =  .015). No 
association with deprivation was observed for young 
women.
Use o f contraceptive services for supplies
The m ajority o f young m en and w om en w ho had expe­
rienced sexual intercourse reported  accessing a health or 
commercial service to obtain contraceptive supplies at som e 
time (Table 3). The m ost frequently  cited  service accessed 
by young women for supplies was general practice. Young 
women’s use o f school-based services to obtain contracep­
tive supplies increased significantly over the 4 years. C om ­
mercial venues (either pharm acies or vending m achines) 
were the m ost com m on source fo r young men. However, 
young m en’s use o f the com m ercial sector declined signif­
icantly during the period, w hile the ir use o f  general practice 
and family planning clinics increased.
Factors associated with young peop le’s use of services 
for contraceptive supplies
Data on type o f  service accessed and age at interview, 
age at first sexual intercourse and living in a deprived area 
are presented in Table 4. Young people who reported having 
first sexual intercourse prior to 16 years and those living in 
m ore deprived areas, were on the whole, m ore likely to use 
fam ily planning clinics and designated young people’s clin­
ics, than those w ho reported first sexual intercourse at 16 
years or over and those living in m ore affluent areas. Young 
wom en reporting first sexual intercourse before their 16th 
birthday were significantly m ore likely to use school-based 
services. Both young women and men living in deprived areas 
were less likely to use a commercial service for contraceptive 
supplies than those living in more affluent areas.
The associations observed with contraceptive service ac­
cess using the area-level data are presented in Table 5. A 
significant association was found in term s o f greater effort 
put into the delivery o f sexual health services (TPU data) 
and young m en’s increased use o f services, but no such 
association observed for young w om en’s use o f services. 
H igher Strategy expenditure at an area level was not asso­
ciated with increased service use by young people. There 
was no association between access and distance from any 
sexual health service, but there was an association between 
access to designated young peop le’s services and distance 
from  these services, particularly evident am ongst the young 
women.
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Table 5
Area-level factors associated with use o f services for contraceptive 
supplies by gender (denominator =  respondents reporting sexual 
intercourse)
Men n (%) Women n (%)
Area TPU “effort” score p  =  .022 p  =  .877
Very good 345 (82.5) 382 (91.6)
Good 475 (77.2) 632 (91.1)
Satisfactory 453 (77.7) 528 (92.0)
Poor 62 (71.3) 103 (91.2)
Level o f allocated strategy expenditure p  =  .756 p  =  .245
1" quintile (lowest) 345 (78.9) 414(92.8)
2nd quintile 303 (78.9) 357 (91.5)
3rd quintile 265 (77.9) 320 (90.9)
4th quintile 226 (76.6) 310(91.2)
5th quintile (highest) 196 (79.4) 244 (90.4)
Average distance to any sexual health
service p  =  .809 p  =  .814
<  1 km 391 (79.0) 486 (91.0)
>  1- <  2 km 473 (78.1) 578 (92.0)
2 -5  km 369 (78.2) 441 (91.1)
>  5 km 102 (78.5) 140(92.1)
Average distance to designated young
people’s service p  =  .058 p  =  .008
<  1 km 29 (9.5) 39(11 .0 )
>  1 - <  2 km 29 (6.1) 51 (10.1)
2 -5  km 41 (6.3) 69 (10.4)
>  5 km 14(5.2) 9 (3 .3 )
Discussion
Im proving young peop le 's  know ledge and access to ser­
vices are goals that have been set to m eet the Teenage 
Pregnancy S trategy’s aim  o f reducing under 18-year-old 
conception rates. L ittle change in know ledge o f contracep­
tive availability and services was observed, w ith the excep­
tion that over the 4 years m ore young men were aware that 
contraception is free o f  charge and condom s are freely 
available irrespective o f age. A third o f young wom en and 
just under half o f young men rem ain unaw are that they can 
obtain contraceptives w ithout their paren ts’ know ledge. 
This suggests there is still a need for consistent m essages 
about confidentiality o f sexual health services to be con­
veyed to young people and for training o f  health care w ork­
ers on confidentiality and young people. There appears to be 
confusion about confidentiality relating to provision o f con­
traception to young people under 16-years-old in particular. 
An audit conducted over 2001-2002  found that one or more 
GPs in 14% o f English practices would not see young people 
under 16 years without a parent present [7]. Specific guidance 
has since been provided for health professionals on contracep­
tive provision to those less than 16 years o f age [8].
There is some evidence that patterns o f young peop le’s 
use o f different services for contraceptive advice and/or 
supplies is changing. H ow ever, there w ere no significant 
increases observed am ongst young w om en and m en’s over­
all use o f contraceptive services. The survey data suggested 
young wom en are increasingly using school-based services
and inform ation sources, such as helplines and websites, to 
gain contraceptive advice. The proportion o f  young people 
obtaining contraceptive advice prior to first sexual inter­
course, and in particular those having sexual intercourse 
before 16 years, declined over the evaluation period. H ow ­
ever, it is not clear w hether this is because young people felt 
unable, for w hatever reason, to seek advice or w hether it is 
because they did not feel it necessary to seek advice as they 
already had all the inform ation they required through, for 
exam ple, SRE and m edia sources.
Overall, general practice is the main provider o f contra­
ceptive supplies for young wom en, and the com m ercial 
sector is the main provider for young men. A lthough young 
men are far less likely to access general practice than young 
women, there was a significant increase in their use of 
general practice and fam ily planning clinics and a decrease 
in their use o f the com m ercial sector over the evaluation. 
This corresponded w ith young m en’s increased knowledge 
o f contraceptive availability. A lthough the “effort” scores 
need to be interpreted w ith caution due to their subjective 
and non-validated m ethod o f  allocation, local authorities 
rated as “very good” by Regional panel assessm ents in 
term s o f  effort put into sexual health services have been 
particularly successful in attracting young men, a group 
often identified as hard to reach. However, condom s are still 
not provided in m ost general practices, so there is little in 
term s o f supplies that can be offered to young men in this 
setting. Health care w orkers are less likely to raise the topic 
o f contraception w ith m en [9], and qualitative work has 
shown young m en still view  contraceptive services as fe­
m ale orientated [10].
The survey asked about actual service use rather than 
preferred use. For m any young people, a visit to their 
general practice m ay be the only option. There are still 
relatively few specific services for young people, particu­
larly in rural areas. The num ber o f areas in which there was 
at least one sexual health service dedicated to young people 
did increase steadily from  68%  at the beginning o f 2000 to 
84% by the end o f 2001 [11]. Proxim ity and ease o f getting 
to clinics have been cited as prom inent reasons for choosing 
a particular service [12,13]. W e found no association be­
tween access and distance to services used overall, but use 
o f designated young people’s services did decline the fur­
ther young people had to travel. It should be noted distance 
was m easured along road networks, and did not take ac­
count o f transport links. O pening tim es can also provide 
barriers to access. An audit o f contraceptive services con­
ducted during the early stages o f the TPSE showed two 
thirds o f services targeting young people were only open 
once a week [11J. Young people reporting sexual inter­
course before age 16 and those living in m ore deprived 
areas were m ore likely to use designated young people’s 
services than those reporting sexual intercourse aged 16 
years or above and those living in m ore affluent areas. 
However, these services tend to offer a narrow er range o f
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contraceptive methods than mainstream services, and in gen­
eral, young people are less likely than older women to be 
offered longer acting more reliable methods o f contraception.
M uch research on young people and contraceptive ser­
vice use has been conducted w ithin service settings and 
therefore om its non-users. A strength o f  this study’s com ­
munity approach was that both service users and non-users 
w ere in terview ed. R espondents w ere se lected  through 
random -location sam pling, therefore at each wave people 
living in the selected geographical areas were interviewed 
rather than the sam e individuals. However, we noted no 
difference in the characteristics of interviewees over time. A 
random  probability sam ple was excluded on grounds o f cost 
and tim e as it was calculated som e 25 addresses would need 
to be screened to identify each within-scope contact Random - 
location sam pling has been show n to perform  as well as 
random  probability sam pling in m ost circum stances [14J 
and this m ethodology was viewed to be beneficial due to the 
com patibility o f  the survey data with the area-level data 
collected. A nother m ajor benefit o f our survey was that both 
male and fem ale respondents betw een the ages o f 13-21 
years were interviewed. O ther large-scale U K  population- 
based surveys, such as the N ational Survey o f Sexual A tti­
tudes and Lifestyles (N atsal-2000) and the O m nibus Sur­
veys, looking at contraceptive service use have interviewed 
people aged 16 years and above [15-17]. Therefore patterns 
of service use am ongst som e o f the m ost vulnerable young 
people were not exam ined.
It was not possible to produce the number of non­
responders, e ither due to young people or their parent/guard­
ian declining participation, because o f the random location 
sampling approach. Another factor that needs to be considered 
when interpreting results is that those young people not living 
at home or not living independently, such as those living in 
care homes, were not approached to take part in the survey.
An area that warrants further research is young people’s 
use o f school-based services. O ur findings suggest that 
young women are increasingly using these services to ob­
tain contraceptive advice and supplies. School-based ser­
vices have the potential to engage with young people prior 
to the starting o f sexual activity, they are easily accessible 
and may have less stigm a associated w ith their use in 
com parison to designated sexual health services as the rea­
son for the visit is not apparent. H ow ever, our understand­
ing o f how these services are provided in school settings 
needs further exam ination.
The provisional 2004 conception rate in England for 
individuals under 18 years are 41.5 per 1000 girls aged 
15-17 [18]. This represents an 11.1% decline from  the 
baseline rates in 1998. The T PSE  found the most significant 
declines in m ore deprived areas with higher baseline con­
ception rates that received m ore funding [19]. The Teenage 
Pregnancy Strategy has am bitious targets, and it may be too 
soon since the start o f its im plem entation to observe dra­
matic changes in young peop le’s use o f contraceptive ser­
vices. G uidance for m aking services m ore youth friendly 
has been produced since our evaluation [20]. W e found that 
the proportion o f  w om en who have had sexual intercourse 
reporting use o f services for contraceptive supplies in the 
last year is already high at over 90% , and it may therefore 
be appropriate to  target those young people at higher risk o f 
teenage pregnancy rather than the general population in 
term s o f  im proving access. Evidence suggests that the ma­
jority o f young people “at risk” for pregnancy do use contra­
ception [21]. Therefore, access to services is only part o f the 
equation. W ays o f improving young people’s contraceptive 
choices and correct use o f methods also need to be addressed.
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Appendix A.2. Evidence for the underlying decision analysis
STI evidence and estimates 
Side effect evidence and estimates 
Bother estimates
Table A2.1. Probability of STI acquisition in one year: Men
A B C D E F G
STI Probability of 
female to male 
transmission 
per sexual act
Evidence for B Probability of 
female to male 
transmission per 
partnership*
Prevalence 
Rate per 100 
women
Evidence for E Risk of  
acquisition in 
one year**
Gonorrhoea 0.25 Modelling/Expert opinion
(Garnett and Bowden, 
2000)(187) and Garnett GP 
personal communication)
0.9994 0.18 Surveillance data (Source: PHLS 
and ONS)
2001 population estimates in 
England for 15-19 year old 
women calculated using GUM 
returns KC60 data and census 
population figures.
0.0018
Chlamydial
infection
0.323 Modelling (Katz, 1992)( 190) 
Provides estimates for 
heterosexual transmission 
probabilities derived from a 
deterministic model o f 
transmission using o f data 
generated from a contact tracing 
programme in a US STI clinic.
0.9999 3.0 Random probability sample
(Fenton et al, 2001)(196) 
Prevalence amongst women aged 
16-44 in the UK. Urine samples 
tested for Chlamydia trachomatis 
using urinary LCR. Amongst 
women aged 18-24 (weighted base 
= 364) prevalence = 3.0% (95%
Cl 1.7-5.0)
0.03
Syphilis 0.63 Review/Expert opinion
(Garnett et al, 1997(271) and 
Garnett GP, personal 
communication)
Review o f prospective cohort 
studies o f discordant couples 
and retrospective studies of 
infected couples
1.0 0.0007 Surveillance data (Source: PHLS 
and ONS)
2001 population estimates in 
England for 15-19 year old 
women calculated using GUM 
returns KC60 data and census 
population figures.
0.000007
Trichomoniasis 0.5 (per 
partnership)
Modelling (Bowden and 
Garnett, 2000)(272)
Estimate calculated from 
retrospective partnership studies 
data
0.5 0.1 Surveillance data (Waghom et al, 
1998)(273)
UK cervical smear specimens,
52 440 samples tested between 
1996-6
0.0005
t ou>oo
Table A2.1. (Contd.) Probability of STI acquisition in one year: Men
A B C D E F G
STI Probability of 
female to male 
transmission 
per sexual act
Evidence for B Probability of 
female to male 
transmission per 
partnership*
Prevalence 
Rate per 100 
women
Evidence for E Risk of 
acquisition in 
one year**
Herpes simplex 
virus Type 2
0.00015 Prospective cohort (Wald et al, 
2001X189)
Monogamous discordant 
couples 528 monogamous 
couple discordant for HSV-2 
infection, including an HSV-2 
susceptible population of 261 
men and 267 women. In US. 
Subjects had participated in a 
double-blind randomised 
placebo controlled o f an 
ineffective HSV-2 vaccine.
0.0039 5.1 Surveillance data (Vyse et al, 
2000X274)
HSV-2 seroprevalence amongst 
16-69 year olds in England & 
Wales. Samples collected as part 
o f a PHLS surveillance 
programme -  anonymous residues 
o f samples submitted for 
microbiological or biochemical 
testing to 15 public health labs. 
3347 samples tested.
0.0002
Human
papilloma virus
0.75 (per 
partnership)
Expert opinion (Garnet GP, 
personal communication) 
Modelling o f data from Koutsky 
et al study(275) to obtain 
probability estimate o f HPV 
transmission per partnership.
0.75 15.0 Review (Koutsky, 1997 XI97) 
Studies using direct-detection 
methods, such as Southern blots, 
have given HPV DNA prevalence 
estimates between 10-20%. 15% 
cited in Koutsky et al 1988(275)
0.1125
HIV 0.0013 Prospective cohort studies of 
discordant couples (Gray et al, 
2001)(192)
174 monogamous couples, in 
which one partner was 
identified HIV-1 negative were 
retrospectively identified from a 
population cohort in Uganda. 
Sexual behavioural data and 
biological samples collected 
prospectively.
0.051737 0.0046 Surveillance data (Source: PHLS, 
Rice R, personal communication) 
Estimates calculated using data on 
15-19 year old women resident in 
England who attended for HIV- 
related care in 2001 - GUM KC60 
returns.
0.00003
Notes:
* D=l-(1-B)26. Assumes 26 acts of vaginal intercourse per partnership (Source: Natsal 2000 data, Median number of sexual acts per heterosexual partnership for men). 
** G=1-(1-D*(E/100))'. Assumes one partnership per year (Source: Natsal 2000 data, Median number of sexual partners amongst sexually active heterosexual men) 
N/K = Not known; N/A = Not applicable
N>
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Table A2.2. Probability of STI acquisition in one year: Women
A B C D E F G
STI Probability of 
male to female 
transmission 
per sexual act
Evidence for B Probability of male 
to female 
transmission per 
partnership*
Prevalence 
Rate per 100 
men
Evidence for E Risk of 
acquisition in 
one year**
Gonorrhoea 0.5 Retrospective cohort study
(Platt e ta l, 1983)(276)
Female spread contacts (n=26) 
o f male index patients identified 
with gonococcal infection in a 
US STI clinic. Index cases’ date 
o f infection must have been 
known within previous 2 weeks, 
as well as dates o f subsequent 
sexual contact. 6/12 women 
reporting one episode o f sexual 
contact infected.
1.0 0.12 Surveillance data (Source: PHLS 
and ONS)
2001 population estimates in 
England for 15-19 year old men 
(excluding homosexually acquired 
infection) calculated using GUM 
returns KC60 data and census 
population figures.
0.0012
Chlamydial
infection
0.395
Modelling (Katz, 1992X190) 
Provides estimates for 
heterosexual transmission 
probabilities derived from a 
deterministic model o f 
transmission using of data 
generated from a contact tracing 
programme in a US STI clinic.
1.0 2.7 Random probability sample
(Fenton et al, 2001)(196) 
Prevalence amongst men aged 16- 
44 in the UK. Urine samples 
tested for Chlamydia trachomatis 
using urinary LCR. Amongst men 
aged 18-24 (weighted base = 388) 
prevalence = 2.7% (95% Cl 1.2- 
5.8)
0.027
Syphilis
0.63
Review of prospective cohort 
studies of discordant couples 
and retrospective studies of 
infected couples/Expert 
opinion (Garnett et al, 
1997(271) and Garnet GP, 
personal communication)
1.0 0.0006 Surveillance data (Source: PHLS 
and ONS)
2001 population estimates in 
England for 15-19 year old men 
calculated using GUM returns 
KC60 data and census population 
figures.
0.000006
N)
O
Table A2.2. (Contd.) Probability of STI acquisition in one year: Women
A B C D E F G
STI Probability of 
male to female 
transmission 
per sexual act
Evidence for B Probability of male 
to female 
transmission per 
partnership*
Prevalence 
Rate per 100 
men
Evidence for E Risk of 
acquisition in 
one year**
Trichomoniasis 0.85 (per 
partnership
Retrospective cohort study
(Catterall 1960)(277) 126 men 
diagnosed in two London STI 
clinics. 57/67 female contacts 
tested were positive to 
trichomoniasis.
0.85 0.0044 Surveillance data (Source: PHLS 
and ONS)
1999-2001 population estimates in 
England for 15-19 year old men 
(excluding homosexually acquired 
infection) calculated using GUM 
returns KC60 data and census 
population figures.
0.00004
Herpes simplex 
virus
0.00089 Prospective cohort (Wald et al, 
2001)(189)
Monogamous discordant 
couples 528 monogamous 
couple discordant for HSV-2 
infection, including an HSV-2 
susceptible population of 261 
men and 267 women. In US. 
Subjects had participated in a 
double-blind randomised 
placebo controlled o f an 
ineffective HSV-2 vaccine.
0.0512 3.3 Surveillance data (Vyse et al, 
2000)(274)
HSV-2 seroprevalence amongst 
16-69 year olds in England & 
Wales. Samples collected as part 
o f a PHLS surveillance 
programme -  anonymous residues 
o f samples submitted for 
microbiological or biochemical 
testing to 15 public health labs. 
3347 samples tested.
0.0017
Human papilloma 
virus
0.75 (per 
partnership)
Expert opinion (Garnet GP, 
personal communication) 
Modelling o f data from Koutsky 
et al study(275) to obtain 
probability estimate o f HPV 
transmission per partnership.
0.75 15.0 Review (Koutsky, 1997 XI97) 
Studies using direct-detection 
methods, such as Southern blots, 
have given HPV DNA prevalence 
estimates between 10-20%. 15% 
(cited in Koutsky et al 1988X258)
0.1125
K>
Table A2.2. (Contd.) Probability of STI acquisition in one year: Women
A B c D E F G
STI Probability of 
male to female 
transmission 
per sexual act
Evidence for B Probability of male 
to female 
transmission per 
partnership*
Prevalence 
Rate per 100 
men
Evidence for E Risk of 
acquisition in 
one year**
HIV 0.00009 Prospective cohort studies of 
discordant couples (Gray et al, 
2001)(192)
174 monogamous couples, in 
which one partner was 
identified HIV-1 negative were 
retrospectively identified from a 
population cohort in Uganda. 
Sexual behavioural data and 
biological samples collected 
prospectively.
0.033256 0.0013 Surveillance data (Source: PHLS, 
Rice R. personal communication) 
Estimates calculated using data on 
15-19 year old men resident in 
England who attended for HIV- 
related care in 2001 
(heterosexually acquired infection 
or route of infection unknown) - 
GUM KC60 returns
0.00001
Notes:
* D=l-(1-B)26. Assumes 26 acts o f vaginal intercourse per partnership (Source: Natsal 2000 data, Median number of sexual acts per heterosexual partnership for men). 
** G=1-(1-D*(E/100))'. Assumes one partnership per year (Source: Natsal 2000 data, Median number of sexual partners amongst sexually active heterosexual men) 
N/K = Not known; N/A = Not applicable
to
Table A2.3. Probability olf acquiring gonorrhoea in one year by contraceptive method
G H I J
Contraceptive
methods
RR for 
method users 
acquiring 
gonorrhoea Evidence for H
Prob of acquiring 
gonorrhoea in 
one year by 
method
Men
Chance N/A See Table A.2.1. 0.0018
Spermicides 1.0 Team assumption 0.0018
Cap 0.75 Team assumption 0.0013
Withdrawal 1.0 Team assumption 0.0018
Condom (male) 0.34 Prospective cohort study (Darrow, 1989)(278)
STD clinic attendees, USA 557 participants given condoms. 122 returned for FU and had had sexual intercourse since 
last visit. Condom use defined as any use versus non-use. Data collection period 1971 RR obtained from Cates and 
Stone review(279)
0.0006
Condom (female) N/A Assume an additional protective effect o f 10% over the male condom. Difference between two methods lost through 
rounding up o f numbers.
0.0006
Pill 1.0 Team assumption 0.0018
IUD 1.0 Team assumption 0.0018
Injectables 1.0 Team assumption 0.0018
Subdermal implant 1.0 Team assumption 0.0018
Women
Chance N/A See Table A.2.2. 0.0012
Spermicides 0.97 Systematic Review (WHO, 2003)(203)
Presentation by Wilkinson on evidence from a systematic review o f RCTs comparing use o f spermicides versus non­
use at the technical consultation on nonoxynol-9. Women participating in the included trials tended to be sex workers or 
from other high risk groups.
RR for gonorrhoea obtained from 6 studies with a total o f 3017 women. 95% Cl 0.85-1.11
0.0012
Cap/diaphragm 0.35 Cross-sectional study (Rosenberg et al, 1992)(204)
Target group: Female STI clinic attendees, US. Data collection period Jan. 1987 -  Dec. 1988 
Women asked about single most used contraceptive method over the last month. Women using sponge, diaphragm, or 
condoms were compared to a group using no method or tubal ligation. Women using other methods were excluded 
from the analysis Diaphragm users=227 Condon= 1021. Nothing or tubal ligation=4332
0.0004
Withdrawal 1.0 Team assumption 0.0012
Condom (male) 0.66 Cross-sectional study (Rosenberg et al, 1992)(204) 
See cap entry above for study details.
0.0008
Condom (female) N/K Assumed an additional 10% protective effective than male condoms. Difference between two methods lost through 
rounding up o f numbers.
0.0008
K>
u>
Table A2.3. (Contd.) Probability of acquiring gonorrhoea in one year by contraceptive method
G H I J
Contraceptive
methods
RR for 
method users 
acquiring 
gonorrhoea Evidence for H
Prob of acquiring 
gonorrhoea in 
one year by 
method
Pill 1.03 Case-control study (Austin et al, 1984)(212)
Target group: Female STI clinic attendees, US. Cases: 735 women diagnosed with gonorrhoea. Controls: 958 
women, 400 diagnosed with another STI and 500 with no STI. Data collected period: July, 1982 -  Feb. 1983. Oral 
contraceptive use = ever relative to none. (RR 1.03, 90% Cl 1.0-1.5)
0.0012
IUD 0.8 Assumed same relative risk as risk o f chlamdydial infection i.e 0.8 (see Table A.2.4.) 0.001
Injectables 1.0 Team assumption 0.0012
Subdermal implant 1.0 Team assumption 0.0012
4^4^
Table A2.4. Probability ol' acquiring chlamydial infection in one year by contraceptive method
G H I J
Contraceptive
methods
RR for 
method users 
acquiring 
chlamydia Evidence for H
Prob of acquiring 
chlamydia in one 
year by method
Men
Chance N/A See Table A.2.1. 0.03
Spermicides 1.0 Team assumption 0.03
Cap/diaphragm 0.75 Team assumption 0.0225
Withdrawal 1.0 Team assumption 0.03
Condom (male) 0.34 Assumed same RR as that for chlamydial infection i.e. 0.34 0.0102
Condom (female) N/K Assumed additional protective effect o f 10% over male condoms 0.0092
Pill 1.0 Team assumption 0.03
IUD 1.0 Team assumption 0.03
Injectables 1.0 Team assumption 0.03
Subdermal implant 1.0 Team assumption 0.03
Women
Chance N/A See Table A.2.2. 0.027
Spermicides 0.88 Systematic Review (WHO, 2003)(203)
Presentation by Wilkinson on evidence from a systematic review o f RCTs comparing use o f spermicides versus non­
use at the technical consultation on nonoxynol-9. Women participating in the included trials tended to be sex workers or 
from other high risk groups.
RR for Dhlamydia obtained from 5 studies with a total o f 2955 women. 95% Cl 0.77-1.01
0.0238
Cap/diaphragm 0.29 Cross-sectional study (Rosenberg et al, 1992)(204)
Target group: Female STI clinic attendees, US. Data collection period Jan. 1987 -  Dec. 1988 
Women asked about single most used contraceptive method over the last month. Women using sponge, diaphragm, or 
condoms were compared to a group using no method or tubal ligation. Women using other methods were excluded 
from the analysis Diaphragm users=227 Condon=1021. Nothing or tubal ligation=4332
0.0078
Withdrawal 1.0 Team assumption 0.027
Condom (male) 0.97 Cross-sectional study (Rosenberg et al, 1992)(204) 
See cap entry above for study details.
0.0262
Condom (female) N/K Assumed additional 10% protective effect over male condoms 0.0236
to
Table A2.4. (Contd.) Probability of acquiring chlamydial infection in one year by contraceptive method
G H I J
Contraceptive
methods
RR for 
method users 
acquiring 
chlamydia Evidence for H
Prob of acquiring 
chlamydia in one 
year by method
Pill 1.04 Cross-sectional study (Magder et al, 1988)(205)
Target group: STI clinic attendees, U.S. Data collection period: Sept. 1981-June 1983. Screened on Mons. & Tues.
172 o f the 1031 (15%) women recruited had cervical swabs positive to chlamydial infection.
54/254 pills users Chlamydia positive vs. 89/436 women using no contraception. RR calculated from these data. 
Suggestion in the paper that the risk o f chlamydial infection amongst pill users under 20 years is higher. Therefore 1.04 
may be an under-estimate.
0.0281
IUD 0.8 Cross-sectional study (Magder et al, 1988)(205)
See above pill entry for study details.
10/61 IUD users Chlamydia positive vs. 89/436 women using no contraception. RR calculated from data in paper.
0.0216
Injectables 1.0 Team assumption 0.027
Subdermal implant 1.0 Team assumption 0.027
to
o
Table A2.5. Probability of acquiring syphilis in one year by contraceptive method
G H I J
Contraceptive
methods
RR for 
method users 
acquiring 
syphilis Evidence for H
Prob of acquiring 
syphilis in one 
year by method
Men
Chance N/A See Table A.2.1. 0.000007
Spermicides 1.0 Team assumption 0.000007
Cap/diaphragm 0.75 Team assumption 0.000005
Withdrawal 1.0 Team assumption 0.000007
Condom (male) 0.24 Case control study (Finelli et al, 1993)(280)
Comparison of individuals diagnosed with syphilis and those free of syphilis to investigate sexual behaviour and drug- 
use risks factors associated with acquisition of infection. Participants recruited in a US STI clinic. Male cases n= 46 and 
controls n=37
OR for early syphilis if used condom in the last three months = 0.24 (95% Cl 0.08-0.67). Condom use not defined.
0.000002
Condom (female) N/A Assumed additional 10% protective effect over male condoms. Difference between two methods lost through rounding 
up o f numbers.
0.000002
Pill 1.0 Team assumption 0.000007
IUD 1.0 Team assumption 0.000007
Injectables 1.0 Team assumption 0.000007
Subdermal implant 1.0 Team assumption 0.000007
Women
Chance N/A See Table A.2.2. 0.000006
Spermicides 0.88 Assumed RR=0.88. Same as CT 0.000006
Cap/diaphragm 0.29 Assumed RR=0.29. Same at CT 0.000002
Withdrawal 1.0 Team assumption 0.000006
Condom (male) 0.89 Case control study (Finelli et al, 1993)(280)
See above entry for men and condom use for study details.
Female cases n= 41 and controls n=20. OR for early syphilis if used condom in the last three months = 0.89 (95% Cl 
0.25-3.22).
0.000006
Condom (female) N/K Assumed additional 10% protective effect over condoms 0.000005
Pill 1.04 Assumed same RR as that for chlamydial infection i.e. 1.04 (see Table. A.2.4.) 0.000007
IUD 0.8 Assumed same RR as that for chlamydial infection i.e. 0.8 (See Table A.2.4.) 0.000005
Injectables 1.0 Team assumption 0.000006
Subdermal implant 1.0 Team assumption 0.000006
'-I
Table A2.6. Probability of acquiring trichomoniasis in one year by contraceptive method
G H I J
Contraceptive
methods
RR for method 
users 
acquiring 
trichomoniasis Evidence for H
Prob of 
acquiring 
trichomoniasis 
in one year by 
method
Men
Chance N/A See Table A.2.1. 0.0005
Spermicides 1.0 Team assumption 0.0005
Cap/diaphragm 0.75 Team assumption 0.0004
Withdrawal 1.0 Team assumption 0.0005
Condom (male) 0.44 Cross sectional study (Barlow, 1977)(281)
Target group=STI clinic attendees, UK Data collection period: Jan. 1975-July 1975. Data from “approximately” 3300 men 
included.
Men asked about condom use with recent sexual partners
1/257 condom users and 27/3083 diagnosed with trichmoniasis. RR calculated from data presented in the paper. Condom 
use included both “correct” and “incorrect” (i.e. condom not necessarily used consistently) use.
0.0002
Condom (female) N/K Assumed 10% additional protective effect over male condoms. Difference between two methods lost through rounding up 
o f numbers.
0.0002
Pill 1.0 Team assumption 0.0005
IUD 1.0 Team assumption 0.0005
Injectables 1.0 Team assumption 0.0005
Subdermal implant 1.0 Team assumption 0.0005
Women
Chance N/A See Table A.2.2. 0.00004
Spermicides 0.84 Systematic Review (WHO, 2003)(203)
Presentation by Wilkinson on evidence from a systematic review of RCTs comparing use of spermicides versus non-use 
at the technical consultation on nonoxynol-9. Women participating in the included trials tended to be sex workers or from 
other high risk groups.
RR for trichomoniasis obtained from 3 studies with a total of 1011 women. 95% Cl 0.69-1.02
0.00003
Cap/diaphragm 0.24 Cross-sectional study (Rosenberg et al, 1992)(204)
Target group: Female STI clinic attendees, US. Data collection period Jan. 1987 -  Dec. 1988 
Women asked about single most used contraceptive method over the last month. Women using sponge, diaphragm, or 
condoms were compared to a group using no method or tubal ligation. Women using other methods were excluded from 
the analysis Diaphragm users=227 Condon= 1021. Nothing or tubal ligation=4332
0.000009
Withdrawal 1.0 Team assumption 0.00004
K>
00
Table A2.6. (Contd.) Probability of acquiring trichomoniasis in one year by contraceptive method
G H I J
Contraceptive
methods
RR for method 
users 
acquiring 
trichomoniasis Evidence for H
Prob of 
acquiring 
trichomoniasis 
in one year by 
method
Pill 1.04 Assumed same RR as that for chlamydial infection i.e. 1.04 (see Table. A.2.4.) 0.00004
IUD 0.8 Assumed same RR as that for chlamydial infection i.e. 0.8 (See Table A.2.4.) 0.00003
Injectables 1.0 Team assumption 0.00004
Subdermal implant 1.0 Team assumption 0.00004
to
Table A2.7. Probability of acquiring herpes simplex virus in one year by contraceptive method
G H I J
Contraceptive
methods
RR for method 
users acquiring 
herpes
Evidence for H Prob of 
acquiring 
herpes in one 
year by 
method
Men
Chance N/A See Table A.2.1. 0.0002
Spermicides 1.0 Team assumption 0.0002
Cap/diaphragm 0.75 Team assumption 0.0001
Withdrawal 1.0 Team assumption 0.0002
Condom (male) 2.99 Cross-sectional study (Obasi et al 1999)(282)
Baseline survey. Random subsample from a trial cohort, Tanzania. Selection o f subjects stratified by age, weighted to 
maximise number o f young people. 231 men. HSV-2 serology at baseline. Condom use defined as ever used vs. never 
used. Crude Odds = 3.01. Adjusted for lifetime sex partners, marital status, and TPHA status 2.99 (95% Cl 0.92-9.75)
0.0006
Condom (female) N/K Assumed 10% additional protective effect over male condoms 0.0005
Pill 1.0 Team assumption 0.0002
IUD 1.0 Team assumption 0.0002
Injectables 1.0 Team assumption 0.0002
Subdermal implant 1.0 Team assumption 0.0002
Women
Chance N/A See Table A.2.2. 0.0017
Spermicides 1.0 Team assumption 0.0017
Cap/diaphragm 0.8 Cross sectional survey (Kjaer et al, 1990)(209)
Random population-based survey. Greenland and Denmark. Greenland and Denmark. Women aged 20-39 years from 
Greenland (n=586) and Denmark (n=695) chosen at random through the Danish Central Population Register. Conducted 
interviews, serology and gynaecological examination. Analysis for HSV-2 virus antibodies tested on a random subset 
(388 in Denmark and 390 in Greenland) Definition = barrier methods (condom or diaphragm) ever used. (OR 0.8,95%  
Cl 0.6-1.2)
0.9 Adjusted OR for age, area, age at first intercourse, number o f sexual partners and years with unprotected cervix
0.0014
Withdrawal 1.0 Team assumption 0.0017
Condom (male) 0.8 Cross sectional survey (Kjaer et al, 1990)(209) 
See cap entry above for study details
0.0014
Condom (female) N/K Assumed 10% additional protective effect over male condoms 0.0012
Pill 0.9 Cross sectional survey (Kjaer et al, 1990)(200) 9See cap entry above for study details
Pill use ever (OR 0.9, 95% Cl 0.6-1.3) 0.9 Adjusted OR for age, area, age at first intercourse, number o f sexual partners 
and years with unprotected cervix.
0.0015
N)
O
Table A2.7. (Contd.) Probability of acquiring herpes simplex virus in one year by contraceptive method
G H I J
Contraceptive
methods
RR for method 
users acquiring 
herpes
Evidence for H Prob of 
acquiring 
herpes in one 
year by 
method
IUD 1.0 Team assumption 0.0017
Injectables 1.0 Team assumption 0.0017
Subdermal implant 1.0 Team assumption 0.0017
N)
Table A2.8. Probability of acquiring HPV in one year by contraceptive method
G H I J
Contraceptive
methods
RR for method 
users acquiring 
HPV Evidence for H
Prob of 
acquiring 
HPV in one 
year by 
method
Men
Chance N/A See Table XX. 0.1125
Spermicides 1.0 Team assumption 0.1125
Cap/diaphragm 0.75 Team assumption 0.0844
Withdrawal 1.0 Team assumption 0.125
Condom (male) 0.7 Case control study (Wen et al., 1999)(201)
Comparison o f Australian GUM attendees diagnosed with genital warts and those not. Male cases = 649 and 
controls=649. Always condom use (excluding breakages). OR 0.7 (95% Cl 0.3-0.9) adjusted for age group, number of 
lifetime sexual partners and smoking.
0.0788
Condom (female) N/K Assumed 10% additional protective effect over male condoms 0.0709
Pill 1.0 Team assumption 0.1125
IUD 1.0 Team assumption 0.1125
Injectables 1.0 Team assumption 0.1125
Subdermal implant 1.0 Team assumption 0.1125
Women
Chance N/A See Table XX 0.1125
Spermicides 1.0 Team assumption 0.1125
Cap/diaphragm 1.0 Cross sectional survey (Kjaer et al, 1990)(209)
Random population-based survey. Greenland and Denmark. Greenland and Denmark. Women aged 20-39 years from 
Greenland (n=586) and Denmark (n=695) chosen at random through the Danish Central Population Register. Conducted 
interviews, serology and gynaecological examination. Definition = barrier methods (condom or diaphragm) use ever. 
Screened for HPV type 6/11, type 16/18 or both
(OR 1.0 95% Cl 0.7-1.5) Definition = barrier methods (condom or diaphragm) ever used. 1.0 (95% Cl 0.7-1.4)= 
Adjusted OR for age, area, age at first intercourse, number of sexual partners and cervical smear result.
0.1125
Withdrawal 1.0 Team assumption 0.1125
Condom (male) 1.0 Cross sectional survey (Kjaer et al, 1990)(209) 
See cap entry above for study details
0.1125
Condom (female) N/K Assumed 10% additional protective effect over male condoms 0.1013
K>
K>
Table A2.8. (Contd.) Probability of acquiring HPV in one year by contraceptive method
G H I J
Contraceptive
methods
RR for method 
users acquiring 
HPV Evidence for H
Prob of 
acquiring 
HPV in one 
year by 
method
Pill 1.4 Cross sectional survey (Kjaer et al, 1990)(209)
See cap entry above for study details 
Ever used pill. OR 1.4, 95% Cl 0.9-2.1
Adjusted OR for age, area, age at first intercourse, number of sexual partners and cervical smear result = 1.4, 95% Cl 
0.9-2.2.
0.1575
IUD 1.0 Team assumption 0.1125
Injectables 1.0 Team assumption 0.1125
Subdermal implant 1.0 Team assumption 0.1125
to
Table A2.9. Probability of acquiring HIV in one year by contraceptive method
G H I J
Contraceptive
methods
RR for method 
users acquiring 
HIV Evidence for H
Prob of 
acquiring HIV 
in one year by 
method
Men
Chance N/A See Table A.2.1. 0.00003
Spermicides 1.0 Team assumption 0.00003
Cap/diaphragm 0.75 Team assumption 0.00002
Withdrawal 1.0 Team assumption 0.00003
Condom (male) 0.15 Systematic review (Davis and Weller, 1999)(208)
Study inclusion criteria: 1) examination of sexual transmission o f HIV among serodiscordant heterosexual couples 
having penetrative sexual intercourse; 2) determined HIV status by serology; 3) inquired about condom usage 
25 studies included in analysis
Condom effectiveness (measured by comparing always with never users) in reducing female to male transmission = 
84.7% (aggregate lower and upper confidence limits for both men and women 60.0% - 95.8%)
0.000005
Condom (female) N/K Assumed 10% additional protective effect over male condoms 0.000004
Pill 1.0 Team assumption 0.00003
IUD 1.0 Team assumption 0.00003
Injectables 1.0 Team assumption 0.00003
Subdermal implant 1.0 Team assumption 0.00003
Women
Chance N/A See Table A.2.2. 0.00001
Spermicides 1.14 Systematic Review (WHO, 2003)(203)
Presentation by Wilkinson on evidence from a systematic review o f RCTs comparing use o f spermicides versus non-use 
at the technical consultation on nonoxynol-9. Women participating in the included trials tended to be sex workers or 
from other high risk groups.
RR for HIV obtained from 5 studies with a total of 3570 women. 95% Cl 0.92-1.41
0.00001
Cap/diaphragm 0.7 Expert opinion (Kresge, 2003)(283)
Article quoting Padian who describes anticipated reduction in HIV acquisition amongst female diaphragm o f 30%
0.000009
Withdrawal N/K Assumed RR=1.0 0.00001
Condom (male) 0.13 Systematic review (Davis and Weller, 1999)(208)
Study inclusion criteria: 1) examination of sexual transmission of HIV among serodiscordant heterosexual couples 
having penetrative sexual intercourse; 2) determined HIV status by serology; 3) inquired about condom usage 
25 studies included in analysis
Condom effectiveness (measured by comparing always with never users) in reducing male to female transmission= 
86.8% (aggregate lower and upper confidence limits for both men and women 60.0% - 95.8%)
0.000002
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Table A2.9. (Contd.) Probability of acquiring HIV in one year by contraceptive method
G H I J
Contraceptive
methods
RR for method 
users acquiring 
HIV Evidence for H
Prob of 
acquiring HIV 
in one year by 
method
Condom (female) N/K Assumed 10% additional protective effect over male condoms 0.000001
Pill 0.3 Systematic review and meta-analysis (Stephenson, 1998)(206)
Pooled data from two o f the methodologically strongest studies - prospective partner studies- from a systematic review. 
Strongest studies were two prospective partnership studies (De Vincenzi et al, 1994(284) and Nagachinta et al, 
1996(285)) pooled RR = 0.30 (95% Cl 0.05-2.1) for HIV acquisition amongst pill users
0.000004
IUD 1.2 Case-control study (Mati et al, 1995)(202)
Comparison o f  HIV seropositive and HIV seronegative women to establish risk ( if  any) associated with current 
and previous contraceptive use. W omen (n=4404) recruited in two family planning clinics in Nairobi, Kenya. HIV 
prevalence 4.9%.Odds associated with previous IUD use = 1.2 (95% Cl 0.8-1.7)
0.00001
Injectables 3.7 Prospective cohort study (Martin et al, 1994)(216)
Prospective study o f  HIV negative casual sex workers in Mombasa, Kenya to determine risk factors associated 
with seroconversion. 435 enrolled between Feb 1993 - Feb. 1994. 16 seroconverted.. HIV infection was associated 
with the use o f  depo provera (OR 3.7, 1.4-9.6)
0.00005
Subdermal implant 1.0 Team assumption 0.00001
L/i
A2.10. Probability of side effects whilst using different contraceptive methods: Weight gain1
C on tracep tive  M ethod P robab ility  o f w eight gain 
a ttr ib u ta b le  to  the  m ethod
Evidence
Spermicides 0.0 Team assumption
Cap 0.0 Team assumption
Withdrawal 0.0 Team assumption
Condom (male) 0.0 Team assumption
Condom (female) 0.0 Team assumption
Pill 0.001 R C T  (Redmond et al, 1999 (219)
Intervention: Pill (n=228) vs. placebo (n=234).
Participants and setting: 15-49 years with moderate acne in the US. 
Follow-up: 6 months
Probability o f  weight gain in pill users = 0.022 
Probability o f  weight gain in controls = 0.021
IUD 0.0 Team assumption
Injectables 0.179 Team assumption=0.2
Probability o f  weight gain in controls assumed to be 0.021 (see above entry for the pill)
Subdermal implant 0.05 M eta-analysis (Urbancsek, 1998)(286)
Meta-analysis o f  13 different clinical trials (6 open, noncomparative trials o f  Implanon and 7 open 
randomised, comparative trials o f  Implanon versus Norplant. Implanon N=1716, Norplant N=689. 
Trials conducted in Europe, North and South America and Southeast Asia between 1989-1997. 
Participants: 18-40 years, in good health.
Increase in body weight o f  >10%  from baseline at least once during contraceptive use was considered 
clinically significant.
Probability o f  weight gain in implant users = 0.071
Probability o f  weight gain in controls assumed to be 0.021 (see above entry for the pill)
Notes
1 Weight gain = reported weight gain by the user or the investigators, unless otherwise stipulated
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A2.ll. Probability of side effects whilst using different contraceptive methods: Heavy/prolonged bleeding
C on tracep tive  M ethod P robab ility  o f heavy 
bleeding a ttr ib u tab le  to 
the m ethod
Evidence
Spermicides 0.0 Team assumption
Cap 0.0 Team assumption
Withdrawal 0.0 Team assumption
Condom (male) 0.0 Team assumption
Condom (female) 0.0 Team assumption
Pill 0.01 Assumed probability o f  heavy/prolonged bleeding in pill users = 0.05
Probability o f  heavy/prolonged bleeding in non-contraceptive users = 0.04 Reference period=10-12 
months 3893 menstrual diaries (Source: Population Information Program. Summary o f  WHO 
studies)(287)
IUD 0.16 Assumed probability o f  heavy/prolonged bleeding in IUD users = 0.2
Probability o f  heavy/prolonged bleeding in non-contraceptive users = 0.04 (see pill entry above)
Injectables 0.125 S um m ary  o f P rospective S tudies (Population Information Program, 1995)(287)
Probability o f  heavy/prolonged bleeding in DMPA users=0.165 Reference period=10-12 months 241 
menstrual diaries. W HO multicentre studies, 1983-1988
Probability o f  heavy/prolonged bleeding in non-contraceptive users = 0.04 Reference period=10-12 
months 3893 menstrual diaries (Source: Population Information Program. Summary o f  WHO studies)
Subdermal implant 0.061 M eta-analysis (Affandi, 1998)(288)
Meta-analysis o f  13 different clinical trials (6 open, noncomparative trials o f  Implanon and 7 open 
randomised, comparative trials o f  Implanon versus Norplant. Implanon N=1716, N orplant N=689. 
Trials conducted in Europe, North and South America and Southeast Asia between 1989-1997. 
Participants: 18-40 years, in good health and had regular menstrual cycles.
Prolonged bleeding was defined as bleeding or spotting within a consecutive 90-day period for more 
than 14 days.
Probability o f  prolonged bleeding in Implanon users = 0.101
Probability o f  heavy/prolonged bleeding in non-contraceptive users = 0.04 (see pill entry above)
K>
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A2.12. Probability of side effects whilst using different contraceptive methods: No periods
C on tracep tive  M ethod P robab ility  o f no periods 
a ttr ib u ta b le  to  the  m ethod
Evidence
Spermicides 0.0 Team assumption
Cap 0.0 Team assumption
Withdrawal 0.0 Team assumption
Condom (male) 0.0 Team assumption
Condom (female) 0.0 Team assumption
Pill 0.014 Assumed probability o f  amenorrhoea in pill users = 0.03
Probability o f  amenorrhoea in non-contraceptive users = 0.016 (see injectable entry below)
IUD 0.0 Team assumption
Injectables 0.37 S um m ary  o f Prospective S tudies (Population Information Program, 1995)(287)
Probability o f  amenorrhoea in DMPA users=0.386 Reference period=10-12 months 241 menstrual 
diaries. W HO multi centre studies, 1983-1988
Probability o f  amenorrhoea in non-contraceptive users = 0.016 Reference period=10-12 months 3893 
menstrual diaries (Source: Population Information Program. Summary o f  WHO studies)(
Subdermal implant 0.17 M eta-analysis (Affandi, 1998)(288)
M eta-analysis o f  13 different clinical trials (6 open, noncomparative trials o f  Implanon and 7 open 
randomised, comparative trials o f  Implanon versus Norplant. Implanon N=1716, Norplant N=689. 
Trials conducted in Europe, North and South America and Southeast Asia between 1989-1997. 
Participants: 18-40 years, in good health and had regular menstrual cycles.
Amenorrhoea (no periods) was defined as no bleeding or spotting within a consecutive 90-day period. 
Probability o f  no periods in Implanon users = 0.186
Probability o f  amenorrhoea in non-contraceptive users = 0.016 (see DMPA entry above) 0.016
N>
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A2.13. Probability of side effects whilst using different contraceptive methods: Nausea
Contraceptive Method Probability of nausea 
attributable to the method
Evidence
Spermicides 0.0 Team assumption
Cap 0.0 Team assumption
Withdrawal 0.0 Team assumption
Condom (male) 0.0 Team assumption
Condom (female) 0.0 Team assumption
Pill 0.037 RCT (Redmond et al, 1999 )(219)
Intervention: Pill (n=228) vs. placebo (n=234). All participants were advised to also use non-steroidal 
contraception. Condoms were distributed.
Participants and setting: 15-49 years with moderate acne in the US.
Follow-up: 6 months
Probability o f  nausea in pill uses = 0.127
Probability o f  nausea in non-pill users = 0.09
IUD 0.0 Team assumption
Injectables 0.04 Prospective cohort (Harel et al, 1995)(289)
Prospective follow up o f  78 adolescents aged 1 2 -2 0  years from urban hospital adolescent clinic, US. 
9 months follow up.
Probability o f  nausea in DMPA users = 0.13
Probability o f  nausea in non-DM PA users assumed to be 0.09 (see above entry for the pill)
Subdermal implant 0.027 Meta-analysis (Urbancsek, 1998)(286)
Meta-analysis o f  13 different clinical trials (6 open, noncomparative trials o f  Implanon and 7 open 
randomised, comparative trials o f  Implanon versus Norplant. Trials conducted in Europe, North and 
South America and Southeast Asia between 1989-1997.
Participants: 18-40 years, in good health. Implanon N=1716, Norplant N=689.
Probability o f  nausea in implant users = 0.036
Probability o f  nausea in non-implant users assumed to be 0.09 (see above entry for the pill)
t o
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A2.14. Probability of side effects whilst using different contraceptive methods: Acne
C on tracep tive  M ethod P robab ility  o f acne 
a ttr ib u ta b le  to  the  m ethod
Evidence
Spermicides 0.0 Team assumption
Cap 0.0 Team assumption
Withdrawal 0.0 Team assumption
Condom (male) 0.0 Team assumption
Condom (female) 0.0 Team assumption
Pill 0.0 M ulti-cen tre  open random ised tr ia l (Endrikat et al, 1999)(221)
Trial o f  different preparations o f  low dose oral contraceptives. 67 European centres.
Participants: 18-35 years. N=1059. Follow up= 7 cycles.
Probability o f  acne in pill users (calculated by combining data from the different treatment arms) 
=0.03
Probability o f  acne (“mild/moderate”) in general female population assumed to be 0.05 (data from 
Rademaker et al, 1989.(220) 2014 randomly selected children aged 12-17 years from 15 Glaswegian 
schools (females =1041). Independent assessments o f  facial acne using a recognised scoring system)
IUD 0.0 Team assumption
Injectables 0.0 Assumed probability o f  acne in injectable users = 0.02
Probability o f  acne (“mild/moderate”) in general female population assumed to be 0.05 (see entry for 
the pill above)
Subdermal implant 0.111 M eta-analysis (Urbancsek, 1998)(286)
Meta-analysis o f  13 different clinical trials (6 open, noncomparative trials o f  Implanon and 7 open 
randomised, comparative trials o f  Implanon versus Norplant. Implanon N=1716, Norplant N=689. 
Trials conducted in Europe, North and South America and Southeast Asia between 1989-1997. 
Participants: 18-40 years, in good health.
Probability o f  acne in implant users = 0.161
Probability o f  acne (“mild/moderate”) in general female population assumed to be 0.05 (see entry for 
the pill above)
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A2.15. Probability of side effects whilst using different contraceptive methods: Thrombosis
Contraceptive Method Probability of thrombosis 
attributable to the method
Evidence
Spermicides 0.0 Team assumption
Cap 0.0 Team assumption
Withdrawal 0.0 Team assumption
Condom (male) 0.0 Team assumption
Condom (female) 0.0 Team assumption
Pill 0.0000645 Modelling (Farley et al, 1998)(222)
Combined national reporting statistics and evidence from studies addressing the cardiovascular 
effects of oral contraceptive use -  international perspective
Attributable risk of thrombosis from oral contraceptive use amongst 20-24 year olds
IUD 0.0 Team assumption
DMPA 0.0 Team assumption
Subdermal implant 0.0 Team assumption
A2.16. Bother factor probabilities*
None Withdrawal
Cycle
awareness
Cap / 
diaphragm
Spermicides
alone
Condom
(male)
Condom
(female)
Double dutch 
(pill & 
condom) Pill Injectable IUD
Subdermal
implant
ANY BOTHER
Bother getting 0 0 0.25 1 0.25 0.25 0.25 1 1 1 1 1
Bother remembering 0 0.25 1 1 1 1 1 1 1 0.1 0 0
Invasive procedure 0 0 0 0.5 0 0 0 0 0 1 1 1
Effect on sex 0.25 0.75 1 0.5 0.5 0.5 0.5 0.5 0 0 0 0
Notes
* Based on team assumptions
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M ortim er M arket,
O ff Capper Street,
London W C 1E 6A U
Telephone + 44 (0)20 7387 9300 
Fax: +44 (0)20 7388 4179
Lead Investigator: Rebecca French
VERSION 3 -26 September 2004 
A computer program to facilitate informed contraceptive choice. 
(“MyWay”) 
Information Sheet 
Program pilot with Young People
CONFIDENTIAL
You are being invited to take part in a research study. Before you decide it is important for you to 
understand why the research is being done and what it will involve. Please take time to read the 
following information carefully and discuss with others if you wish. Ask us if there is anything that 
is not clear or if you would like more information. Take time to decide whether or not you wish to 
take part.
What is the purpose of this study?
The proposed work addresses the challenge of teenage pregnancy and Sexually Transmitted 
Infections (STIs) through an interactive computer program (‘My Way’), initially for use in a young 
people’s contraceptive and STI clinic. It uses decision analytic principles to combine an individual’s 
values (e.g. attitude to becoming pregnant) with data on the outcomes and effectiveness of different 
methods of contraception (e.g. probability of becoming pregnant, of STI infection).
Essentially, decision analysis is a method for breaking down complex problems or questions into 
manageable components, and then combining them logically to show the best course of action. The 
model works by combining the best available scientific evidence on the outcomes and effectiveness 
of available contraceptive options, such as probability of pregnancy while on the pill, with 
quantitative assessments of the user’s own preferences and values (known as ‘utilities’), such as 
how they feel about the consequences of becoming pregnant. The model provides a ranking and 
rating of the various available options for each user, based on both scientific evidence and personal 
values. Hence it indeed has the potential to identify ‘my way’.
Why have I been chosen?
Part of this research involves interviewing people aged 13-21 years. We are planning to recruit 25 
young people who do not wish to get pregnant.
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Do I have to take part?
It is up to you to decide whether or not to take part. If you do decide to take part you will be given 
this information sheet to keep and be asked to sign a consent form. If you decide to take part you 
are still free to withdraw at any time and without giving a reason.
What will happen to me if I take part?
You will be asked to fill out a computer-based questionnaire which will ask you questions such as: 
What is the reason for your visit to the clinic today? What contraceptive methods have you used in 
the past? What factors do you/would you consider in choosing a form of contraception? Some of the 
questions may be quite personal so if there is a question that you do not want to answer or 
information you do not wish to provide, just say so. You are free to stop the interview at anytime 
without giving a reason.
Next you will be asked to experience ‘My Way’ the program we have developed to help young 
people select a contraceptive method according to the effectiveness of the various methods (e.g. the 
probability of pregnancy while on the pill) and the values they place on factors such as how they 
feel about the consequences of becoming pregnant. The contraceptive nurse or doctor will go 
through the program with you. A researcher will sit in on this consultation so that they can see what 
sorts of questions and/or difficulties you and the nurse/doctor may be having with the program.
You will then be asked to participate in a face-to-face interview with the researcher to discuss your 
experience using ‘My Way’.
Will my taking part in the study be kept confidential?
The questionnaire will be strictly confidential. We will not be collecting any information that can be 
linked back to you. Your computer output will be saved but there will be no information linking you 
to the specific output you receive. The interview will be taped. This is to help us remember what 
was said and the tape will be destroyed once we have written up the interview. Your name will not 
be put onto the questionnaire or the tape, instead they will be identified by a study number.
What will happen to the results of the research study?
UCL and LSHTM will be the designated data owners. Researchers at the two institutions will 
collect, store and handle the anonymized data. They will analyse the questionnaires, computer 
outputs and exit interviews. The results from the questionnaires and focus groups will be used to 
write a report for the funders and to write research articles in health service research journals.
Who is funding this research?
This work has been funded by the North Central London Community Research Consortium.
Contact information
If you have any queries about the interview or any of the issues it raises, please ask the interviewer 
or contact Rebecca French (one of the researchers) on 020 7387 9300 ext. 8190 or email 
rfrench@gum.ucl.ac.uk. The researcher will also give you a list of help-lines and contact numbers 
for any questions about sexual and reproductive health you may have in the future.
"All proposals for research using human subjects are reviewed by a research ethics committee 
before they can proceed. This proposal was reviewed by UCLH Ethics Committee."
Your help with this piece of work is much appreciated. Thank you.
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Royal Free and University College Medical School 
UNIVERSITY COLLEGE LONDON 
DEPARTMENT OF SEXUALLY TRANSMITTED DISEASES
The M ortim er M arket Centre,
M ortim er Market,
O ff Capper Street,
London W C 1E 6A U
Telephone + 44 (0)20 7387 9300 
Fax: +44 (0)20 7388 4179
Lead Investigator: Rebecca French
CONSENT FORM  
Questionnaire/ My Way Program/ Observation of consultations/ Exit interview
CONFIDENTIAL
To be completed by all participants agreeing to be interviewed for the My Way Program
pilot study
1. The researcher has explained the purpose of this research 
2 Any questions about the research have been answered by the researcher.
I confirm that I have had sufficient time to consider whether or not want to be 
3- included in the study
4. I understand that any information I provide is completely confidential.
 ^ I understand that I am free to stop my involvement with the research at any time 
without giving a reason.
6. I am .............. years old
A. Participant B. Researcher
Signed...........................................................  Signed....................................................
Name (please print)....................................... Name..................................................
D ate...............................................................  D ate....................................................
Yes / No
Yes / No
Yes/No 
Yes / No
Yes/No
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Helplines and w ebsites 
Where can I  go for  help or advice?
First, thank you for being so open and for helping us with the My Way pilot. 
Some of the questions we've asked have been personal and might have raised 
issues that you'd like to find out more about or discuss further. On this page 
are some numbers and web sites, if you want more facts, advice or someone to 
talk to.
Sexual Health line www.playinasafelv.co.uk 0800 567123
Run by the Department of Health. Confidential information and advice on 
HIV/AIDS and other sexually transmitted infections. Can put people in touch 
with local face-to-face services and send out free literature. Free calls. Open 
24-hours
Sexual Health Direct (FPA) www.fpa.orq.uk 0845 310 1334/0207 837 5432
Run by the fpa (formerly known as the family planning association). 
Confidential information and advice on contraception, planning pregnancies, 
sexually transmitted infections (STTs), unplanned pregnancies and other 
sexual and reproductive health concerns. Details of family planning clinics, STI 
clinics and other sexual health services anywhere in the UK. Local rates. 9am- 
7pm Mon- Fri
Avert www.avert.org
An international HIV and AIDS charity based in the UK. The website includes 
information, news, FAQs, sex education and personal stories.
bpas (formerly known as British Pregnancy Advisory Service)
0845 7304 030
Run by bpas. Information and advice on abortion and counselling after 
abortion. Local rates. Mon-Fri 8am-9pm, Sat 8:30am-6pm, Sun 9:30-2:30pm
Terrence Higgins Trust Direct line 0845 1221 200
Run by the Terrence Higgins Trust Pregnancy Unit. A gateway to HIV 
services, support and information. Local rates. Monday to Friday 10am to 
10pm; 12 pm to 6 pm Saturday and Sunday. Menu with recorded messages 
about services offered also available. E-mail contact info@tht.orq.uk
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Brook Advisory Centres: www.brook.org.uk 0800 0185 023
Run by Brook. Specially for under 25s. You can get the address of a centre 
near you to go to for advice and information on contraception STIs, 
pregnancy, abortion. Freephone number. Mon -Fri 9am-5pm (closed Thu 12:15- 
1:45). 24 hours recorded information on sexual health on 0207 617 8000.
Sexwise 0800 28 29 30
Run by the Department of Health. Conf idential advice on sex, relationships, 
and contraception for young people aged 12-18. Freephone number. Mon- Sun 
7am to midnight.
London Lesbian and Gay Switchboard 0207 837 7324
Run as a voluntary organization, it offers confidential advice on diverse 
subjects such as sexual health, coming out and employment rights as well as 
counselling and support. 24hrs.
National child protection helpline 0808 800 5000
Confidential counselling, information and advice for anyone concerned about a 
child at risk of ill treatm ent or abuse. Freephone number. 24 hours.
NHS NHS Direct 0845 4647
Nurse-led advice and health information inc. self help and support groups.
Local rates. 24 hours, www.nhs.uk Local service search-complete searchable 
directory of dental practices, G? surgeries, opticians, pharmacies and other 
NHS organisations in England.
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FAQs
Why is My Way relevant to me?
Research has shown that some young people feel that they are not given enough 
information about which contraceptive methods are best suited to their individual current 
circumstances and preferences. The MyWay program was created to help young people 
choose the contraceptive method they feel best suits their current situation and reflects their 
particular concerns. So for example, if you are very concerned about getting pregnant and 
worried about getting a sexually transmitted infection (STI), the MyWay program would 
score highly methods that reflect these concerns. The program also allows you to express 
concerns about practical factors, such as having to go to a clinic to get your contraception 
or having to remember when to take it.
How does MyWay work?
MyWay combines available evidence about the various contraceptive methods (in terms of 
how effective they are at preventing pregnancy and different sexually transmitted infections 
(STIs), as well as their side effects) with the importance you give to unwanted outcomes of 
sex (STIs and pregnancy, as well as side effects such as weight gain, heavier or no periods) 
into a mathematical equation to calculate which method best suits your current 
circumstance according to your selections. You can see a simple example of how a 
particular score was calculated by clicking here.
Where do you get the evidence that goes into the ratings for the various options?
The numbers come from published research papers conducted on contraceptive 
effectiveness and side effects as well as expert advice when there was a lack o f published 
evidence.
The information on different contraceptive methods/ options (such as on average how likely 
are you to get pregnant using a particular method or combination of methods) is then 
combined with the relative importance you placed on the concerns/ attributes you selected 
(such as how concerned would you be if you became pregnant now).
Why do I have to fill-out a Questionnaire?
The purpose o f the questionnaire is to collect some information on the individuals who use 
MyWay, to see what choices you make considering your current situation. The 
questionnaire and your MyWay responses will be linked for analysis by researchers, but 
since we do not ask for any personal information by which you can be identified, we have 
no way of knowing who you are.
Will anyone else know what I’ve entered into EITHER the Questionnaire OR the 
software?
The questionnaire will be strictly confidential. We will not be collecting any information 
that can be linked back to you. Your computer output will be saved, but there will be no 
information linking you to the specific output you receive. Your questionnaire results and 
MyWay outcome will be linked purely for research purposes to see what selections people 
in different circumstances make.
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Why can’t I see the score bar chart when I’m making my choices or weighting my 
concerns?
You may already have feelings about the different contraceptive methods, but if you do, 
MyWay assumes you genuinely want to find out whether these prior feelings are in line 
with the consequences you value and the evidence about them. After you select which 
options and concerns (or attributes) you want to look at, you get to give each attribute a 
level of importance (or weight) by moving the borders o f the coloured segments in the 
weighting box. At this point you get to see all your selected attributes and if you feel like 
changing them, you can go back to the selection page before saving your options and 
getting the result score bar chart. You do not see the score bar chart at this point in order 
that you are not influenced to select or weight your attributes based on which method 
scores highest as a result.
What Does The Score Bar Chart Mean?
The chart shows you which o f the contraceptive options you selected scores highest given 
the evidence included in MyWay and what you have told MyWay about your concerns and 
preferences
Each bar in the chart represents a different contraceptive method, or combination of 
methods.
The height o f each score bar depends on two things:
1. How you weighted the undesirability of each concern (or importance of each 
attribute) using the weighting box provided.
2. The evidence available to MyWay on how effective each contraceptive option is in 
eliminating or reducing each attribute you selected.
These two pieces of information are combined into a score by a process which is 
illustrated here.
Why are some contraceptive options not available in MyWay?
Emergency contraception (either through use of progestogen pill or insertion o f an IUD) is 
taken to prevent a potential pregnancy after intercourse has taken place. MyWay has been 
designed to help young people to identify contraception options for regular use; therefore 
emergency contraception has not been included in the list o f contraceptive options.
New methods o f contraception are constantly under development. When we designed this 
program the contraceptive patch, for example, was not available to the general public. If 
you would like to find out more information about the patch or emergency contraception 
please ask the doctor or nurse.
Why are some attributes not available?
We conducted some research with young people to find out what was most important to 
them when making decisions about contraception. This work helped us come up with the 
list of attributes. However, you may have concerns that have not been included in our list, 
for example concerns about long-term health risks. Please discuss any concerns you may 
have with the nurse or doctor at the clinic.
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HOW TOs
How can I start using MyWay?
Find out your administrator’s name at your location and enter this in the administrator box 
on the MyWay homepage. First, you will be asked to complete a questionnaire. Then you 
will have a choice of 2 demonstrations to go through to help you use MyWay and 
understand how MyWay works. You will then be asked to select the methods of 
contraception you are interested in and to identify the main concerns you have, such as 
getting pregnant, acquiring an infection, experiencing a side effect or having some sort of 
‘bother’.
How do I select the contraceptive methods I am interested in?
You choose up to 8 o f the 12 listed contraceptive methods by clicking on the boxes next to 
them. If you do not know what some of the methods are, you can roll over them with the 
cursor to get a pop up definition. Further details on each method are provided in the 
glossary.
How do I select the ‘concerns/attributes’ that are important to me?
You can choose up to 8 o f the 21 listed attributes or concerns by clicking on the boxes 
alongside them. If you do not know what some of the attributes mean, you can roll over 
them with the cursor to get a pop up definition. Further details on each attribute are 
provided in the glossary.
How do I show which of the concerns I have chosen are most important to me?
You do this in the ‘weighting box’ by using the cursor to move the inner borders o f the 
segments which represent the concerns/ attribute you selected. You can increase or 
decrease the size o f a segment to give each one the importance or weight you want. The 
bigger you make a segment, the greater weight you give to that concern (i.e. the more you 
want to avoid that attribute). The smaller a segment, the less importance you give to that 
concern/ attribute. You will be able to see the changes you make on the screen as you move 
the borders.
How do I move the borders of the attribute/concern segments?
You need to put the cursor on the inner borders of the weighting box. When the 4 arrow 
(crosshair) icon appears, hold either the left or right button of the mouse down, drag the 
border to where you want it to be and release the button.
How do I see and interpret the results?
After you are happy that the areas o f the segments represent the relative importance o f the 
concerns/attributes you selected, you can click on the ‘Click her to save and see option 
scores’ or ‘next’ button to store your choices on the system. You will then see a score bar 
chart showing the scores for each of the contraceptive options you have chosen. The 
highest bar shows the contraceptive option which scores best given the evidence MyWay 
uses and the weights you have given to the various concerns/ attributes. The lowest bar 
shows the option that scores worst. The weighting box with the concerns/ attributes you 
selected is to the right o f the graph. You can now move the segment borders to see how 
changing the weight you have placed on each of the concerns/attributes changes the scores 
of the contraceptive options you selected.
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How do I change the options I selected?
As long as you have not taken the last step -and seen the results in the score bar chart- you 
can go back and change the contraceptive options and attributes/concerns you selected. 
However, once you have clicked to see the final score bar chart, you will have to return to 
the start o f the questionnaire to use MyWay with a different set of options and attributes.
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Glossary/Roll Over Definitions
Term for use on screen Definitions
CONTRACEPTIVE
METHODS
None Use of no contraceptive method for protection against pregnancy or sexually transmitted infections during 
sexual intercourse.
Withdrawal This means removing the penis from the vagina before ejaculation.
Cycle awareness Fertility awareness helps you recognise the fertile times and infertile times during the menstrual cycle.
Cap Caps are barrier methods of contraception. They fit inside a woman’s vagina and cover the cervix. They need to 
be used with a spermicide.
Spermicide Spermicides are chemicals that destroy sperm.
Diaphragm Diaphragms are barrier methods of contraception. They fit inside a woman’s vagina and cover the cervix. They 
need to be used with a spermicide.
Condom Condoms are barrier methods of contraception. They stop sperm meeting an egg.
Pill The combined pill is usually just called the pill. It contains two hormones -  oestrogen and progestogen. These 
are similar to the natural hormones women produce in their ovaries.
Injectable Injections use a progestogen hormone. This is injected into a muscle and is released very slowly into your body.
IUD An IUD, also known as the coil, is a small plastic and copper device that is fitted into a woman’s womb.
Implant Implanon is a type of contraceptive implant which is a very small, flexible tube, about the size of a matchstick. 
It is placed just under the skin of a woman’s inner upper arm. It steadily releases a progestogen hormone into 
the blood stream.
Double Dutch This is a term used to describe the use of both the pill and condoms as a method of contraception.
Emergency contraception Emergency contraceptive pills, also known as the ‘morning after pill’ contain the hormone progestogen. They 
should be started within 72 hours (3 days) of having unprotected sex. They are more effective the sooner they 
are taken. The IUD can also be used as emergency contraception. It can be fitted up to five days after you have 
had unprotected sex.
The contraceptive patch The Evra contraceptive patch is a small, thin, beige coloured patch. It is stuck on a woman’s skin and releases 
two hormones - oestrogen and progestogen. These are similar to the natural hormones that women produce in 
their ovaries and like those used in the combined oral contraceptive pill.
INFECTIONS
Gonorrhoea Gonorrhoea is a bacterial infection. Women may notice an unusual vaginal discharge, which may be thin/watery 
or yellow/green and have a strong smell. Men frequently notice a white, yellow or green discharge from the tip 
of the penis and pain when urinating.
Syphilis Syphilis is a bacterial sexually transmitted infection. In the early stages of syphilis, sores can develop, usually 
found in the genital area.
Chlamydia Chlamydia trachomatis is the most common bacterial sexually transmitted infection. About 50% of infected 
men and 70% of infected women have no symptoms at all. Women may notice an unusual vaginal discharge, 
pain when passing urine, and/or bleeding between periods or after sex. Men may notice a white/cloudy and 
watery discharge from the tip of the penis and pain when passing urine.
Trichomonaisis Trichomoniasis is a genital infection with the germ Trichomonas vaginalis. Although it most commonly affects 
the vagina in women, who may notice an unusual vaginal discharge and pain when passing urine, there may be 
no symptoms. It may also involve the urine tube (urethra) of both men and women, and the prostate gland in 
men.
Genital wart virus Genital warts are caused by a virus called Human Papilloma Virus (HPV). Genital warts are small fleshy 
growths that may appear anywhere on a man or a woman's genital area.
Herpes Genital herpes is a common virus infection caused by the herpes simplex virus (HSV). There are two types of 
HSV that can cause genital herpes. Both of these can cause sores around the mouth (cold sores) and around the 
genital and anal region.
HIV HIV stands for Human Immunodeficiency Virus. This is the virus known to cause AIDS (Acquired Immune 
Deficiency Syndrome).
Bother General term for characteristics associated with a contraceptive option such as having to visit a clinic, remember 
to take a pill every day, remember to carry condoms or having to put a condom on during sex.
Bother getting This means having to see a doctor or nurse to obtain a particular contraceptive method.
Invasive procedure This means having to have an invasive procedure in order to be fitted with a particular contraceptive method. 
For example, having to have a vaginal examination in order to get an IUD fitted.
Bother remembering This means for example having to remember to take the pill every day, or having to remember to carry your 
condoms.
Effect on sex This means that certain contraceptive methods may disrupt sexual intercourse. For example, putting on 
condoms during sex.
SIDE EFFECTS
Weight gain
No periods This means that a woman has no bleeding during menstrual cycle for 90 days.
Heavy periods This means having heavier bleeding than is normal for a particular woman during her period.
Acne Acne is another word for spots.
Nausea Nausea means feeling sick.
Thrombosis Thrombosis means the clotting of blood within an artery or a vein.
DECISION AID 
TERMS
Option Any contraceptive method (e.g. the pill, condoms) or combination of methods (e.g. ‘Double Dutch’) contained 
in a list of possible options from which the user must choose one.
Rating The chance that an option will produce a specified outcome (e.g. the chance of getting pregnant on the pill).
Attribute One characteristic or one possible outcome of an option (e.g. the possibility of getting pregnant when using a 
particular method of contraception)
Weighting Box A box diagram within which each selected attribute is represented by a rectangular coloured sub-area.
Weight The relative undesirability attached to an attribute or outcome when it is a concern.
Score A summary measure of how well an option performs in relation to the other selected options,
Score Bar Chart A diagram in which the scores for each option are displayed side by side, the height of the bar indicating the 
score.
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Appendix 4 Research Instruments
Facilitator comment sheet
Questionnaire
Observation sheet
Exit interview topic guide
My Way
Facilitator Comment Sheets
Version 2 November 2004
P art 1
(Before use of My W ay program )
Date_____________
User ID__________
Your favoured contraceptive option based on initial risk assessment_______________
What option do you think the young person is most likely to actually im plem ent?________
P art 2
(After use of My W ay program )
Highest score bar on My Way__________________
Did the My Way session change your favoured option in any way? Why? Why not?
To be completed after young person leaves for exit interview:
What option do you think the young person is most likely to actually implement? _  
Y our Comments:
About the experience of the young person with My Way:_______________________
About how My Way affected your interaction with the young person:
Other:
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A computer program to facilitate informed contraceptive choice by teenagers
(“My Way”)
CONFIDENTIAL
Questionnaire 
Version 9-November, 2004
The purpose of this project is to find out whether the program we have developed 
is useful in helping young people chose contraceptive methods that are most 
appropriate for their needs. We will be asking you to:
■ Fill out this questionnaire
■ Use the MY Way program
■ Discuss your views on the program
Some of the questions may seem a bit personal, but your answers will not be seen 
by anyone other than the researcher. Do not put your name on the questionnaire, 
so no one will know how you have answered any questions. Please use this 
questionnaire to tell us about the things that matter to you in choosing a 
contraceptive method. If you do not wish to fill in this questionnaire for any reason, 
please hand it back empty.
If you would like any more information about this study, you can phone the 
researcher Rebecca French at the Royal Free and University College Medical 
School on 020 7387 9300 Ex. 8190.
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Site  I
Q.1. How old are you?
Age (in years): ..
Q.3. Why are you visiting this service today? (Please select aU that apply)
To find out if I have a sexually transmitted infection D1
My partner has had an infection and I need treatment D2
To get treatment for a sexually transmitted infection D3
For HIV testing D4
For advice on contraception D5
To pick up condoms D6
For emergency contraception D7
To start a new method of contraception D8
For a repeat prescription D9
For a contraception check up D10
For a pregnancy test D11
I came with my partner D12
Other reason D13
Don’t know D14
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Below are a number of statements about young people and sex. Please 
indicate whether you agree or disagree with each of these statements. 
It doesn’t matter if they don’t really apply to you at the moment, we are 
also interested in what you think.
A. I would find it really difficult to talk to my partner about 
contraception.
Agree D1 
Disagree D2
B. Condoms make sex less fun.
Agree D1 
Disagree D2
C. Young women shouldn’t take the pill because it’s bad for 
their health.
Agree D1 
Disagree U2
D. I am not the sort of person who would become a teenage 
parent.
Agree D1 
Disagree D2
E. There is no reason for anyone to be a parent at my age if 
they don’t want to -  we’re all in control of our lives
Agree D1 
Disagree D2
F. Using emergency contraception (the morning after pill) to 
prevent an unwanted pregnancy is always wrong.
Agree D1 
Disagree D2
G. Contraception is a woman’s responsibility.
Agree O1 
Disagree D2
H. I am not the sort of person to get a sexually transmitted 
infection.
Agree D1 
Disagree D2
I. You can tell by looking at people whether they have a 
sexually transmitted infection.
Agree D1 
Disagree D2
J. Older people are more likley to have sexually transmitted 
infections.
Agree D1 
Disagree D2
K. There is no need to use condoms in longterm relationships.
Agree D1 
Disagree D2
Q.5. When you were growing up, in which of the ways listed here did you 
learn about sexual matters? (Please select aU that app/y)
mother □ 1 television/radio □ 9
father □ 2 videos □ 10
brother or sister □ 3 books □ 11
other relative(s) □ 4 magazines/newspapers □ 12
lessons at school □ 5 cinema/films (other than □ 13
TV/video)
□ 14friends of about my own age □ 6 the internet
boy/girl friend/sexual partner □ 7 No method/ Did not learn □ 15
□ 8
about sexual matters
doctor/nurse/clinic other □ 16
>► Please specify
Q.6. In the past year have you obtained contraceptive supplies, from any of 
these sources?
Source
Have not obtained any supplies 
GP
Family Planning clinic 
Young person’s sexual 
health/contraceptive clinic 
Chemist/pharmacy (e.g. Boots) 
School nurse
Vending machine (e.g. in pubs or 
clubs)
Supermarket/Petrol Station 
Through the post 
Emergency department at hospital 
Boyfriend/girlfriend provides 
Given by parent/relative/friend 
Other please
specify________________
Don’t know
Ever used 
(Please select 
all that apply)
□ 4
□ 5
□ 6
□ 7
□ 8
□ 9
□ 10
□ 11
□ 12
□ 13
□ 14
Preferred 
source 
(Please select 
one only)
□ 4
□ 5
□ 6
□ 7
□ 8
□ 9
□ 10
□ 11
□ 12
O13
r-i14
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Q.7. Thinking about the first time you went to get contraceptive supplies, 
was this (Please select one only)...
Before you first had sex D1
After you first had sex D2
Have not had sex D3
Don’t know/can’t remember D4
Q. 8. Hypothetically, if you were thinking of starting or changing your 
method of contraception which method would you choose?
SECTION B. The questions in this section are about sexual experience
Q.9. Have you had vaginal sexual intercourse (vaginal sexual intercourse 
means a man putting his penis into a woman’s vagina)? (Please select 
one only)
Yes D1
No a 2
(If no, skip to Q.35)
Q. 10. How old were you the first tim e? ..................
Q.11. When you FIRST had sexual intercourse, did you or your partner use 
or do anything to prevent pregnancy and/or sexually transmitted 
infections?
Yes □ 1
No □ 2
Don’t know/can’t remember
(if no or don’t know skip to Q. 13)
□ 3
f yes, what did you use? (Please select all that applrf
Condom □ 1
The Pill □ 2
Emergency contraceptive pill □ 3
Withdrawal □ 4
Can’t remember □ 5
Don’t know □ 6
Other
I------ Please specify.............
□ 7
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Q. 13. Which contraceptive methods have you or a partner used?
No method 
The pill
Coil/intrauterine device (IUD) 
Condom
Femidom (female condom)
Cap/diaphragm
Spermicide
Fertility awareness (eg. safe 
period/rhythm)
Withdrawal 
Injections I Depo 
Implanted capsules (Implanon) 
Emergency contraception 
Abstinence (not having sex) 
Other please specify________
Ever used 
(Please 
select all 
that apply) 
□ 1 
□ 2 
□ 3 
□ 4
n
110
111
112
113
.14
Currently 
using 
(Please select 
all that apply) 
□ 1 
□ 2 
□ 3 
□ 4 
□ 5 
□ 6 
□ 7 
□ 8
□ 9
□ 10
□ 11
□ 12
□ 13
□ 14
Q. 14. On how many occasions, if ever, have you or a partner used the 
emergency contraceptive pill? (Please select one only)
None
One
Two
Three or more times 
Don’t know
□ 1
□ 2
□ 3
□ 4
□ 5
Q.15. How many sexual partners have you had in the last year?
(If 0 skip to Q.21 if female and Q. 28 if male)
Q.16. How many sexual partners have you had in the last 4 weeks?
Q.17. How many times have you had sexual intercourse in the past 4 weeks?
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Q. 18. And have you had unprotected intercourse at all in the past 4 weeks? 
By that, we mean sexual intercourse where you haven’t used any form 
of contraception at all?
Yes D1
No a 2
Don’t know D3
Q. 19. Do you have a regular sexual partner at the moment (that is a
boyfriend or girlfriend who you are having sexual intercourse with)? 
(Please select one only)
Yes □ '
No D2
(If no, skip to Q.21 if female and Q. 28 if male)
Q. 20. How long have you been together? (Please select one only)
□ 1 y ea rs ..................
□ 2 months..................
□ 3 w eeks..................
FEMALE ONLY
Q. 21. Have you ever been pregnant? (Please select one only)
Yes -  In the past D1
Yes - 1 am at the moment D2
No, never D3
Don’t know D4
(If no or don’t know, skip to Q.35)
Q. 22. How many times have you been pregnant? (Please select one only)
Once D1
Twice D2
Three or more times D3
Don’t know D4
Q. 23. When you (first) became pregnant, how old were you? 
Type in age in y e a rs .......
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Q. 24. Was the pregnancy planned?
Yes D1
No D2
Don’t know D3
Q. 25. What happened?
I had I am having the baby D1
I had a miscarriage D2
I had I am having an abortion D3
Don’t know D4
Q. 26. In the month that you became pregnant, which of these applies? 
(Please select one only)
11 We were not using contraception D1
11 We were using contraception but not every occasion D2
11 We always used contraception but knew that the method D3
had failed (broken, come off/out, not worked, etc) at least once 
11 We always used contraception D4
Don’t know D5
Q. 27. In the month you became pregnant, which of the following methods of
contraception, if any, did you use? (Please select aH that apply)
Did not use contraception □ 1
Condom □ 2
Pill □ 3
Injectable / Depo contraception □ 4
Diaphragm / cap □ 5
IUD/coil □ 6
Safe period □ 7
Withdrawal □ 8
Emergency contraception □ 9
Other □ 10
Don’t know □ 11
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MALE ONLY
Q.28. Have you ever made a woman pregnant? 
Yes D1
No a2
Don’t know D3
(If no or don’t know, skip to Q.35)
Q. 29. How many times? (Please select one only)
Once □
Twice □
Three or more □
times
Don’t know □
Q. 30. How old were you (the first time if more than once)? 
Type in age in y e a rs .......
Q. 31. Was the pregnancy planned?
Yes □ ’
No a 2
Don’t know D3
Q. 32. What happened? (Please select one only)
She is still pregnant and will have the baby
She had the baby
She had a miscarriage
She had/will have an abortion
Don’t know
Q. 33. In the month that your partner became pregnant, which of these 
applies? (Please select one only)
I / We were not using contraception □
I / We were using contraception but not every occasion □
I I We always used contraception but knew that the □ 
method had failed (broken, come off/out, not worked, etc)
at least once
I / We always used contraception □
Don’t know □
□ 
□ 
□ 
□ 
□
Q. 34. In the month your partner became pregnant, which of the following 
methods of contraception, if any, did you use? (Please select all that 
apply)
Did not use contraception D1
Condom U2
Pill D3
Injectable I Depo contraception D4
Diaphragm I cap U5
IUD I coil D6
Safe period D7
Withdrawal D8
Emergency contraception D9
Other please specify.....................  □ 10
Don’t know D11
ALL
Q. 35. Have you ever been told by a doctor that you had any of the following? 
(Please select aH that apply)
Genital herpes □ 1 Genital warts □ 7
Trichomonas □ 2 Pelvic inflammatory disease □ 8
Gonorrhoea □ 3 Vaginal thrush □ 9
Syphilis □ 4 Yes but can’t remember □ 10
which one
□ 11Chlamydia □ 5 None of these
Non-specific/non- □ 6
gonococcal urethritis (NSU)
Q. 36. How at risk do you feel:
(Please select one only in each row)
Don’t 
know
of getting pregnant □ 1 U* D5
of getting HIV D1 U2 D3 U4 D5
of getting other D1 D2 D3 D4 D5
sexually transmitted 
infections
Greatly Quite a Not very Not at all
at risk lot much at risk
□ 1 □ 2 □ 3 □ 4
□ 1 □ 2 □ 3 □ 4
□ 1 □ 2 □ □ 4
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Q.37. The next question asks about things that matter to you NOW, in 
relation to contraception. If you were thinking about starting 
contraception TODAY (taking account of your current personal 
circumstances, for example where you are living, etc.) how concerned 
would you be about the following factors:
(Please select one only in each row)
You or your Very A bit Generally Not at all Don’t
partner... concerned concerned unconcerned concerned know
becoming pregnant □ 1 □ 2 □ 3 □ 4 □ 5
getting sexually
transmitted
infections
□ 1 □ 2 □ 3 □ 4 O5
What your friends 
think
□ 1 □ 2 □ 3 □ 4 □ 5
What your 
boyfriend/ 
girlfriend thinks
□ 1 □ 2 □ 3 □ 4 □ 5
Parents finding out □ 1 □ 2 □ 3 □ 4 □ 5
Possible side 
effects
□ 1 □ 2 □ 3 □ 4 □ 5
Possible long-term 
health risks
□ 1 □ 2 □ 3 □ 4 □ 5
Having to 
remember when to 
take contraceptive 
method (e.g. 
remembering to 
take the pill or 
carry condoms)
□ 1 □ 2 □ 3 □ 4 □ 5
Having to go to a 
clinic to get it
□ 1 □ 2 □ 3 □ 4 □ 5
Having to be 
examined by a 
doctor or nurse
□ 1 □ 2 □ 3 □ 4 □ 5
The next question is for WOMEN ONLY. MEN GO STRAIGHT TO Q39
Q. 38. Some women can experience some side-effects when using hormonal 
contraceptives (e.g. the pill, injections). Often these side-effects settle 
after a few months. If you were experiencing any of the side effects 
listed below, having started a new method of contraception a couple of 
months ago, how likely would it be that you would STOP using it: 
(Please select one only in each row)
Very Likely Unlikely Very Don’t
Headaches
likely
□ 1 □ 2 □ 3
unlikely
□ 4
know
□ 5
Weight gain □ 1 □ 2 □ 3 □ 4 □ 5
Heavy periods □ 1 □ 2 □ 3 □ 4 □ 5
No periods/very □ 1 □ 2 □ 3 □ 4 □ 5
light periods 
Feeling nauseous/ □ 1 □ 2 □ 3 □ 4 □ 5
sick
Acne/spots □ 1 □ 2 □ 3 □ 4 □ 5
s the last section of questions . We now need to ask you some
questions about yourself, so that we can look at your answers alongside the 
answers of people like you. None of the information you provide will be 
linked back to you.
Q.39. Which of these describes the main thing you do?
(Please select one only)
At school □
At college/university □
Paid employment □
Government training / employment □
scheme
Unemployed □
Looking after home or family □
Other Please specify □
Don’t know □
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Q.40. Thinking realistically, which of these is the highest qualification you 
think you will achieve? (Please select one only)
Degree or higher qualification □ 1
A level or equivalent □ 2
GCSE or equivalent □ 3
Completed recognised trade □ 4
apprenticeship
HND □ 5
NVQ □ 6
Clerical or commercial qualification □ 7
(e.g. book keeping/typing/commerce)
None of these □ 8
Other □ 9
Don’t know □ 10
Q.41 What is your father’s  jo b ? .......
Q. 42. What is your mother’s  jo b ? ........
Q.43. What is your religious denomination? (Please select one only)
Catholic □ 1
Presbyterian □ 2
Church of England □ 3
Methodist □ 4
Other protestant □ 5
Muslim □ 6
Sikh □ 7
Hindu □ 8
Jewish □ 9
Other □ 10
None of these □ 11
Don’t know □ 12
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Q.44. Can you tell me which best describes your ethnicity? (Please select 
one only)
White □ 1
Black-Caribbean □ 2
Black-African □ 3
Black-other Black groups □ 4
Indian □ 5
Pakistani □ 6
Bangladeshi □ 7
Chinese □ 8
Other □ 9
None of these □ 10
Don’t know □ 11
Q. 45. Do you personally have access to the internet nowadays, whether it is 
at home, school or somewhere else? (Please select ah that apply)
No -  no access D1
Yes -  at home D2
Yes -  at school I college I university D3
Yes -  at work D4
Yes -  at cybercafes D5
Yes -  at a friend or relative’s  house D6
Yes - elsewhere D7
Don’t know D8
(If no, end)
Q.46. How often do you use the internet? (Please select one only)
□ 1 D4
Everyday Less often
Less than everyday, but at D2 Never E 5
least once a week
Less often than once a week, D3 _  ,. . D6. . . , . .. Don t knowbut a t least once a month
Thank you very much for your help and time with this project.
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My Way
Observer Comment Sheet 
Version 1-10 December 2004
Date___________
User ID________
Facilitators explanation of MyWay.
e.g. Language used, questions raised by young person.
Use of MyWay
e.g. Process
Understanding of output
e.g. Questions raised about the output
Other
e.g. Observer opinions on how young person engaged with program
Questionnaire start  end.
MyWay use start_______ end_
Interview start  end
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A computer program to facilitate informed contraceptive choice by teenagers
("My Way")
Topic guide for ex it interviews: Pilot 
Version 4 -  3rd December, 2004
A.  About the My Way website
What do you think about the web site?
Would you recommend this site to a friend? Why yes/ n o ? .................
Design -homepage, main headings, menu, ease of navigation
Colour -background, text, graphics, artwork, logo
Language -tone, wording, font legibility
Best/worst features 
Omissions/ comments
B. About the information provided
information provided on the website?
availability of "help", clarifications
info on STIs, contraception, new information learnt, links
too complicated, specify... 
too simple, specify...
Missing info/links/ comments
What did you think about the
Clarity of instructions/ purpose 
Usefulness
Level information was pitched at
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C. Experience of using My Way
What was your experience of using the program?
How has the experience compared with other times you have discussed contraception with a 
doctor or nurse?
What setting would you like to consult MyWay in?
Would you use it completely on your own (after an introduction)?
What did you like about it?
What would you change?
Omissions/ comments
About decision making model
Are there other factors besides those listed, you would like to consider when 
thinking about contraception?
Were you surprised about the options which scored highest for you?
Was it useful to include your personal 'concerns' in choosing a contraceptive method for you? 
Is  it likely that you will use the method that scored highest for you? Why y e s / no?
About your decision making process
Was the whole experience useful in thinking about making contraceptive choices?
Was the MyWay experience useful in developing your ability to think about other sorts of life 
choices you face?
Do you understand how incorporating your personal 'concerns' a ffects  your contraceptive 
choice?
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C. Experience of using My Way
What was your experience of using the program?
How has the experience compared with other times you have discussed contraception with a 
doctor or nurse?
What setting would you like to consult MyWay in?
Would you use it completely on your own (after an introduction)?
What did you like about it?
What would you change?
Omissions/ comments
About decision making model
Are there other factors besides those listed, you would like to consider when 
thinking about contraception?
Were you surprised about the options which scored highest for you?
Was it useful to include your personal 'concerns' in choosing a contraceptive method for you? 
Is  it likely that you will use the method that scored highest for you? Why y e s / no?
About your decision making process
Was th e  whole experience useful in thinking about making contraceptive choices?
Was the MyWay experience useful in developing your ability to think about other sorts of life 
choices you face?
Do you understand how incorporating your personal ’concerns' a ffec ts  your contraceptive 
choice?
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